200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 750512-03-9
750512-03-9 | 4-(DIMETHYLTRIAZENO)IMIDAZOLE-5-CARBOXAMIDE
CAS No: 750512-03-9 Catalog No: AG01DKWA MDL No:
Product Description
Catalog Number:
AG01DKWA
Chemical Name:
4-(DIMETHYLTRIAZENO)IMIDAZOLE-5-CARBOXAMIDE
CAS Number:
750512-03-9
IUPAC Name:
4-(dimethylaminodiazenyl)-1H-imidazole-5-carboxamide
InChI:
InChI=1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H2,7,13)(H,8,9)
InChI Key:
FDKXTQMXEQVLRF-UHFFFAOYSA-N
EC Number:
224-396-1
Properties
Complexity:
215
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
182.092g/mol
Formal Charge:
0
Heavy Atom Count:
13
Hydrogen Bond Acceptor Count:
5
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
182.187g/mol
Monoisotopic Mass:
182.092g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
99.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
1
XLogP3:
-0.6
Literature
| Title | Journal |
|---|---|
| Rare pulmonary primitive neuroectodermal tumor metastasizing to the right atrium: a case report. | Medical oncology (Northwood, London, England) 20121201 |
| Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma. | Leukemia & lymphoma 20121201 |
| Novel tubulin polymerization inhibitors overcome multidrug resistance and reduce melanoma lung metastasis. | Pharmaceutical research 20121101 |
| Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities. | The British journal of dermatology 20121101 |
| [Systemic therapy for malignant melanoma]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20121101 |
| Up-regulation of endogenous PML induced by a combination of interferon-beta and temozolomide enhances p73/YAP-mediated apoptosis in glioblastoma. | Cancer letters 20121028 |
| NK cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT. | Pediatric blood & cancer 20121001 |
| Comparison of two dosing schedules of palonosetron for the prevention of nausea and vomiting due to interleukin-2-based biochemotherapy. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20121001 |
| Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus. | Leukemia & lymphoma 20121001 |
| Vemurafenib: in unresectable or metastatic melanoma. | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20121001 |
| Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond. | Annals of the New York Academy of Sciences 20121001 |
| International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120920 |
| Hypopigmentation in the sites of regressed melanoma metastases after successful dacarbazine therapy. | International journal of dermatology 20120901 |
| A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival? | The British journal of radiology 20120901 |
| Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement. | International journal of radiation oncology, biology, physics 20120901 |
| AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts. | Cancer chemotherapy and pharmacology 20120901 |
| Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. | The Lancet. Oncology 20120901 |
| Glioblastoma therapy in the elderly: one age does not fit all. | The Lancet. Oncology 20120901 |
| How recent advances in immunotherapy are changing the standard of care for patients with metastatic melanoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20120901 |
| Non-uniform response to temozolomide therapy in a pituitary gonadotroph adenoma. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20120901 |
| A restricted cell population propagates glioblastoma growth after chemotherapy. | Nature 20120823 |
| Cancer: Resolving the stem-cell debate. | Nature 20120823 |
| Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120820 |
| Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas. | Cancer 20120801 |
| Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma. | Leukemia & lymphoma 20120801 |
| Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients. | Journal of surgical oncology 20120801 |
| Paradoxical relationship between the degree of EGFR amplification and outcome in glioblastomas. | The American journal of surgical pathology 20120801 |
| Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model. | Biomaterials 20120801 |
| A rare case of primary rhabdoid melanoma of the urinary bladder treated with ipilimumab, an anti-CTLA 4 monoclonal antibody. | Melanoma research 20120801 |
| ABVD vs. radiotherapy in early stage Hodgkin's lymphoma: A critical look at the NCIC HD.6 trial. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120801 |
| Elderly people with glioblastoma. | The Lancet. Oncology 20120801 |
| Elderly people with glioblastoma. | The Lancet. Oncology 20120801 |
| [Soft-tissue sarcoma: recent developments]. | Deutsche medizinische Wochenschrift (1946) 20120801 |
| BRAF inhibition and beyond in advanced melanoma. | Lancet (London, England) 20120728 |
| Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. | Lancet (London, England) 20120728 |
| Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120720 |
| Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro. | Oncogene 20120719 |
| Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies. | Journal of the National Cancer Institute 20120718 |
| In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines. | International journal of cancer 20120715 |
| Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma. | Cancer research 20120715 |
| Improved survival with MEK inhibition in BRAF-mutated melanoma. | The New England journal of medicine 20120712 |
| [Diagnostic difficulties caused by a pulmonary infiltrate]. | Orvosi hetilap 20120708 |
| Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents. | International journal of cancer 20120701 |
| The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma. | Gene therapy 20120701 |
| Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient. | Cancer immunology, immunotherapy : CII 20120701 |
| Adolescents with Hodgkin lymphoma: old children or young adults? | Leukemia & lymphoma 20120701 |
| Effects of chemotherapeutics on organotypic corticostriatal slice cultures identified by a panel of fluorescent and immunohistochemical markers. | Neurotoxicity research 20120701 |
| Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20120701 |
| ABVD as the treatment option in advanced Hodgkin's lymphoma patients older than 45 years. | Pathology oncology research : POR 20120701 |
| Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments. | Journal of cellular biochemistry 20120701 |
| Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy. | Journal of neuro-oncology 20120701 |
| Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy. | Journal of neuro-oncology 20120701 |
| Management of highly emetogenic chemotherapy. | Current opinion in oncology 20120701 |
| Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma. | International journal of pharmaceutics 20120701 |
| Combined therapy of temozolomide and ZD6474 (vandetanib) effectively reduces glioblastoma tumor volume through anti-angiogenic and anti-proliferative mechanisms. | Molecular medicine reports 20120701 |
| Cerebral ganglioneuroblastoma of adult onset: two patients and a review of the literature. | Clinical neurology and neurosurgery 20120701 |
| Fatal pneumonia associated with temozolomide therapy in patients with malignant glioma. | Japanese journal of clinical oncology 20120701 |
| Treatment of newly diagnosed advanced stage Hodgkin lymphoma. | Blood reviews 20120701 |
| Drug-induced cholestatic hepatitis: how late can it occur even after the cessation of the culpable drug? | Neuro-oncology 20120701 |
| Prognosis of pediatric high-grade gliomas with temozolomide treatment: a retrospective, multicenter study. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20120701 |
| Treatment of elderly patients with glioblastoma. | The Lancet. Oncology 20120701 |
| Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. | The Lancet. Oncology 20120701 |
| Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO). | Anti-cancer drugs 20120701 |
| The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas. | Cancer chemotherapy and pharmacology 20120701 |
| Vemurafenib in patients with BRAF V600E mutation-positive advanced melanoma. | Clinical therapeutics 20120701 |
| New therapeutic agents in uveal melanoma. | Anticancer research 20120701 |
| MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells. | Anticancer research 20120701 |
| Chemotherapy-associated steatohepatitis with temozolomide and dexamethasone. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20120701 |
| Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD. | Blood 20120621 |
| Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide. | American journal of clinical oncology 20120601 |
| Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience. | Cancer 20120601 |
| Successful administration of rituximab-bendamustine regimen in the relapse of Hodgkin lymphoma after autologous hemopoietic stem cell transplantation. | Hematological oncology 20120601 |
| Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial. | Acta neuropathologica 20120601 |
| Temozolomide in the management of dopamine agonist-resistant prolactinomas. | Clinical endocrinology 20120601 |
| Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment. | Clinical endocrinology 20120601 |
| Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway. | Oncology reports 20120601 |
| Towards personalized medicine with a three-dimensional micro-scale perfusion-based two-chamber tissue model system. | Biomaterials 20120601 |
| A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine. | European journal of endocrinology 20120601 |
| Pancreatic neuroendocrine and carcinoid tumors: what's new, what's old, and what's different? | Current oncology reports 20120601 |
| Temozolomide dosing regimens for glioma patients. | Current neurology and neuroscience reports 20120601 |
| SSBP2 variants are associated with survival in glioblastoma patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120601 |
| Multiple endocrine neoplasia type 2A. | The Kaohsiung journal of medical sciences 20120601 |
| Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy. | The Korean journal of hematology 20120601 |
| Ipilimumab. Immunostimulant; more assessment needed. | Prescrire international 20120601 |
| Positional periodic alternating vertical nystagmus with PCA-Tr antibodies in Hodgkin lymphoma. | Neurology 20120529 |
| Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma. | Blood 20120503 |
| Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma. | Blood 20120503 |
| Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy. | International journal of radiation oncology, biology, physics 20120501 |
| Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study. | Leukemia & lymphoma 20120501 |
| Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. | International journal of radiation oncology, biology, physics 20120501 |
| Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery. | International journal of radiation oncology, biology, physics 20120501 |
| Progressive pericardial effusion during chemotherapy for advanced Hodgkin lymphoma. | American journal of hematology 20120501 |
| DESI-MS2: a rapid and innovative method for trace analysis of six cytostatic drugs in health care setting. | Analytical and bioanalytical chemistry 20120501 |
| Prognostic significance of MRP5 immunohistochemical expression in glioblastoma. | Cancer chemotherapy and pharmacology 20120501 |
| Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia. | European journal of haematology 20120501 |
| CXCL12 mediates apoptosis resistance in rat C6 glioma cells. | Oncology reports 20120501 |
| Narrowing the knowledge gaps for melanoma. | Upsala journal of medical sciences 20120501 |
| Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy. | Clinical neurology and neurosurgery 20120501 |
| Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system. | Neuro-oncology 20120501 |
| Successful pregnancy and delivery after concomitant temozolomide and radiotherapy treatment of glioblastoma multiforme. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20120501 |
| In vitro evaluation of combined temozolomide and radiotherapy using X rays and high-linear energy transfer radiation for glioblastoma. | Radiation research 20120501 |
| The next challenge in cancer immunotherapy: controlling T-cell traffic to the tumor. | Cancer research 20120501 |
| Interdigitating dendritic cell sarcoma occured alone in axilla. | Journal of the Korean Surgical Society 20120501 |
| Molecular mechanisms of temozolomide resistance in glioblastoma multiforme. | Expert review of anticancer therapy 20120501 |
| BRIM-1, -2 and -3 trials: improved survival with vemurafenib in metastatic melanoma patients with a BRAF(V600E) mutation. | Future oncology (London, England) 20120501 |
| Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor. | Future oncology (London, England) 20120501 |
| Radiation necrosis of a high-grade glioma. | Medicine and health, Rhode Island 20120501 |
| Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma. | Acta histochemica et cytochemica 20120426 |
| Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection. | AIDS (London, England) 20120424 |
| Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries. | Cancer 20120415 |
| Metastatic melanoma and vemurafenib: novel approaches. | Rare tumors 20120412 |
| A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial. | Investigational new drugs 20120401 |
| Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. | International journal of radiation oncology, biology, physics 20120401 |
| Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120401 |
| Cerebellar gliomatosis in a toddler: case report of a challenging condition and review of the literature. | Journal of child neurology 20120401 |
| Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour. | Acta oncologica (Stockholm, Sweden) 20120401 |
| Glioblastoma survival in the United States before and during the temozolomide era. | Journal of neuro-oncology 20120401 |
| Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor. | Journal of neuro-oncology 20120401 |
| Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience. | Journal of neuro-oncology 20120401 |
| Going past the data for temozolomide. | Cancer chemotherapy and pharmacology 20120401 |
| Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme. | Acta oncologica (Stockholm, Sweden) 20120401 |
| [Involved-node radiotherapy combined with deep-inspiration breath-hold technique in patients with Hodgkin lymphoma]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20120401 |
| Temozolomide for pediatric high-grade gliomas. | Current neurology and neuroscience reports 20120401 |
| Responsive fluorescent Bi(2)O(3)@PVA hybrid nanogels for temperature-sensing, dual-modal imaging, and drug delivery. | Biomaterials 20120401 |
| Upcoming strategies for the treatment of metastatic melanoma. | Archives of dermatological research 20120401 |
| Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma. | Neuro-oncology 20120401 |
| Sorafenib in melanoma. | Expert opinion on investigational drugs 20120401 |
| Temozolomide and other potential agents for the treatment of glioblastoma multiforme. | Neurosurgery clinics of North America 20120401 |
| Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series. | Neurosurgery clinics of North America 20120401 |
| Temozolomide-associated bronchiolitis obliterans organizing pneumonia successfully treated with high-dose corticosteroid. | Journal of Korean medical science 20120401 |
| [New toxicity of fotemustine: diffuse interstitial lung disease]. | Annales de dermatologie et de venereologie 20120401 |
| Radiotherapy with concurrent or sequential temozolomide in elderly patients with glioblastoma multiforme. | Journal of medical imaging and radiation oncology 20120401 |
| Malignant melanoma of unknown primary origin presenting as cardiac metastasis. | Korean circulation journal 20120401 |
| Kinase inhibitors for advanced medullary thyroid carcinoma. | Clinics (Sao Paulo, Brazil) 20120401 |
| [Retrospective analysis of 157 patients with pediatric Hodgkin lymphoma in Japan: investigation by four pediatric cancer study groups]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20120401 |
| Helping patients make the best decision regarding duration of temozolomide chemotherapy treatment. | Continuum (Minneapolis, Minn.) 20120401 |
| Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120320 |
| Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control. | Cell cycle (Georgetown, Tex.) 20120315 |
| Failure of temozolomide and conventional doses of pegvisomant to attain biochemical control in a severe case of acromegaly. | Pituitary 20120301 |
| Management of anorectal melanoma: report of 17 cases and literature review. | Journal of gastrointestinal cancer 20120301 |
| Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinoma. | Medical oncology (Northwood, London, England) 20120301 |
| Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas. | International journal of cancer 20120301 |
| Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20120301 |
| High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20120301 |
| Bevacizumab and daily temozolomide for recurrent glioblastoma. | Cancer 20120301 |
| The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management. | Leukemia & lymphoma 20120301 |
| New targeted therapies in pituitary carcinoma resistant to temozolomide. | Pituitary 20120301 |
| Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial. | Leukemia & lymphoma 20120301 |
| O⁶-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment. | Journal of neuro-oncology 20120301 |
| Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines. | Journal of neuro-oncology 20120301 |
| Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation. | Journal of neuro-oncology 20120301 |
| Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status. | Oncology reports 20120301 |
| Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells. | International journal of oncology 20120301 |
| Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. | Journal of cancer research and clinical oncology 20120301 |
| Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006. | Neuro-oncology 20120301 |
| A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054). | Neuro-oncology 20120301 |
| Twice-daily dosing of temozolomide in combination with fotemustine for the treatment of patients with refractory glioblastoma. | Anticancer research 20120301 |
| Synthetic lethality of cohesins with PARPs and replication fork mediators. | PLoS genetics 20120301 |
| Isolated limb perfusion with hyperthermia and chemotherapy: predictive factors for regional toxicity. | Clinics (Sao Paulo, Brazil) 20120301 |
| Treatment strategies for Hodgkin lymphoma recurring following autologous hematopoietic stem cell transplantation. | The Korean journal of hematology 20120301 |
| The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival. | Oncotarget 20120301 |
| Present status and problems on molecular targeted therapy of cancer. | Cancer research and treatment : official journal of Korean Cancer Association 20120301 |
| The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models. | British journal of cancer 20120227 |
| Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120215 |
| Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120215 |
| Cardiac tumors in a tertiary care cancer hospital: clinical features, echocardiographic findings, treatment and outcomes. | Heart international 20120203 |
| Chemotherapy alone for early-stage Hodgkin's lymphoma. | The New England journal of medicine 20120202 |
| ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma. | The New England journal of medicine 20120202 |
| Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas. | International journal of radiation oncology, biology, physics 20120201 |
| Phase I clinical trial assessing temozolomide and tamoxifen with concomitant radiotherapy for treatment of high-grade glioma. | International journal of radiation oncology, biology, physics 20120201 |
| First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). | Annals of oncology : official journal of the European Society for Medical Oncology 20120201 |
| Low incidence of long-term respiratory impairment in Hodgkin lymphoma survivors. | Annals of hematology 20120201 |
| Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option. | International journal of radiation oncology, biology, physics 20120201 |
| Predictive models for pulmonary function changes after radiotherapy for breast cancer and lymphoma. | International journal of radiation oncology, biology, physics 20120201 |
| Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients. | Leukemia research 20120201 |
| Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL). | Annals of hematology 20120201 |
| A phase I study of bortezomib and temozolomide in patients with advanced solid tumors. | Cancer chemotherapy and pharmacology 20120201 |
| A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study. | Journal of neuro-oncology 20120201 |
| New treatment strategies in advanced neuroendocrine tumours. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20120201 |
| Efficacy and toxicity of CyberKnife re-irradiation and 'dose dense' temozolomide for recurrent gliomas. | Acta neurochirurgica 20120201 |
| Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis. | Acta neurochirurgica 20120201 |
| Health-related quality of life among patients with metastatic melanoma: results from an international phase 2 multicenter study. | Melanoma research 20120201 |
| IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma. | Cancer science 20120201 |
| Avastin: more questions than answers. . | Journal of neurosurgery 20120201 |
| A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma. | Journal of neurosurgery 20120201 |
| Current and emerging treatment options for castration-resistant prostate cancer: a focus on immunotherapy. | Journal of clinical immunology 20120201 |
| LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway. | Molecular medicine reports 20120201 |
| Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03). | European journal of cancer (Oxford, England : 1990) 20120201 |
| Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. | Biomaterials 20120201 |
| Lymphoma study group of JCOG. | Japanese journal of clinical oncology 20120201 |
| Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. | Nature genetics 20120201 |
| Reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide: changes defined by 18F-fluoromisonidazole positron emission tomography: two case reports. | Japanese journal of clinical oncology 20120201 |
| Radiotherapy with and without temozolomide in elderly patients with glioblastoma. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120201 |
| Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours. | Endocrine-related cancer 20120201 |
| [Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab]. | Bulletin du cancer 20120201 |
| Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: a randomised phase II trial. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120201 |
| Multidisciplinary treatment and long-term outcomes in six patients with leiomyosarcoma of the inferior vena cava. | Journal of the Korean Surgical Society 20120201 |
| [Sustained remission of blastic plasmacytoid dendritic cell neoplasm with ABVD chemotherapy]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20120201 |
| Hematological cancer: Localized non-bulky Hodgkin lymphoma--future questions. | Nature reviews. Clinical oncology 20120131 |
| Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120120 |
| TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells. | International journal of cancer 20120115 |
| Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120115 |
| Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. | Free radical biology & medicine 20120115 |
| Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120115 |
| Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block. | Cancer biology & therapy 20120115 |
| Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells. | Journal of the National Cancer Institute 20120104 |
| Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma. | British journal of cancer 20120103 |
| Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients. | The Journal of clinical investigation 20120103 |
| Enhancing melanoma treatment with resveratrol. | The Journal of surgical research 20120101 |
| Irradiation and bevacizumab in high-grade glioma retreatment settings. | International journal of radiation oncology, biology, physics 20120101 |
| Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas. | International journal of radiation oncology, biology, physics 20120101 |
| Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme. | International journal of radiation oncology, biology, physics 20120101 |
| Hematologic adverse events associated with temozolomide. | Cancer chemotherapy and pharmacology 20120101 |
| [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications]. | Revista espanola de medicina nuclear e imagen molecular 20120101 |
| Clinical outcome in children and adolescents with Hodgkin lymphoma after treatment with chemotherapy alone - the results of the United Kingdom HD3 national cohort trial. | European journal of cancer (Oxford, England : 1990) 20120101 |
| Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status. | Journal of neuro-oncology 20120101 |
| Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression. | Journal of neuro-oncology 20120101 |
| Intravenous administration of temozolomide as a useful alternative over oral treatment with temozolomide capsules in patients with gliomas. | Journal of neuro-oncology 20120101 |
| Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study. | Leukemia & lymphoma 20120101 |
| Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life. | Journal of neuro-oncology 20120101 |
| Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. | Journal of neuro-oncology 20120101 |
| Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20120101 |
| MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis. | International journal of oncology 20120101 |
| Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen. | Cell biochemistry and biophysics 20120101 |
| Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients. | European journal of nuclear medicine and molecular imaging 20120101 |
| Fatal leptomeningeal melanoma in neurocutaneous melanosis. | Pediatric dermatology 20120101 |
| Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation. | Journal of oncology 20120101 |
| Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents. | Pigment cell & melanoma research 20120101 |
| Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study. | Neuro-oncology 20120101 |
| Ipilimumab, a promising immunotherapy with increased overall survival in metastatic melanoma? | Dermatology research and practice 20120101 |
| Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). | Gut 20120101 |
| Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia. | American journal of hematology 20120101 |
| Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120101 |
| Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120101 |
| Biomarkers as key contributors in treating malignant melanoma metastases. | Dermatology research and practice 20120101 |
| Evolving drug targets in DNA base excision repair for cancer therapy. | Current molecular pharmacology 20120101 |
| Temozolomide: mechanisms of action, repair and resistance. | Current molecular pharmacology 20120101 |
| Juvenile angiofibroma: evolution of management. | International journal of pediatrics 20120101 |
| Primary malignant melanoma of the stomach: report of a case. | Surgery today 20120101 |
| Volumetric and MGMT parameters in glioblastoma patients: survival analysis. | BMC cancer 20120101 |
| Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma. | Dermatology research and practice 20120101 |
| Successful treatment of leptomeningeal gliomatosis of pilomyxoid astrocytoma after failed frontline chemotherapy. | The neurologist 20120101 |
| Antiproliferative and apoptosis-inducing effects of lipophilic vitamins on human melanoma A375 cells in vitro. | Biological & pharmaceutical bulletin 20120101 |
| Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1. | Journal of translational medicine 20120101 |
| Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma. | PloS one 20120101 |
| Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel. | Cancer investigation 20120101 |
| Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab Vedotin. | Clinical Medicine Insights. Oncology 20120101 |
| Safety and efficacy of everolimus in adult patients with neuroendocrine tumors. | Clinical Medicine Insights. Oncology 20120101 |
| Novel treatments for metastatic cutaneous melanoma and the management of emergent toxicities. | Clinical Medicine Insights. Oncology 20120101 |
| Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma. | BMC cancer 20120101 |
| HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART. | Advances in hematology 20120101 |
| Development, characterization, and in vitro evaluation of tamoxifen microemulsions. | Journal of drug delivery 20120101 |
| Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG. | Radiation oncology (London, England) 20120101 |
| Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells. | Oncotarget 20120101 |
| Status quo--standard-of-care medical and radiation therapy for glioblastoma. | Cancer journal (Sudbury, Mass.) 20120101 |
| Monoclonal antibodies and Fc fragments for treating solid tumors. | Biologics : targets & therapy 20120101 |
| Eribulin mesylate in the treatment of metastatic breast cancer. | Biologics : targets & therapy 20120101 |
| Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate. | Case reports in dermatology 20120101 |
| Modulation of tumor tolerance in primary central nervous system malignancies. | Clinical & developmental immunology 20120101 |
| Current management and novel agents for malignant melanoma. | Journal of hematology & oncology 20120101 |
| The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma. | Cancer management and research 20120101 |
| [Sequential monitoring of plasma EBV-DNA level in a patient with EBV-positive Hodgkin lymphoma]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20120101 |
| Therapy for metastatic melanoma: the past, present, and future. | BMC medicine 20120101 |
| MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR. | Journal of translational medicine 20120101 |
| Translatability scoring in drug development: eight case studies. | Journal of translational medicine 20120101 |
| AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy. | Advances in hematology 20120101 |
| Targeted agents for the treatment of metastatic melanoma. | OncoTargets and therapy 20120101 |
| Companion diagnostics: changing patient management. | Ecancermedicalscience 20120101 |
| Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma. | PloS one 20120101 |
| The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action. | BMC cancer 20120101 |
| The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond. | TheScientificWorldJournal 20120101 |
| NF-κB as potential target in the treatment of melanoma. | Journal of translational medicine 20120101 |
| Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts. | Radiation oncology (London, England) 20120101 |
| A randomized trial of brief treatment of early- stage Hodgkin lymphoma: Is it effective? | Hematology/oncology and stem cell therapy 20120101 |
| Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. | PloS one 20120101 |
| Atypical, invasive, recurring Crooke cell adenoma of the pituitary. | Hormones (Athens, Greece) 20120101 |
| Antiproliferative and Proapoptotic Effects of Labisia pumila Ethanol Extract and Its Active Fraction in Human Melanoma HM3KO Cells. | Evidence-based complementary and alternative medicine : eCAM 20120101 |
| Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival. | Molecular cancer 20120101 |
| Liposarcoma of the nasopharynx: diagnosis and management of a rare diagnostic entity. | Case reports in medicine 20120101 |
| Multifocal capillary hemangioma (hemangiomatosis) of the spleen. | Tumori 20120101 |
| Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death. | PloS one 20120101 |
| Targeting costimulatory molecules to improve antitumor immunity. | Journal of biomedicine & biotechnology 20120101 |
| Cryopreservation of ovarian tissue in pediatric patients. | Obstetrics and gynecology international 20120101 |
| Treatment of liver metastases in patients with neuroendocrine tumors of gastroesophageal and pancreatic origin. | International journal of hepatology 20120101 |
| A multimodal approach to the management of neuroendocrine tumour liver metastases. | International journal of hepatology 20120101 |
| Immunomodulating antibodies in the treatment of metastatic melanoma: the experience with anti-CTLA-4, anti-CD137, and anti-PD1. | Journal of immunotoxicology 20120101 |
| Proceedings of tumor board meeting. | Journal of Indian Association of Pediatric Surgeons 20120101 |
| Cancer, fertility preservation, and future pregnancy: a comprehensive review. | Obstetrics and gynecology international 20120101 |
| Survival outcome and neurotoxicity in patients of high-grade gliomas treated with conformal radiation and temozolamide. | Journal of cancer research and therapeutics 20120101 |
| Cell cycle gene networks are associated with melanoma prognosis. | PloS one 20120101 |
| Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials. | PloS one 20120101 |
| Metronomic chemotherapy with the COMBAT regimen in advanced pediatric malignancies: a multicenter experience. | Oncology 20120101 |
| High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma. | Hematology (Amsterdam, Netherlands) 20120101 |
| The role of BRAF V600 mutation in melanoma. | Journal of translational medicine 20120101 |
| Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame. | PloS one 20120101 |
| Solitary fibrous tumors and so-called hemangiopericytoma. | Sarcoma 20120101 |
| Melanoma vaccines and modulation of the immune system in the clinical setting: building from new realities. | Frontiers in immunology 20120101 |
| A retrospective pooled analysis of response patterns and risk factors in recurrent malignant glioma patients receiving a nitrosourea-based chemotherapy. | Journal of translational medicine 20120101 |
| Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. | Clinical sarcoma research 20120101 |
| Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment. | Clinical sarcoma research 20120101 |
| An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma. | Clinical sarcoma research 20120101 |
| Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report. | Journal of medical case reports 20120101 |
| Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles. | International journal of nanomedicine 20120101 |
| 'Malignant' perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. | Sarcoma 20120101 |
| [The optimal radiation volume after first-line chemotherapy in Hodgkin lymphoma]. | Voprosy onkologii 20120101 |
| [Role of response to first-line chemotherapy and of the primary lesion in Hodgkin lymphoma]. | Voprosy onkologii 20120101 |
| [Primary refractory and relapsed Hodgkin lymphoma with unfavorable prognosis]. | Voprosy onkologii 20120101 |
| Recent medical management of glioblastoma. | Advances in experimental medicine and biology 20120101 |
| Prolonged survival in a patient with neuroendocrine tumor of the cecum and diffuse peritoneal carcinomatosis. | Case reports in gastroenterology 20120101 |
| Alveolar soft part sarcoma: a single-center 26-patient case series and review of the literature. | Sarcoma 20120101 |
| Bladder Carcinoma after ABVD Chemotherapy for Hodgkin's Lymphoma: A Case Report. | Case reports in oncology 20120101 |
| Melanoma chemotherapy leads to the selection of ABCB5-expressing cells. | PloS one 20120101 |
| Tamoxifen in trimodal therapy with cytotoxic drugs and hyperthermia in vivo significantly enhance therapeutic efficacy against B16-F10 melanoma. | Tumori 20120101 |
| Symptomatic pericardial effusion in Hodgkin's lymphoma: a rare occurrence. Case report and review of the literature. | Tumori 20120101 |
| An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review. | Case reports in medicine 20120101 |
| Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases. | Dermatology research and practice 20120101 |
| The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy. | Mediterranean journal of hematology and infectious diseases 20120101 |
| Long term experience in high grade glial tumors with temozolomide. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20120101 |
| Inhibition of Na(+)-K(+)-2Cl(-) cotransporter isoform 1 accelerates temozolomide-mediated apoptosis in glioblastoma cancer cells. | Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20120101 |
| [Relapse in Hodgkin lymphoma]. | Voprosy onkologii 20120101 |
| Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols. | Journal of hematology & oncology 20120101 |
| [Temodal--an alkylating cytostatic agent. Effectiveness in patients with malignant gliomas]. | Voprosy onkologii 20120101 |
| Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma. | PloS one 20120101 |
| Long-term survival in metastatic malignant melanoma: ipilimumab followed by vemurafenib in a patient with brain metastasis. | Internal medicine (Tokyo, Japan) 20120101 |
| New therapeutical strategies in the treatment of metastatic disease. | Dermatologic therapy 20120101 |
| Lymphocyte-depleted Hodgkin lymphoma complicating hemophagocytic lymphohistiocytosis as an initial manifestation: a case report and review of the literature. | Internal medicine (Tokyo, Japan) 20120101 |
| Noscapine inhibits tumor growth in TMZ-resistant gliomas. | Cancer letters 20111222 |
| A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20111215 |
| Re-evaluating PARP1 inhibitor in cancer. | Nature biotechnology 20111208 |
| Predicting the myelotoxicity of chemotherapy: the use of pretreatment O6-methylguanine-DNA methyltransferase determination in peripheral blood mononuclear cells. | Melanoma research 20111201 |
| Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor. | Pituitary 20111201 |
| A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma. | International journal of radiation oncology, biology, physics 20111201 |
| Primary gastric Hodgkin lymphoma and metachronous early gastric carcinoma: a case report. | Medical oncology (Northwood, London, England) 20111201 |
| MGMT immunoexpression in adamantinomatous craniopharyngiomas. | Pituitary 20111201 |
| The status of Tsukuba BNCT trial: BPA-based boron neutron capture therapy combined with X-ray irradiation. | Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20111201 |
| Phase II clinical study of boron neutron capture therapy combined with X-ray radiotherapy/temozolomide in patients with newly diagnosed glioblastoma multiforme--study design and current status report. | Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20111201 |
| Primary gliosarcoma--clinical experience from a regional cancer centre in north India. | British journal of neurosurgery 20111201 |
| Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site. | Annals of surgical oncology 20111201 |
| Leptomeningeal dissemination of anaplastic glioma: prolonged survival in two patients treated with temozolomide. | Journal of neuro-oncology 20111201 |
| [Descriptive analysis of cutaneous recurrence patterns in patients with melanoma]. | Actas dermo-sifiliograficas 20111201 |
| A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma. | Journal of neuro-oncology 20111201 |
| O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry. | Biochimica et biophysica acta 20111201 |
| Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas. | European journal of haematology 20111201 |
| Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. | Neuro-oncology 20111201 |
| Communicating hydrocephalus following surgery and adjuvant radiochemotherapy for glioblastoma. | Journal of neurosurgery 20111201 |
| Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin. | Journal of neurosurgery 20111201 |
| MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis. | Stem cells (Dayton, Ohio) 20111201 |
| Reirradiation and concomitant metronomic temozolomide: an efficient combination for local control in medulloblastoma disease? | Journal of pediatric hematology/oncology 20111201 |
| Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trial. | Melanoma research 20111201 |
| Fotemustine for the treatment of melanoma. | Expert opinion on pharmacotherapy 20111201 |
| Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy? | Experimental dermatology 20111201 |
| [Intensity-modulated radiotherapy and involved-node concept in patients with Hodgkin lymphoma: experience of the Gustave-Roussy Institute]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20111201 |
| Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide: a 10-year experience at a single institution. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20111201 |
| Early post-treatment pseudo-progression amongst glioblastoma multiforme patients treated with radiotherapy and temozolomide: a retrospective analysis. | Journal of medical imaging and radiation oncology 20111201 |
| Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells. | Cell death & disease 20111201 |
| Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear. | The Yale journal of biology and medicine 20111201 |
| Ipilimumab and cancer immunotherapy: a new hope for advanced stage melanoma. | The Yale journal of biology and medicine 20111201 |
| Retrospective study of patients with brain metastases from melanoma receiving concurrent whole-brain radiation and temozolomide. | Anticancer research 20111201 |
| Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects. | Oncotarget 20111201 |
| Angiotropic metastatic malignant melanoma in a canine mammary gland. | Laboratory animal research 20111201 |
| Expression of EGFRvIII in glioblastoma: prognostic significance revisited. | Neoplasia (New York, N.Y.) 20111201 |
| Select interviews from the 2011 San Antonio Breast Cancer Symposium (SABCS) and American Society of Hematology (ASH) Annual Meeting. | Oncology (Williston Park, N.Y.) 20111201 |
| [Dacarbazine, a chemotherapeutic against metastatic melanoma and a reference drug for new treatment modalities]. | Postepy higieny i medycyny doswiadczalnej (Online) 20111123 |
| Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. | International journal of radiation oncology, biology, physics 20111115 |
| Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control. | Cancer research 20111115 |
| Veliparib plus temozolomide in metastatic melanoma trends toward increased PFS but results are not statistically significant. | Oncology (Williston Park, N.Y.) 20111115 |
| Systemic management strategies for metastatic soft tissue sarcoma. | Drugs 20111112 |
| Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110 |
| Can the therapeutic effects of temozolomide be potentiated by stimulating AMP-activated protein kinase with olanzepine and metformin? | British journal of pharmacology 20111101 |
| Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. | Cancer 20111101 |
| Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic. | Journal of neuro-oncology 20111101 |
| Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine. | Acta oncologica (Stockholm, Sweden) 20111101 |
| Using different schedules of Temozolomide to treat low grade gliomas: systematic review of their efficacy and toxicity. | Journal of neuro-oncology 20111101 |
| MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20111101 |
| Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20111101 |
| Application of homology modeling to generate CYP1A1 mutants with enhanced activation of the cancer chemotherapeutic prodrug dacarbazine. | Molecular pharmacology 20111101 |
| Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways. | Oncology reports 20111101 |
| Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs. | Chemistry and physics of lipids 20111101 |
| Conditional probability of survival in patients with newly diagnosed glioblastoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101 |
| Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101 |
| Loco-regional treatments in first-diagnosis glioblastoma: literature review on association between Stupp protocol and Gliadel. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20111101 |
| Rechallenge with temozolomide in recurrent glioma. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20111101 |
| Combination therapy with rituximab and temozolomide for recurrent and refractory primary central nervous system lymphoma. | Yonsei medical journal 20111101 |
| Vemurafenib (PLX4032): an orally available inhibitor of mutated BRAF for the treatment of metastatic melanoma. | The Annals of pharmacotherapy 20111101 |
| Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20111101 |
| Ipilimumab: showing survival benefit in metastatic melanoma. | Future oncology (London, England) 20111101 |
| [Linear porokeratosis]. | Annales de dermatologie et de venereologie 20111101 |
| Cell death forms and HSP70 expression in U87 cells after ionizing radiation and/or chemotherapy. | Anticancer research 20111101 |
| Prolonged administration of temozolomide in adult patients with anaplastic glioma. | Anticancer research 20111101 |
| Secondary gliosarcoma after the treatment of primary glioblastoma multiforme. | North American journal of medical sciences 20111101 |
| Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome. | Blood 20111027 |
| Small intestine perforation due to metastatic uterine cervix interdigitating dendritic cell sarcoma: a rare manifestation of a rare disease. | Rare tumors 20111021 |
| Malignant melanoma of the nasal cavity: a case report with examination of KIT and platelet derived growth factor receptor-α(PDGFRA). | Rare tumors 20111021 |
| Vemurafenib in melanoma with BRAF V600E mutation. | The New England journal of medicine 20111013 |
| Vemurafenib in melanoma with BRAF V600E mutation. | The New England journal of medicine 20111013 |
| Vemurafenib in melanoma with BRAF V600E mutation. | The New England journal of medicine 20111013 |
| Poly(methyl malate) nanoparticles: formation, degradation, and encapsulation of anticancer drugs. | Macromolecular bioscience 20111010 |
| Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence! | Nature reviews. Clinical oncology 20111004 |
| North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme. | International journal of radiation oncology, biology, physics 20111001 |
| Induction of autophagy in temozolomide treated malignant gliomas. | Neuropathology : official journal of the Japanese Society of Neuropathology 20111001 |
| Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution. | Annals of surgical oncology 20111001 |
| Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status. | European journal of clinical investigation 20111001 |
| Consolidative radiation therapy for stage III Hodgkin lymphoma in patients who achieve complete response after ABVD chemotherapy. | American journal of clinical oncology 20111001 |
| Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experience. | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20111001 |
| Analysis of the functional integrity of the p53 tumor-suppressor gene in malignant melanoma. | Melanoma research 20111001 |
| Temozolomide decreases invasion of glioma stem cells by down-regulating TGF-β2. | Oncology reports 20111001 |
| Chemoresistance as a function of the pretherapy tumor burden and the chemotherapy regimen administered: differences observed with 2 current chemotherapy regimens for advanced Hodgkin lymphoma. | Clinical lymphoma, myeloma & leukemia 20111001 |
| Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab. | Melanoma research 20111001 |
| Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition. | The Journal of investigative dermatology 20111001 |
| Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma. | Cancer chemotherapy and pharmacology 20111001 |
| MGMT immunoexpression in growth hormone-secreting pituitary adenomas and its correlation with Ki-67 labeling index and cytokeratin distribution pattern. | Endocrine 20111001 |
| [Glioblastoma in the elderly]. | Revue neurologique 20111001 |
| Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111001 |
| Barrett esophagus in long-term survivors of childhood solid tumors. | Journal of pediatric hematology/oncology 20111001 |
| Down-regulation of EGFR prolonged cell growth of glioma but did not increase the sensitivity to temozolomide. | Anticancer research 20111001 |
| Primary central nervous system lymphoma presenting as Parinaud syndrome. | Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20111001 |
| American Society of Clinical Oncology 2011 CNS tumors update. | Expert review of anticancer therapy 20111001 |
| Familial adenomatous polyposis and desmoid tumors. | Clinics (Sao Paulo, Brazil) 20111001 |
| [Anti-CTLA-4 monoclonal antibody: a major step in the treatment of metastatic melanoma]. | Medecine sciences : M/S 20111001 |
| Recurrent renal leiomyosarcoma mimicking a colonic submucosal tumor: a case report. | Journal of the Korean Society of Coloproctology 20111001 |
| Medical management of pheochromocytoma: Role of the endocrinologist. | Indian journal of endocrinology and metabolism 20111001 |
| Ipilimumab plus dacarbazine in melanoma. | The New England journal of medicine 20110929 |
| Ipilimumab plus dacarbazine in melanoma. | The New England journal of medicine 20110929 |
| Ipilimumab plus dacarbazine in melanoma. | The New England journal of medicine 20110929 |
| Early-stage progress on glioma vaccines. | Journal of the National Cancer Institute 20110921 |
| Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110920 |
| Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. | Neurology 20110920 |
| Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans. | Blood 20110915 |
| Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours. | British journal of cancer 20110906 |
| Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure. | Nature reviews. Clinical oncology 20110906 |
| Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats. | Medical oncology (Northwood, London, England) 20110901 |
| Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series. | International journal of radiation oncology, biology, physics 20110901 |
| Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab. | Journal of neuro-oncology 20110901 |
| MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas. | Journal of neuro-oncology 20110901 |
| A multicenter phase I trial of combination therapy with interferon-β and temozolomide for high-grade gliomas (INTEGRA study): the final report. | Journal of neuro-oncology 20110901 |
| Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05). | Journal of neuro-oncology 20110901 |
| Treatment of pituitary neoplasms with temozolomide: A review. | Cancer 20110901 |
| Temozolomide may induce therapy-related acute lymphoblastic leukaemia. | British journal of haematology 20110901 |
| The unique characteristics and management of patients over 60 years of age with classic Hodgkin lymphoma. | Current hematologic malignancy reports 20110901 |
| Effect of temozolomide on cell viability in gonadotroph adenoma cell lines. | Oncology reports 20110901 |
| Dacarbazine promotes stromal remodeling and lymphocyte infiltration in cutaneous melanoma lesions. | The Journal of investigative dermatology 20110901 |
| Chemotherapy only for localized Hodgkin lymphoma. | Journal of internal medicine 20110901 |
| Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110901 |
| YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma. | International journal of cancer 20110901 |
| Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteins. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110901 |
| New drugs in melanoma: it's a whole new world. | European journal of cancer (Oxford, England : 1990) 20110901 |
| Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas. | International journal of oncology 20110901 |
| In regard McDonald et al., to Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma (Int J Radiat Oncol Biol Phys 2011;79:130-136). | International journal of radiation oncology, biology, physics 20110901 |
| Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20110901 |
| Interaction of dacarbazine and imexon, in vitro and in vivo, in human A375 melanoma cells. | Anticancer research 20110901 |
| [Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma]. | Revue des maladies respiratoires 20110901 |
| Temozolomide induced liver injury. | Acta neurologica Belgica 20110901 |
| Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110815 |
| Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine. | The Journal of biological chemistry 20110812 |
| Rare phenomenon: liver metastases from glioblastoma multiforme. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110810 |
| Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma. | The Cochrane database of systematic reviews 20110810 |
| Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy. | Journal of neuro-oncology 20110801 |
| Cisplatin and temozolomide combination in the treatment of leptomeningeal carcinomatosis from ethmoid sinus intestinal-type adenocarcinoma. | Journal of neuro-oncology 20110801 |
| Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era. | Journal of neuro-oncology 20110801 |
| Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide. | Journal of neuro-oncology 20110801 |
| Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas. | Journal of neuro-oncology 20110801 |
| The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review. | British journal of neurosurgery 20110801 |
| Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. | International journal of cancer 20110801 |
| Complete remission of recurrent and refractory uterine epithelioid leiomyosarcoma using weekly administration of bevacizumab and temozolomide. | European journal of obstetrics, gynecology, and reproductive biology 20110801 |
| Seizure control: a secondary benefit of chemotherapeutic temozolomide in brain cancer patients. | Epilepsy research 20110801 |
| Immunotherapy for glioblastoma: the devil is in the details. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801 |
| Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801 |
| A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo. | Neuro-oncology 20110801 |
| Determination of temozolomide in serum and brain tumor with micellar electrokinetic capillary chromatography. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110801 |
| Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies. | British journal of cancer 20110726 |
| A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma. | British journal of cancer 20110726 |
| Targeted therapies: Improved outcomes for patients with metastatic melanoma. | Nature reviews. Clinical oncology 20110726 |
| ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned. | The New England journal of medicine 20110721 |
| Hodgkin's lymphoma--the great teacher. | The New England journal of medicine 20110721 |
| Efficacy of trabectedin in metastatic solitary fibrous tumor. | Rare tumors 20110711 |
| Strides in melanoma announced: maximizing value comes next. | Journal of the National Cancer Institute 20110706 |
| Synthesis of triazenoazaindoles: a new class of triazenes with antitumor activity. | ChemMedChem 20110704 |
| Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors. | Cancer chemotherapy and pharmacology 20110701 |
| Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study. | Journal of neuro-oncology 20110701 |
| Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma. | Journal of neuro-oncology 20110701 |
| Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma. | Journal of neuro-oncology 20110701 |
| Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial. | Journal of neuro-oncology 20110701 |
| MGMT promoter methylation and temozolomide response in choroid plexus carcinoma. | Brain tumor pathology 20110701 |
| Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells. | Cancer biology & therapy 20110701 |
| Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera? | Expert opinion on investigational drugs 20110701 |
| Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275. | Anti-cancer drugs 20110701 |
| Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110701 |
| Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032). | European journal of cancer (Oxford, England : 1990) 20110701 |
| Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110701 |
| Successful treatment of Hodgkin lymphoma in second trimester of pregnancy: feasibility of ABVD regimen. | International journal of hematology 20110701 |
| Glioblastoma: patterns of recurrence and efficacy of salvage treatments. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20110701 |
| Melanoma-associated retinopathy: a presenting sign of metastatic disease. | Journal of the American Academy of Dermatology 20110701 |
| Pancreatic endocrine tumors: a report on a patient treated with sorafenib. | Journal of Korean medical science 20110701 |
| Improved survival with vemurafenib in melanoma with BRAF V600E mutation. | The New England journal of medicine 20110630 |
| Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. | The New England journal of medicine 20110630 |
| Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110620 |
| Intrinsic anticancer drug resistance of malignant melanoma cells is abrogated by IFN-β and valproic acid. | Cancer research 20110615 |
| The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110615 |
| How fine a slice: treatment of newly diagnosed glioblastoma with an epidermal growth factor receptor variant III peptide vaccine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110610 |
| Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy. | British journal of cancer 20110607 |
| Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens. | British journal of cancer 20110607 |
| A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma. | Investigational new drugs 20110601 |
| Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide. | Journal of neuro-oncology 20110601 |
| Correlation of MRI sequences to assess progressive glioblastoma multiforme treated with bevacizumab. | Journal of neuro-oncology 20110601 |
| Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. | Journal of neuro-oncology 20110601 |
| Quantitative analysis of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas. | Journal of neuro-oncology 20110601 |
| Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA. | Journal of neuro-oncology 20110601 |
| Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis. | Acta oncologica (Stockholm, Sweden) 20110601 |
| A nanoemulsion formulation of dacarbazine reduces tumor size in a xenograft mouse epidermoid carcinoma model compared to dacarbazine suspension. | Nanomedicine : nanotechnology, biology, and medicine 20110601 |
| Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. | Journal of neurosurgery 20110601 |
| Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria. | European journal of nuclear medicine and molecular imaging 20110601 |
| Treatment of glioblastoma multiforme with radiotherapy and concomitant and adjuvant temozolomide: translation of randomised controlled trial evidence into routine clinical practice. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20110601 |
| Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: a report of two cases. | The journal of obstetrics and gynaecology research 20110601 |
| A mechanism of acquiring temozolomide resistance during transformation of atypical prolactinoma into prolactin-producing pituitary carcinoma: case report. | Neurosurgery 20110601 |
| [Benefit of a prolonged adjuvant treatment with temozolomide for the management of patients with glioblastoma]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20110601 |
| The insulin-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy. | Oncology reports 20110601 |
| Temozolomide chemoresistance heterogeneity in melanoma with different treatment regimens: DNA damage accumulation contribution. | Melanoma research 20110601 |
| Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia. | Melanoma research 20110601 |
| Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion. | Acta neurochirurgica 20110601 |
| Temozolomide and pituitary adenoma. | Journal of neurosurgery 20110601 |
| Overall survival and extent of surgery in adult versus elderly glioblastoma patients: A population based retrospective study. | Wiener klinische Wochenschrift 20110601 |
| Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging. | Journal of magnetic resonance imaging : JMRI 20110601 |
| Successful desensitization with temozolomide. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20110601 |
| Glioblastoma multiforme: enhancing survival and quality of life. | Clinical journal of oncology nursing 20110601 |
| International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. | Neuro-oncology 20110601 |
| Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761. | Neoplasia (New York, N.Y.) 20110601 |
| [Cutaneous neutrophils infiltrates. Case 4. Pseudo-tumoral cutaneous alternariosis]. | Annales de pathologie 20110601 |
| Thyroid functions in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy and radiotherapy. | Journal of clinical research in pediatric endocrinology 20110601 |
| [Problems of chemotherapy for glioma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110601 |
| Up-regulation of the DR5 expression by proteasome inhibitor MG132 augments TRAIL-induced apoptosis in soft tissue sarcoma cell lines. | Cancer research and treatment : official journal of Korean Cancer Association 20110601 |
| Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. | Blood 20110519 |
| Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110515 |
| Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110515 |
| Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study. | British journal of cancer 20110510 |
| Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110501 |
| Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme. | International journal of radiation oncology, biology, physics 20110501 |
| Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study. | Cancer chemotherapy and pharmacology 20110501 |
| A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma. | Journal of neuro-oncology 20110501 |
| Hepatic encephalopathy after treatment with temozolomide. | Journal of neuro-oncology 20110501 |
| Feasibility study of 21-day-on/7-day-off temozolomide in children with brain tumors. | Journal of neuro-oncology 20110501 |
| Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma. | Journal of neuro-oncology 20110501 |
| Immature and absolute platelet count changes and thrombocytopenia in malignant glioma. | European journal of clinical investigation 20110501 |
| Dopamine agonist-resistant prolactinomas. | Journal of neurosurgery 20110501 |
| The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma. | European journal of cancer (Oxford, England : 1990) 20110501 |
| Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group. | Leukemia & lymphoma 20110501 |
| In situ laser-induced photochemical silver substrate synthesis and sequential SERS detection in a flow cell. | Analytical and bioanalytical chemistry 20110501 |
| Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells. | Neuro-oncology 20110501 |
| N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide. | Neuro-oncology 20110501 |
| Temozolomide-induced modification of the CXC chemokine network in experimental gliomas. | International journal of oncology 20110501 |
| Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells. | International journal of radiation biology 20110501 |
| Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres. | British journal of haematology 20110501 |
| Genz-644282, a novel non-camptothecin topoisomerase I inhibitor for cancer treatment. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110501 |
| An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting. | Cancer chemotherapy and pharmacology 20110501 |
| Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma. | International journal of radiation oncology, biology, physics 20110501 |
| Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110501 |
| Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20110501 |
| Considering temozolomide as a novel potential treatment for esophageal cancer. | Cancer 20110501 |
| Radionuclide ventriculography detects early anthracycline cardiotoxicity in children with Hodgkin lymphoma. | Journal of pediatric hematology/oncology 20110501 |
| ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II. | Journal of the American College of Radiology : JACR 20110501 |
| PARP inhibitors stumble in breast cancer. | Nature biotechnology 20110501 |
| NRAS-mutant melanoma: response to chemotherapy. | Archives of dermatology 20110501 |
| The effect of PTEN on proliferation and drug-, and radiosensitivity in malignant glioma cells. | Anticancer research 20110501 |
| [News on melanoma from the 2010 Dermatology Days in Paris]. | Annales de dermatologie et de venereologie 20110501 |
| Early toxicity predicts long-term survival in high-grade glioma. | British journal of cancer 20110426 |
| Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study. | Cancer 20110415 |
| Humanized bone marrow mouse model as a preclinical tool to assess therapy-mediated hematotoxicity. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110415 |
| A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme. | Journal of neuro-oncology 20110401 |
| Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma. | Journal of neuro-oncology 20110401 |
| Kitten-transmitted Bordetella bronchiseptica infection in a patient receiving temozolomide for glioblastoma. | Journal of neuro-oncology 20110401 |
| Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide. | Journal of neuro-oncology 20110401 |
| Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20110401 |
| Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells. | Journal of cellular physiology 20110401 |
| Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide. | Journal of neurology, neurosurgery, and psychiatry 20110401 |
| Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment. | Pharmaceutical research 20110401 |
| The combi-targeting concept: mechanism of action of the pleiotropic combi-molecule RB24 and discovery of a novel cell signaling-based combination principle. | Cellular signalling 20110401 |
| Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model. | Biomaterials 20110401 |
| Primary Hodgkin's lymphoma of the rectum: an unusual presentation. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110401 |
| Response to temozolomide in patients with metastatic colorectal cancer with loss of MGMT expression: a new approach in the era of personalized medicine? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110401 |
| Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide. | Neuro-oncology 20110401 |
| O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma. | Brain tumor pathology 20110401 |
| Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme. | Neuro-oncology 20110401 |
| Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. | Neuro-oncology 20110401 |
| The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110401 |
| Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients. | British journal of haematology 20110401 |
| Combinational therapy of interferon-α and chemotherapy normalizes tumor vasculature by regulating pericytes including the novel marker RGS5 in melanoma. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20110401 |
| AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme. | Advances in therapy 20110401 |
| [A case of jejunal malignant melanoma diagnosed by enteroscopy and pre-operative biopsy]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110401 |
| [A case of recurrent malignant melanoma of esophagus responsive to combined chemotherapy, radiotherapy and cellular immunotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110401 |
| Response to nimotuzumab in a child with a progressive diffuse intrinsic pontine glioma. | Pediatrics international : official journal of the Japan Pediatric Society 20110401 |
| Phylogenetic discordance of human and canine carcinoembryonic antigen (CEA, CEACAM) families, but striking identity of the CEA receptors will impact comparative oncology studies. | PLoS currents 20110331 |
| Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy. | Neurology 20110329 |
| Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models. | Cancer letters 20110328 |
| A novel approach to overcome temozolomide resistance in glioma and melanoma: Inactivation of MGMT by gene therapy. | Biochemical and biophysical research communications 20110318 |
| Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair. | Cancer research 20110315 |
| BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group. | Blood 20110303 |
| One size for all in Hodgkin lymphoma? | Blood 20110303 |
| Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs. | Cancer chemotherapy and pharmacology 20110301 |
| Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article. | Journal of neurosurgery 20110301 |
| Marked response to imatinib mesylate in metastatic acral lentiginous melanoma on the thumb. | Clinical and experimental dermatology 20110301 |
| Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma. | Journal of neuro-oncology 20110301 |
| Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53. | Journal of neuro-oncology 20110301 |
| Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis. | Annals of oncology : official journal of the European Society for Medical Oncology 20110301 |
| Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy. | Japanese journal of clinical oncology 20110301 |
| Temozolomide for corticotroph pituitary adenomas refractory to standard therapy. | Pituitary 20110301 |
| High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecan. | Pediatric blood & cancer 20110301 |
| Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma. | Pediatric blood & cancer 20110301 |
| Advances in translational research provide a rationale for clinical re-evaluation of high-dose radiotherapy for glioblastoma. | Medical hypotheses 20110301 |
| Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma. | Neuro-oncology 20110301 |
| Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses. | British journal of haematology 20110301 |
| Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome. | Epigenetics 20110301 |
| PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo. | European journal of pharmacology 20110301 |
| Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse. | Journal of pediatric hematology/oncology 20110301 |
| MGMT is a molecular determinant for potency of the DNA-EGFR-combi-molecule ZRS1. | Molecular cancer research : MCR 20110301 |
| Adolescent hodgkin lymphoma: are treatment results more favorable with pediatric than with adult regimens? | Journal of pediatric hematology/oncology 20110301 |
| [Fatal Bacillus cereus sepsis and rhabdomyolysis in a patient with Hodgkin's disease]. | Enfermedades infecciosas y microbiologia clinica 20110301 |
| A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours. | British journal of cancer 20110301 |
| Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. | Neuro-oncology 20110301 |
| Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation. | Journal of molecular medicine (Berlin, Germany) 20110301 |
| Treating soft tissue sarcomas with adjuvant chemotherapy. | Current treatment options in oncology 20110301 |
| [MGMT analysis in gliomas]. | Bulletin du cancer 20110301 |
| Response to temozolomide in supratentorial multifocal recurrence of malignant ependymoma. | Anticancer research 20110301 |
| [Nimotuzumab in combination with chemotherapy for patients with malignant gliomas]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110301 |
| [Pituitary carcinoma]. | Nihon rinsho. Japanese journal of clinical medicine 20110301 |
| STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy? | International journal of cancer 20110215 |
| Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma. | British journal of cancer 20110215 |
| Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines. | British journal of cancer 20110215 |
| Equipoise and the dilemma of randomized clinical trials. | The New England journal of medicine 20110203 |
| Temozolomide-induced inhibition of pituitary adenoma cells. | Journal of neurosurgery 20110201 |
| Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma. | Journal of neuro-oncology 20110201 |
| Treatment of pituitary neoplasms with temozolomide: a review. | Cancer 20110201 |
| siRNA knockdown of ribonucleotide reductase inhibits melanoma cell line proliferation alone or synergistically with temozolomide. | The Journal of investigative dermatology 20110201 |
| Primary malignant melanoma of the esophagus: a study of clinical features, pathology, management and prognosis. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20110201 |
| Classical Hodgkin's lymphoma associated with Langerhans cell histiocytosis: multiagent chemotherapy resulted in histologic resolution of both the classical Hodgkin's lymphoma and Langerhans cell proliferation components. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110201 |
| Anti-tumour effects by a trimodal combination of temozolomide, meloxicam and X-rays in cultures of human glioma cells. | International journal of radiation biology 20110201 |
| Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients. | Neuro-oncology 20110201 |
| In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation. | Apoptosis : an international journal on programmed cell death 20110201 |
| Targeting BRAF for patients with melanoma. | British journal of cancer 20110201 |
| First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response. | Neuro-oncology 20110201 |
| CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. | British journal of cancer 20110201 |
| Case of atypical teratoid/rhabdoid tumor in an adult, with long survival. | Brain tumor pathology 20110201 |
| Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma. | The Journal of dermatology 20110201 |
| Extranodal interdigitating dendritic cell sarcoma presenting in the pleura: a case report. | Journal of Korean medical science 20110201 |
| Bevacizumab as a treatment option for radiation-induced cerebral necrosis. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20110201 |
| The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target. | Oncotarget 20110201 |
| Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide. | Journal of medical imaging and radiation oncology 20110201 |
| Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen--A24 with recurrent or progressive glioblastoma multiforme. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110120 |
| First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. | Cancer 20110115 |
| Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110110 |
| Taming glioblastoma by targeting angiogenesis: 3 years later. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110110 |
| Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110110 |
| Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients. | British journal of cancer 20110104 |
| [Comparison of MGMT and ERCC₂ expression in temozolomide for the treatment of malignant glioma drug resistance and their genetic relationship]. | Zhonghua yi xue za zhi 20110104 |
| Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients. | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. | International journal of radiation oncology, biology, physics 20110101 |
| Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma. | Journal of neuro-oncology 20110101 |
| Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review. | Journal of neuro-oncology 20110101 |
| On assessing the presence of evaluation-time bias in progression-free survival in randomized trials. | Pharmaceutical statistics 20110101 |
| Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information. | Annals of oncology : official journal of the European Society for Medical Oncology 20110101 |
| Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin's lymphoma. | Annals of hematology 20110101 |
| Hodgkin's Disease in Patients with HIV Infection. | Advances in hematology 20110101 |
| Temozolomide-induced severe myelosuppression: analysis of clinically associated polymorphisms in two patients. | Anti-cancer drugs 20110101 |
| Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. | Molecular medicine (Cambridge, Mass.) 20110101 |
| High-field iMRI in glioblastoma surgery: improvement of resection radicality and survival for the patient? | Acta neurochirurgica. Supplement 20110101 |
| Hodgkin's Lymphoma: A Review of Neurologic Complications. | Advances in hematology 20110101 |
| Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma. | Advances in hematology 20110101 |
| Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma. | Neuro-oncology 20110101 |
| Down-regulation of O6-methylguanine-DNA methyl transferase enhances the effect of temozolomide in melanoma cells. | Medical hypotheses 20110101 |
| MGMT promoter methylation in pediatric high-grade gliomas. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20110101 |
| Radiographic patterns of relapse in glioblastoma. | Journal of neuro-oncology 20110101 |
| Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB. | International journal of oncology 20110101 |
| Synergistic therapeutic effects of cytokine-induced killer cells and temozolomide against glioblastoma. | Oncology reports 20110101 |
| Clinical, molecular, and environmental risk factors for hodgkin lymphoma. | Advances in hematology 20110101 |
| Design, synthesis, and biological evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine and its analogs as a novel class of anticancer agents. | Bioorganic & medicinal chemistry 20110101 |
| Clinical experiences of pheochromocytoma in Korea. | Yonsei medical journal 20110101 |
| Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterisation. | Journal of microencapsulation 20110101 |
| [Drug therapy of patients with recurrent glioblastoma: is there any evidence?]. | Wiener medizinische Wochenschrift (1946) 20110101 |
| Incidence patterns and outcomes for hodgkin lymphoma patients in the United States. | Advances in hematology 20110101 |
| Systematic review of medical treatment in melanoma: current status and future prospects. | The oncologist 20110101 |
| A combined preclinical therapy of cannabinoids and temozolomide against glioma. | Molecular cancer therapeutics 20110101 |
| Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: a new hypothesis about disease pathogenesis. | Archives of ophthalmology (Chicago, Ill. : 1960) 20110101 |
| Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats. | Advances in hematology 20110101 |
| Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets. | Sarcoma 20110101 |
| PET Response-Guided Treatment of Hodgkin's Lymphoma: A Review of the Evidence and Active Clinical Trials. | Advances in hematology 20110101 |
| Saddle pulmonary embolism in a cancer patient with thrombocytopenia: a treatment dilemma. | Cardiology research and practice 20110101 |
| Primary malignant mixed Müllerian tumor arising from the mesorectum with a synchronous ovarian cancer: a case report and review of the literature. | Journal of medical case reports 20110101 |
| Ex vivo activity of cardiac glycosides in acute leukaemia. | PloS one 20110101 |
| Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas. | Advances in hematology 20110101 |
| Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography. | Advances in hematology 20110101 |
| Paget's disease of the breast in a male with lymphomatoid papulosis: a case report. | Journal of medical case reports 20110101 |
| Pathogenesis, diagnosis and management of primary melanoma of the colon. | World journal of surgical oncology 20110101 |
| DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer. | PloS one 20110101 |
| [Pseudoprogression or pseudoresponse: a challenge for the diagnostic imaging in Glioblastoma multiforme]. | Wiener medizinische Wochenschrift (1946) 20110101 |
| GRP78/BiP modulation of GRP78/BiP in altering sensitivity to chemotherapy. | Methods in enzymology 20110101 |
| Human Immunodeficiency Virus Infection and Hodgkin's Lymphoma in South Africa: An Emerging Problem. | Advances in hematology 20110101 |
| Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy. | PloS one 20110101 |
| Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. | BMC cancer 20110101 |
| Hodgkin lymphoma at the paediatric oncology unit of gabriel touré teaching hospital, bamako, mali: 5-year experience. | Advances in hematology 20110101 |
| Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma. | PloS one 20110101 |
| O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation. | PloS one 20110101 |
| A case of acute renal failure caused by Hodgkin's lymphoma: concurrent membranous glomerulonephritis and interstitial HL-CD 20 lymphoid infiltration. | Renal failure 20110101 |
| Future perspectives in melanoma research. Meeting report from the 'Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010'. | Journal of translational medicine 20110101 |
| Radiation-induced astrocytoma with rapid malignant transformation: case report. | Neurologia medico-chirurgica 20110101 |
| Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. | International journal of nanomedicine 20110101 |
| [Nephropathy following administration of angiogenesis inhibitors]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20110101 |
| Computational modeling of tumor response to vascular-targeting therapies--part I: validation. | Computational and mathematical methods in medicine 20110101 |
| Combined treatment of uveal melanoma liver metastases. | European journal of medical research 20110101 |
| Food protein-stabilized nanoemulsions as potential delivery systems for poorly water-soluble drugs: preparation, in vitro characterization, and pharmacokinetics in rats. | International journal of nanomedicine 20110101 |
| [Cellular markers based on DNA damage and repair (BER, MMR), expression of MLHI, MSH2, FasR, and cell death of lymphocytes as predictive parameters for clinical response to chemotherapy of melanoma]. | Tsitologiia 20110101 |
| Collagen triple helix repeat containing 1 promotes melanoma cell adhesion and survival. | Journal of cutaneous medicine and surgery 20110101 |
| A melanoma molecular disease model. | PloS one 20110101 |
| Malignant mesenchymal tumor with leiomyosarcoma, rhabdomyosarcoma, chondrosarcoma, and osteosarcoma differentiation: case report and literature review. | Diagnostic pathology 20110101 |
| Promising cytotoxic activity profile of fermented wheat germ extract (Avemar®) in human cancer cell lines. | Journal of experimental & clinical cancer research : CR 20110101 |
| Treatment with DAV for advanced-stage hemangiosarcoma in dogs. | Journal of the American Animal Hospital Association 20110101 |
| Trabectedin: safety and efficacy in the treatment of advanced sarcoma. | Clinical Medicine Insights. Oncology 20110101 |
| Inhibition of B16 murine melanoma metastasis and enhancement of immunity by fever-range whole body hyperthermia. | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20110101 |
| Pathological changes after autologous formalin-fixed tumor vaccine therapy combined with temozolomide for glioblastoma - three case reports - . | Neurologia medico-chirurgica 20110101 |
| Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis. | Case reports in oncology 20110101 |
| Factors that impact susceptibility to fiber-induced health effects. | Journal of toxicology and environmental health. Part B, Critical reviews 20110101 |
| Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies. | Journal of biomedicine & biotechnology 20110101 |
| Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances. | Genome medicine 20110101 |
| Integrin targeted therapeutics. | Theranostics 20110101 |
| Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer. | Journal of translational medicine 20110101 |
| FANCD1/BRCA2 plays predominant role in the repair of DNA damage induced by ACNU or TMZ. | PloS one 20110101 |
| Genetic abnormalities in leukemia secondary to treatment in patients with Hodgkin's disease. | Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20110101 |
| Another cause of pancytopenia in a patient receiving temozolomide. | Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20110101 |
| Marathon running during chemotherapy: where are the limits? | Onkologie 20110101 |
| Marathon run under chemotherapy: is it possible? | Onkologie 20110101 |
| Kinetic studies of the effects of Temodal and quercetin on astrocytoma cells. | Pharmacological reports : PR 20110101 |
| Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy. | Journal of translational medicine 20110101 |
| Retroperitoneal smooth muscle tumor of uncertain malignant potential after hysterectomy: a case report. | Journal of medical case reports 20110101 |
| Interpreting clinical assays for histone deacetylase inhibitors. | Cancer management and research 20110101 |
| Battling Chemotherapy-induced Nausea and Vomiting in Cancer Palliative Care. | Indian journal of palliative care 20110101 |
| Primary malignant melanoma of the uterine cervix treated with ultraradical surgery: a case report. | ISRN obstetrics and gynecology 20110101 |
| Next generation therapies change the landscape in melanoma. | F1000 medicine reports 20110101 |
| Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors. | Journal of hematology & oncology 20110101 |
| Concomitant temozolomide and radiotherapy versus radiotherapy alone for treatment of newly diagnosed glioblastoma multiforme. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101 |
| Diagnostic challenge for ovarian malignant melanoma in premenopausal women: primary or metastatic? | World journal of surgical oncology 20110101 |
| The rare malignancy of the hepatobiliary system: ampullary carcinoid tumor. | Case reports in medicine 20110101 |
| Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma. | Advances in hematology 20110101 |
| The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future. | Advances in hematology 20110101 |
| Delayed intracranial and bony metastasis of paraganglioma. | Surgical neurology international 20110101 |
| Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells. | BMC cancer 20110101 |
| 18F-fluorodeoxyglucose positron emission tomography-positive sarcoidosis after chemoradiotherapy for Hodgkin's disease: a case report. | Journal of medical case reports 20110101 |
| Malignant melanoma of scrotal skin. | Indian journal of dermatology 20110101 |
| Certain imidazotetrazines escape O6-methylguanine-DNA methyltransferase and mismatch repair. | Oncology 20110101 |
| Primary melanoma of the adrenal gland: a case report and review of the literature. | Journal of medical case reports 20110101 |
| Aggressive silent corticotroph adenoma progressing to pituitary carcinoma: the role of temozolomide therapy. | Hormones (Athens, Greece) 20110101 |
| A novel anti-CEACAM5 monoclonal antibody, CC4, suppresses colorectal tumor growth and enhances NK cells-mediated tumor immunity. | PloS one 20110101 |
| Brief report: phase II multicenter study of temozolomide in patients with cisplatin-resistant germ cell tumors. | Oncology 20110101 |
| Primary extranodal, extralymphatic hodgkin lymphoma of the mandible. | Case reports in medicine 20110101 |
| Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101 |
| Hodgkin's Lymphoma in Children and Adolescents: A Saint Petersburg Hodgkin's Lymphoma Group Study. | Journal of oncology 20110101 |
| Uveal melanoma. | Journal of skin cancer 20110101 |
| Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application. | Journal of skin cancer 20110101 |
| Ifosfamide, carboplatin and etoposide in recurrent malignant glioma. | Oncology 20110101 |
| Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft. | Journal of translational medicine 20110101 |
| Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature. | BMC cancer 20110101 |
| [Effectiveness of DNA repair and expression of MLH1, MSH2 and FASR in lymphocytes of patients with chemotherapy-responsive, disseminated cutaneous melanoma]. | Voprosy onkologii 20110101 |
| [Significant regression of glioblastoma with low level of Mgmt gene expression following radiotherapy]. | Voprosy onkologii 20110101 |
| Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma. | BMC cancer 20110101 |
| Multidisciplinary care in pediatric oncology. | Journal of multidisciplinary healthcare 20110101 |
| Extracranial skeletal metastasis in anaplastic oligodendroglioma: case report and review of the literature. | The Journal of international medical research 20110101 |
| Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities. | Radiation oncology (London, England) 20110101 |
| Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection. | World neurosurgery 20110101 |
| Adjuvant temozolomide chemotherapy for treatment of papillary tumor of the pineal region. | World neurosurgery 20110101 |
| Method for novel anti-cancer drug development using tumor explants of surgical specimens. | Journal of visualized experiments : JoVE 20110101 |
| Dacarbazine. | Report on carcinogens : carcinogen profiles 20110101 |
| Younger age as a prognostic indicator in breast cancer: a cohort study. | BMC cancer 20110101 |
| Molecular characteristics of pediatric non-ependymal, non‑pilocytic gliomas associated with resistance to temozolomide. | Molecular medicine reports 20110101 |
| Fermented wheat germ extract--nutritional supplement or anticancer drug? | Nutrition journal 20110101 |
| The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53. | PloS one 20110101 |
| [Advances in clinical treatment of malignant melanoma: B-RAF kinase inhibition]. | Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20110101 |
| Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back? | Radiation oncology (London, England) 20110101 |
| Residents' corner September 2011. Residents' editorial choice. | European journal of dermatology : EJD 20110101 |
| Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma. | PloS one 20110101 |
| Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma. | Molecular cancer 20110101 |
| SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery. | Journal of translational medicine 20110101 |
| Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production. | PloS one 20110101 |
| Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis. | BMC cancer 20110101 |
| Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents. | OncoTargets and therapy 20110101 |
| MicroRNA profile of polyunsaturated fatty acid treated glioma cells reveal apoptosis-specific expression changes. | Lipids in health and disease 20110101 |
| Primitive neuroectodermal tumor of the cervix: a case report. | Journal of medical case reports 20110101 |
| Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity. | International journal of nanomedicine 20110101 |
| The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma. | PloS one 20110101 |
| A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients. | BMC cancer 20110101 |
| An osseous lesion in a 10-year-old boy with Hodgkin's lymphoma: a case report. | Journal of medical case reports 20110101 |
| The challenges of managing glioblastoma multiforme in developing countries: a trade-off between cost and quality of care. | Hematology/oncology and stem cell therapy 20110101 |
| Outcomes of patients with metastatic melanoma treated with molecularly targeted agents in phase I clinical trials. | Oncology 20110101 |
| Chemoresistance of glioblastoma cancer stem cells--much more complex than expected. | Molecular cancer 20110101 |
| Temozolomide-related infections: review of the literature. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101 |
| Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management. | Obstetrics and gynecology international 20110101 |
| Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review. | International journal of hepatology 20110101 |
| Toxicity after radiochemotherapy for glioblastoma using temozolomide--a retrospective evaluation. | Radiation oncology (London, England) 20110101 |
| Malignant tumours of the hand and wrist. | Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India 20110101 |
| Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide: case report and literature review. | European journal of medical research 20110101 |
| Reactivation of hepatitis B virus after glioblastoma treatment with temozolomide--case report. | Neurologia medico-chirurgica 20110101 |
| Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanoma. | Chang Gung medical journal 20110101 |
| Invasion is not an independent prognostic factor in high-grade glioma. | Journal of cancer research and therapeutics 20110101 |
| Mitochondrial peroxiredoxin III is a potential target for cancer therapy. | International journal of molecular sciences 20110101 |
| Rad51 and BRCA2--New molecular targets for sensitizing glioma cells to alkylating anticancer drugs. | PloS one 20110101 |
| Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application. | Journal of translational medicine 20110101 |
| A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma. | ISRN hematology 20110101 |
| 'Il corpo ritrovato': dermocosmetological skin care project for the oncologic patient. | ISRN oncology 20110101 |
| Cerebral melanoma metastases: a critical review on diagnostic methods and therapeutic options. | ISRN surgery 20110101 |
| Giant gastrointestinal stromal tumor presenting as a palpable abdominal mass: an unusual presentation. | ISRN surgery 20110101 |
| [Issues around diffuse glioma]. | Nederlands tijdschrift voor geneeskunde 20110101 |
| Low back pain as the presenting sign in a patient with primary extradural melanoma of the thoracic spine--a metastatic disease 17 years after complete surgical resection. | World journal of surgical oncology 20110101 |
| Therapy-related myeloid neoplasms in patients treated for hodgkin lymphoma. | Mediterranean journal of hematology and infectious diseases 20110101 |
| Case Study in Refractory Non-Hodgkin's Lymphoma: Successful Treatment with Plerixafor. | Case reports in oncology 20110101 |
| Mediastinal choriocarcinoma masquerading as relapsed hodgkin lymphoma. | Case reports in oncology 20110101 |
| A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma. | Journal of translational medicine 20110101 |
| Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. | Breast cancer research : BCR 20110101 |
| A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma. | BMC cancer 20110101 |
| Optimal therapy of advanced Hodgkin lymphoma. | Hematology. American Society of Hematology. Education Program 20110101 |
| Selective internal radiation therapy for gastrointestinal neuroendocrine tumour liver metastases: a new and effective modality for treatment. | International journal of hepatology 20110101 |
| Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma. | BMC cancer 20110101 |
| BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and Resistance. | Journal of skin cancer 20110101 |
| Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. | BMC cancer 20110101 |
| The immune response to tumors as a tool toward immunotherapy. | Clinical & developmental immunology 20110101 |
| [The usefulness of neo- and adjuvant therapy in the treatment of cutaneous melanoma]. | Voprosy onkologii 20110101 |
| Changing patterns in the clinical pathological features of hodgkin lymphoma: a report from debrecen, hungary. | ISRN hematology 20110101 |
| Primary pleural angiosarcoma as a mimicker of mesothelioma: a case report **VS**. | Diagnostic pathology 20110101 |
| Ipilimumab: Melanoma and beyond. | Journal of pharmacy & bioallied sciences 20110101 |
| Adjuvant therapy: melanoma. | Journal of skin cancer 20110101 |
| [Brain metastasis in breast cancer]. | Voprosy onkologii 20110101 |
| [Five year-results of chemoresistance testing in cancer patients]. | Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20110101 |
| Profile of ipilimumab and its role in the treatment of metastatic melanoma. | Drug design, development and therapy 20110101 |
| Managing pregnant women with cancer: personal considerations and a review of the literature. | Ecancermedicalscience 20110101 |
| The state of research into children with cancer across Europe: new policies for a new decade. | Ecancermedicalscience 20110101 |
| Melanoma of the female urethra. | Indian journal of urology : IJU : journal of the Urological Society of India 20110101 |
| An update on the management of peripheral T-cell lymphoma and emerging treatment options. | Journal of blood medicine 20110101 |
| Intraosseous synovial sarcoma of the proximal tibia. | International journal of surgical oncology 20110101 |
| Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101 |
| An unusual case of gastrointestinal bleeding. | Case reports in pediatrics 20110101 |
| Integration of Principles of Systems Biology and Radiation Biology: Toward Development of in silico Models to Optimize IUdR-Mediated Radiosensitization of DNA Mismatch Repair Deficient (Damage Tolerant) Human Cancers. | Frontiers in oncology 20110101 |
| Grand challenges in oncology. | Frontiers in oncology 20110101 |
| CXCR4-positive subset of glioma is enriched for cancer stem cells. | Oncology research 20110101 |
| Lymphocyte Rich Hodgkin's Lymphoma Presented with Warm Hemolytic Anemia: A Case Report and Literature Review. | Case reports in hematology 20110101 |
| Solitary fibrous tumor. | Rare tumors 20101231 |
| Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. | The Journal of biological chemistry 20101224 |
| Synthesis and antitumor activity of 3-methyl-4-oxo-3,4-dihydroimidazo [5,1-d][1,2,3,5]tetrazine-8-carboxylates and -carboxamides. | Molecules (Basel, Switzerland) 20101220 |
| Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain. | The Journal of biological chemistry 20101217 |
| CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. | Cancer research 20101215 |
| Non-stem cell origin for oligodendroglioma. | Cancer cell 20101214 |
| Cancer and renal insufficiency results of the BIRMA study. | British journal of cancer 20101207 |
| Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy? | American journal of clinical oncology 20101201 |
| Tonsillar pseudotumor: complications of chronically-administered temozolomide. | Journal of neuro-oncology 20101201 |
| Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma. | Journal of neuro-oncology 20101201 |
| Nitrosourea-based chemotherapy for low grade gliomas failing initial treatment with temozolomide. | Journal of neuro-oncology 20101201 |
| Receptor activation and inhibition in cellular response to chemotherapeutic combinational mimicries: the concept of divergent targeting. | Journal of neuro-oncology 20101201 |
| Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group. | Pediatric blood & cancer 20101201 |
| Anti-insulin-like growth factor 1 receptor antibody EM164 (murine AVE1642) exhibits anti-tumour activity alone and in combination with temozolomide against neuroblastoma. | European journal of cancer (Oxford, England : 1990) 20101201 |
| A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma. | European journal of cancer (Oxford, England : 1990) 20101201 |
| Both base excision repair and O6-methylguanine-DNA methyltransferase protect against methylation-induced colon carcinogenesis. | Carcinogenesis 20101201 |
| MGMT immunoexpression in aggressive pituitary adenoma and carcinoma. | Pituitary 20101201 |
| Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. | Gynecologic oncology 20101201 |
| Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20101201 |
| Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20101201 |
| Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy. | Melanoma research 20101201 |
| Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. | European journal of endocrinology 20101201 |
| Unsuccessful high dose IL-2 therapy followed immediately by near continuous low dose temozolomide can result in rapid durable complete and near-complete remissions in metastatic melanoma. | Cancer biology & therapy 20101201 |
| Malignant melanoma as a target malignancy for the study of the anti-metastatic properties of the heparins. | Cancer metastasis reviews 20101201 |
| Temozolomide for adult brain stem glioblastoma: case report of a long-term survivor. | The International journal of neuroscience 20101201 |
| Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20101201 |
| Silencing HSF1 by short hairpin RNA decreases cell proliferation and enhances sensitivity to hyperthermia in human melanoma cell lines. | Journal of dermatological science 20101201 |
| Effects of some drugs on human erythrocyte glucose 6-phosphate dehydrogenase: an in vitro study. | Journal of enzyme inhibition and medicinal chemistry 20101201 |
| Low immunohistochemical expression of MGMT in ACTH secreting pituitary tumors of patients with Nelson syndrome. | Endocrine pathology 20101201 |
| Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305). | International journal of hematology 20101201 |
| O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment. | Neurosurgery 20101201 |
| FDA accelerated approval benefits glioblastoma. | The Lancet. Oncology 20101201 |
| Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine. | Molecular cancer therapeutics 20101201 |
| [ABVD chemotherapy for Hodgkin lymphoma at a single institute]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20101201 |
| Pseudoprogression following concurrent temozolomide and radiotherapy in a patient with glioblastoma: findings on functional imaging techniques. | Fukuoka igaku zasshi = Hukuoka acta medica 20101201 |
| What role should cilengitide have in the treatment of glioblastoma? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101120 |
| Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma. | International journal of radiation oncology, biology, physics 20101115 |
| MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature. | Cancer research 20101115 |
| [Carcinoid tumors]. | Orvosi hetilap 20101114 |
| Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma. | British journal of cancer 20101109 |
| Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699. | British journal of cancer 20101109 |
| Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution. | Journal of cancer research and clinical oncology 20101101 |
| Thalidomide for the control of severe paraneoplastic pruritus associated with Hodgkin's disease. | The American journal of hospice & palliative care 20101101 |
| A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study. | Journal of neuro-oncology 20101101 |
| Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid). | Pharmaceutical research 20101101 |
| Phase I/II dose escalation trial of concurrent temozolomide and whole brain radiation therapy for multiple brain metastasis. | Journal of neuro-oncology 20101101 |
| Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance. | Journal of neuro-oncology 20101101 |
| SOM230 (pasireotide) and temozolomide achieve sustained control of tumour progression and ACTH secretion in pituitary carcinoma with widespread metastases. | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20101101 |
| Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells. | Gene therapy 20101101 |
| Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma. | European journal of cancer (Oxford, England : 1990) 20101101 |
| MGMT gene promoter methylation in pediatric glioblastomas. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20101101 |
| The use of temozolomide for the treatment of malignant tumors: clinical evidence and molecular mechanisms of action. | Recent patents on anti-cancer drug discovery 20101101 |
| Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy. | Journal of neurology 20101101 |
| Quantitative relationship between guanine O(6)-alkyl lesions produced by Onrigin™ and tumor resistance by O(6)-alkylguanine-DNA alkyltransferase. | Biochemical pharmacology 20101101 |
| A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma. | Neuro-oncology 20101101 |
| Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide. | Molecular pharmacology 20101101 |
| Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20101101 |
| Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide. | Anti-cancer drugs 20101101 |
| Spontaneous rupture of a functioning adrenocortical carcinoma. | Yonsei medical journal 20101101 |
| Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101101 |
| Intensified adjuvant IFADIC chemotherapy in combination with radiotherapy versus radiotherapy alone for soft tissue sarcoma: long-term follow-up of a prospective randomized feasibility trial. | Wiener klinische Wochenschrift 20101101 |
| [Unknown gonadotoxicity chemotherapy and preservation of fertility: example of Temozolomide]. | Gynecologie, obstetrique & fertilite 20101101 |
| Neuro-oncology, a decade of temozolomide and beyond. | Expert review of anticancer therapy 20101101 |
| Engineering nanomedicines for improved melanoma therapy: progress and promises. | Nanomedicine (London, England) 20101101 |
| Biodegradable microfibers deliver the antitumor drug temozolomide to glioma C6 cells in vitro. | Die Pharmazie 20101101 |
| Perivascular epithelioid cell tumor (PEComa) of the ascending colon: the implication of IFN-α2b treatment. | Korean journal of pediatrics 20101101 |
| Temozolomide: Expanding its role in brain cancer. | Drugs of today (Barcelona, Spain : 1998) 20101101 |
| Targeted therapies in metastatic melanoma: toward a clinical breakthrough? | Anti-cancer agents in medicinal chemistry 20101101 |
| Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres. | Cancer letters 20101028 |
| miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. | Cancer letters 20101028 |
| Activity of irinotecan and temozolomide in the presence of O6-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models. | British journal of cancer 20101026 |
| IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. | Neurology 20101026 |
| Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020 |
| Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. | Chemico-biological interactions 20101006 |
| Population-based analysis of the frequency of anemia and its management before and during chemotherapy in patients with malignant lymphoma. | American journal of clinical oncology 20101001 |
| Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas. | International journal of radiation oncology, biology, physics 20101001 |
| Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide. | Clinical neurology and neurosurgery 20101001 |
| Alterations in the p53 pathway and p16INK4a expression predict overall survival in metastatic melanoma patients treated with dacarbazine. | The Journal of investigative dermatology 20101001 |
| Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours. | European journal of cancer (Oxford, England : 1990) 20101001 |
| Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. | Cancer 20101001 |
| ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma. | Leukemia research 20101001 |
| A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma. | Neuro-oncology 20101001 |
| Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide. | Clinical neurology and neurosurgery 20101001 |
| Core-shell hybrid nanogels for integration of optical temperature-sensing, targeted tumor cell imaging, and combined chemo-photothermal treatment. | Biomaterials 20101001 |
| Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. | The Journal of clinical endocrinology and metabolism 20101001 |
| Nelson's syndrome. | European journal of endocrinology 20101001 |
| First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. | Neurosurgical review 20101001 |
| Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma. | Cancer research 20101001 |
| Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease. | Journal of pediatric hematology/oncology 20101001 |
| Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95. | British journal of haematology 20101001 |
| Sorafenib enhances the in vitro anti-endothelial effects of low dose (metronomic) chemotherapy. | Oncology reports 20101001 |
| In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells. | International journal of oncology 20101001 |
| Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. | Acta obstetricia et gynecologica Scandinavica 20101001 |
| Leptomeningeal metastases from small cell lung cancer responsive to temozolomide therapy. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20101001 |
| Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors. | Clinical colorectal cancer 20101001 |
| Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas. | Expert review of neurotherapeutics 20101001 |
| Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20101001 |
| [A case report of anorectal malignant melanoma showing a complete response after DTIC/ACNU/VCR therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101001 |
| Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease. | Anticancer research 20101001 |
| Ipilimumab: unleashing the power of the immune system through CTLA-4 blockade. | Seminars in oncology 20101001 |
| Brain metastasis in melanoma: clinical activity of CTLA-4 antibody therapy. | Seminars in oncology 20101001 |
| Doxorubicin, bleomycin, vinblastine, and dacarbazine alone in treatment of favorable, limited-stage Hodgkin's lymphoma: do we really have robust data? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100920 |
| Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100920 |
| MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. | Brain research 20100917 |
| Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients. | Cancer research 20100915 |
| MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. | British journal of cancer 20100907 |
| Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma. | British journal of cancer 20100907 |
| Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy. | Neurological research 20100901 |
| Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report. | Medical oncology (Northwood, London, England) 20100901 |
| Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma. | International journal of radiation oncology, biology, physics 20100901 |
| MGMT immunoexpression in silent subtype 3 pituitary adenomas: possible therapeutic implications. | Endocrine pathology 20100901 |
| Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme. | Neuro-oncology 20100901 |
| Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas. | Cancer gene therapy 20100901 |
| Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. | Neuro-oncology 20100901 |
| Temozolomide (Temodar). | AJNR. American journal of neuroradiology 20100901 |
| Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial. | Cancer 20100901 |
| Comment on 'Non-surgical treatment of hormone-secreting pituitary tumors'. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20100901 |
| Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation. | Pediatric blood & cancer 20100901 |
| Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization. | AAPS PharmSciTech 20100901 |
| 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20100901 |
| Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence. | Cancer research 20100901 |
| Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. | Neoplasia (New York, N.Y.) 20100901 |
| Urticarial hypersensitivity reaction caused by temozolomide. | Journal of drugs in dermatology : JDD 20100901 |
| Positron emission tomography/computed tomography: use for initial staging of malignant melanoma. | International journal of dermatology 20100901 |
| Malignant melanoma of the breast: N-isopropyl-p-(123) I-iodoamphetamine single photon emission computed tomography ((123) I-IMP SPECT) is useful for the detection of metastasis. | The Journal of dermatology 20100901 |
| Should biomarkers be used to design personalized medicine for the treatment of glioblastoma? | Future oncology (London, England) 20100901 |
| [A case of metastatic paratesticular rhabdomyosarcoma in an adult successfully treated with multidrug combination chemotherapy]. | Hinyokika kiyo. Acta urologica Japonica 20100901 |
| [Case of primary amelanotic malignant melanoma of the female urethra]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20100901 |
| Clinical significance of molecular biomarkers in glioblastoma. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20100901 |
| [Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case]. | Zhonghua bing li xue za zhi = Chinese journal of pathology 20100901 |
| Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis. | Cancer letters 20100828 |
| Hodgkin lymphoma involving extranodal and nodal head and neck sites: characteristics and outcomes. | Cancer 20100815 |
| Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. | The New England journal of medicine 20100812 |
| Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100810 |
| Effect of alternative temozolomide schedules on glioblastoma O(6)-methylguanine-DNA methyltransferase activity and survival. | British journal of cancer 20100810 |
| Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature. | American journal of clinical oncology 20100801 |
| Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide. | Journal of neurosurgery 20100801 |
| Up-front temozolomide in elderly patients with glioblastoma. | Journal of neuro-oncology 20100801 |
| Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma. | Annals of oncology : official journal of the European Society for Medical Oncology 20100801 |
| Phase II trial of neoadjuvant temozolomide in resectable melanoma patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20100801 |
| MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib. | Neuro-oncology 20100801 |
| Inhibition of poly(ADP-ribose) polymerase enhances the effect of chemotherapy in an animal model of regional therapy for the treatment of advanced extremity malignant melanoma. | Annals of surgical oncology 20100801 |
| Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20100801 |
| Effects of some drugs on human erythrocyte 6-phosphogluconate dehydrogenase: an in vitro study. | Journal of enzyme inhibition and medicinal chemistry 20100801 |
| A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. | Journal of neurosurgery 20100801 |
| A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma. | Melanoma research 20100801 |
| Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma. | Radiology 20100801 |
| A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma. | Cancer 20100801 |
| Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme. | Cancer 20100801 |
| Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3. | American journal of hematology 20100801 |
| Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin lymphoma. | Leukemia & lymphoma 20100801 |
| Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts. | The Tohoku journal of experimental medicine 20100801 |
| Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor alpha in Hodgkin-Reed-Sternberg cells. | Human pathology 20100801 |
| Influence of iMRI-guidance on the extent of resection and survival of patients with glioblastoma multiforme. | Technology in cancer research & treatment 20100801 |
| Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology). | Neurosurgery 20100801 |
| Amelanotic malignant melanoma where primary lesion was discovered 5 years after metastasis in the lymph node. | The Journal of dermatology 20100801 |
| Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo. | The Journal of dermatology 20100801 |
| Combination chemotherapy for Hodgkin's lymphoma during pregnancy: favorable outcome for mother and child. | The journal of obstetrics and gynaecology research 20100801 |
| Long-term outcomes in children with glioblastoma. | Journal of neurosurgery. Pediatrics 20100801 |
| Aplastic anemia as a cause of death in a patient with glioblastoma multiforme treated with temozolomide. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20100801 |
| Pegylated IFN-α sensitizes melanoma cells to chemotherapy and causes premature senescence in endothelial cells by IRF-1 mediated signaling. | Cell death & disease 20100801 |
| The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens. | Oncotarget 20100801 |
| Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100710 |
| Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide. | International journal of radiation oncology, biology, physics 20100701 |
| Multiple-cytokine-producing, mixed-cellularity, classical Hodgkin lymphoma with B symptoms and minimal-change nephrotic syndrome. | Leukemia research 20100701 |
| Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma? | Cancer investigation 20100701 |
| Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib. | Neurosurgical review 20100701 |
| Sensitivity to temozolomide in brain tumor initiating cells. | Neuro-oncology 20100701 |
| Extended phase I evaluation of vincristine, irinotecan, temozolomide, and antibiotic in children with refractory solid tumors. | Pediatric blood & cancer 20100701 |
| Carmustine wafers (Gliadel) plus concomitant temozolomide therapy after resection of malignant astrocytoma: growing evidence for safety and efficacy. | Annals of surgical oncology 20100701 |
| Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: the French experience. | Annals of surgical oncology 20100701 |
| New drugs in neuroendocrine tumors: rising of new therapeutic philosophies? | Current opinion in oncology 20100701 |
| Stratifying osteosarcoma: minimizing and maximizing therapy. | Current oncology reports 20100701 |
| Does rituximab have a place in treating classic hodgkin lymphoma? | Current hematologic malignancy reports 20100701 |
| Initial experience involving treatment and retreatment with carmustine wafers in combination with oral temozolomide: long-term survival in a child with relapsed glioblastoma multiforme. | Journal of pediatric hematology/oncology 20100701 |
| PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors. | Cancer research 20100701 |
| Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival. | Journal of neuropathology and experimental neurology 20100701 |
| Long-term survival in patients with metastatic melanoma treated with DTIC or temozolomide. | The oncologist 20100701 |
| MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC. | European journal of cancer (Oxford, England : 1990) 20100701 |
| Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy. | Molecular cancer therapeutics 20100701 |
| The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. | Molecular cancer research : MCR 20100701 |
| Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential. | The British journal of radiology 20100701 |
| Analysis and stability study of temozolomide using capillary electrophoresis. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100701 |
| Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma. | Neuroscience 20100630 |
| An epidural neuroblastoma causing spinal cord compression in a 67-year-old woman. | Rare tumors 20100630 |
| Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide. | British journal of cancer 20100629 |
| Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma. | Journal of the National Cancer Institute 20100616 |
| Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100615 |
| Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects. | Cancer 20100615 |
| O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers. | Lung cancer (Amsterdam, Netherlands) 20100601 |
| Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme? | American journal of clinical oncology 20100601 |
| Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study. | Neuro-oncology 20100601 |
| Glucocorticoid-dependent expression of O(6)-methylguanine-DNA methyltransferase gene modulates dacarbazine-induced hepatotoxicity in mice. | The Journal of pharmacology and experimental therapeutics 20100601 |
| Gene expression profiling predicts response to temozolomide in malignant gliomas. | International journal of oncology 20100601 |
| Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study. | Oncology reports 20100601 |
| Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100601 |
| Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent. | Current cancer drug targets 20100601 |
| [Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines]. | Bulletin du cancer 20100601 |
| Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study. | Clinical lymphoma, myeloma & leukemia 20100601 |
| Phase I study of temozolomide and laromustine (VNP40101M) in patients with relapsed or refractory leukemia. | Clinical lymphoma, myeloma & leukemia 20100601 |
| Triazenoindazoles and triazenopyrazolopyridines: design, synthesis, and cytotoxic activity. | Archives of pharmacal research 20100601 |
| Vincristine in high-grade glioma. | Anticancer research 20100601 |
| Melanoma metastatic to multiple visceral organs: further considerations. | Oncology (Williston Park, N.Y.) 20100601 |
| Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. | International journal of radiation oncology, biology, physics 20100501 |
| A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. | International journal of radiation oncology, biology, physics 20100501 |
| Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients. | Annals of hematology 20100501 |
| Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. | Journal of neurosurgery 20100501 |
| Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status. | Journal of neuro-oncology 20100501 |
| Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination. | Journal of neuro-oncology 20100501 |
| High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. | Journal of neuro-oncology 20100501 |
| Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. | Journal of neuro-oncology 20100501 |
| The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound. | Pharmacological research 20100501 |
| Long term survival of primary skeletal muscle lymphoma in a miniature dachshund. | The Journal of veterinary medical science 20100501 |
| Effects of concomitant temozolomide and radiation therapies on WT1-specific T-cells in malignant glioma. | Japanese journal of clinical oncology 20100501 |
| Changes of the O6-methylguanine-DNA methyltransferase promoter methylation and MGMT protein expression after adjuvant treatment in glioblastoma. | Oncology reports 20100501 |
| Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20100501 |
| A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors. | Neuro-oncology 20100501 |
| Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial. | Neuro-oncology 20100501 |
| Pseudoprogression after radiotherapy with concurrent temozolomide in a child with anaplastic astrocytoma. | Pediatric hematology and oncology 20100501 |
| Malignant transformation of an optic pathway glioma without prior radiation therapy. | Journal of neurosurgery. Pediatrics 20100501 |
| Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study. | Clinical lung cancer 20100501 |
| Paternalism in practice: informing patients about expensive unsubsidised drugs. | Journal of medical ethics 20100501 |
| Minimally cytotoxic doses of temozolomide produce radiosensitization in human glioblastoma cells regardless of MGMT expression. | Molecular cancer therapeutics 20100501 |
| [Clinical course of patient with malignant pheochromocytoma who was treated with CVD chemotherapy and alpha-methyl-p-tyrosine]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20100501 |
| High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Annals of oncology : official journal of the European Society for Medical Oncology 20100501 |
| A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer. | British journal of cancer 20100427 |
| Optimization of phenyl-substituted benzimidazole carboxamide poly(ADP-ribose) polymerase inhibitors: identification of (S)-2-(2-fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-benzimidazole-4-carboxamide (A-966492), a highly potent and efficacious inhibitor. | Journal of medicinal chemistry 20100422 |
| Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420 |
| Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420 |
| Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466). | Cancer 20100415 |
| Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100415 |
| Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100415 |
| The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. | Cancer research 20100415 |
| Treatment for metastatic malignant melanoma: old drugs and new strategies. | Critical reviews in oncology/hematology 20100401 |
| Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis. | The Journal of investigative dermatology 20100401 |
| A case with Hodgkin lymphoma and fronto-temporal lobular degeneration (FTLD)-like dementia facilitated by chemotherapy. | Japanese journal of clinical oncology 20100401 |
| Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study. | Pediatric blood & cancer 20100401 |
| Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial. | Melanoma research 20100401 |
| Human immunodeficiency and Hodgkin lymphoma. | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20100401 |
| Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401 |
| PARP inhibition: PARP1 and beyond. | Nature reviews. Cancer 20100401 |
| A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown. | Cancer research 20100401 |
| Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing. | Neuro-oncology 20100401 |
| Clinical characteristics of monomorphic post-transplant lymphoproliferative disorders. | Journal of Korean medical science 20100401 |
| Excessive neurotoxicity with ABVD when combined with protease inhibitor-based antiretroviral therapy in the treatment of AIDS-related Hodgkin lymphoma. | Clinical lymphoma, myeloma & leukemia 20100401 |
| Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma. | Molecular cancer therapeutics 20100401 |
| Flow cytometric analysis for the mechanism of the new antineoplastic agent temozolomide in glioma cells. | Brain tumor pathology 20100401 |
| Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20100401 |
| Multimodality management of a locally advanced primary oesophageal melanoma with radical surgery and adjuvant chemoimmunoradiotherapy. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20100401 |
| Generalized melanosis and melanuria in a patient with metastatic melanoma. | Clinical and experimental dermatology 20100401 |
| Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases. | Neurosurgical review 20100401 |
| Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. | British journal of cancer 20100330 |
| Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis. | British journal of cancer 20100330 |
| Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100320 |
| In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100318 |
| Comparison of favorable early-stage hodgkin's lymphoma treatments: a single-institution review. | International journal of radiation oncology, biology, physics 20100315 |
| A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma. | Cancer 20100315 |
| [Glioblastoma multiforme--new hope due to modern therapeutical approaches]. | Praxis 20100303 |
| Evaluation of the exposure equivalence of oral versus intravenous temozolomide. | Cancer chemotherapy and pharmacology 20100301 |
| Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519). | Annals of oncology : official journal of the European Society for Medical Oncology 20100301 |
| Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study. | Journal of neuro-oncology 20100301 |
| Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings. | Journal of neuro-oncology 20100301 |
| Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20100301 |
| Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O(6)-methylguanine-DNA methyltransferase(P140K). | Gene therapy 20100301 |
| The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma. | European journal of haematology 20100301 |
| Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. | Cancer 20100301 |
| Comment on 'Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma'. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20100301 |
| Temozolomide and MGMT forever? | Neuro-oncology 20100301 |
| Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide. | Neuro-oncology 20100301 |
| Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma. | Neuro-oncology 20100301 |
| Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model. | Neurosurgery 20100301 |
| Lestaurtinib enhances the antitumor efficacy of chemotherapy in murine xenograft models of neuroblastoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100301 |
| Patent watch. | Nature reviews. Drug discovery 20100301 |
| A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma. | Archives of neurology 20100301 |
| Second malignant neoplasm occurring years after hyperthermic isolated limb perfusion for melanoma. | Archives of dermatology 20100301 |
| Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy. | Clinical therapeutics 20100301 |
| Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors. | Journal of neurosurgical sciences 20100301 |
| A mathematical model of brain tumour response to radiotherapy and chemotherapy considering radiobiological aspects. | Journal of theoretical biology 20100207 |
| Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. | Journal of neuro-oncology 20100201 |
| Extended-schedule dose-dense temozolomide in refractory gliomas. | Journal of neuro-oncology 20100201 |
| Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. | Journal of neuro-oncology 20100201 |
| Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma. | Melanoma research 20100201 |
| The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma. | Melanoma research 20100201 |
| Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis. | Molecular cancer therapeutics 20100201 |
| Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. | Reproductive biomedicine online 20100201 |
| Congenital pigment synthesizing melanoma of the scalp. | Journal of the American Academy of Dermatology 20100201 |
| Medical oncology: treatment and management of malignant gliomas. | Nature reviews. Clinical oncology 20100201 |
| Patient-tailored, imaging-guided, long-term temozolomide chemotherapy in patients with glioblastoma. | Molecular imaging 20100201 |
| [Treatment of clinically nonfunctioning pituitary adenomas]. | Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20100201 |
| Effects of interleukin-1 receptor antagonist and chemotherapy on host-tumor interactions in established melanoma. | Anticancer research 20100201 |
| Bevacizumab is active as a single agent against recurrent malignant gliomas. | Anticancer research 20100201 |
| Clinical features, management and outcomes of high-grade glioma patients in Ramathibodi Hospital. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20100201 |
| [Particularities of Hodgkin's lymphoma]. | La Revue du praticien 20100120 |
| Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508. | Cancer 20100115 |
| Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents. | Bioorganic & medicinal chemistry 20100115 |
| [Treatment of metastatic malignant melanoma localized to an extremity]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20100114 |
| Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells. | Journal of neurosurgery 20100101 |
| Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice. | Journal of neuro-oncology 20100101 |
| A human brainstem glioma xenograft model enabled for bioluminescence imaging. | Journal of neuro-oncology 20100101 |
| Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20100101 |
| Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials. | Journal of neuro-oncology 20100101 |
| Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide. | Archives of gerontology and geriatrics 20100101 |
| Rapid response to therapy of neurocutaneous melanosis with leptomeningeal melanoma. | Pediatric blood & cancer 20100101 |
| IRF4 is modulated by CD40L and by apoptotic and anti-proliferative signals in Hodgkin lymphoma. | British journal of haematology 20100101 |
| Recurrent glioblastoma of childhood treated with bevacizumab: case report and molecular features. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20100101 |
| Second hematologic malignancies after ABVD: Two case reports and a retrospective study of 183 Hodgkin lymphoma patients. | Acta oncologica (Stockholm, Sweden) 20100101 |
| Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection. | Neurosurgical review 20100101 |
| [Dramatic efficacy of chemotherapy with 5-fluorouracil and dacarbazine in a patient with metastatic glucagonoma and cardiac insufficiency]. | Gastroenterologie clinique et biologique 20100101 |
| Concomitant or adjuvant temozolomide with whole-brain irradiation for brain metastases: a meta-analysis. | Anti-cancer drugs 20100101 |
| Surgical treatment of malignant peritoneal mesothelioma: past, present, and future. | Annals of surgical oncology 20100101 |
| Immunological factors relating to the antitumor effect of temozolomide chemoimmunotherapy in a murine glioma model. | Clinical and vaccine immunology : CVI 20100101 |
| Engineered drug-resistant immunocompetent cells enhance tumor cell killing during a chemotherapy challenge. | Biochemical and biophysical research communications 20100101 |
| EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma. | European journal of cancer (Oxford, England : 1990) 20100101 |
| Intratumoral therapy with interferon-alpha in a locoregional advanced malignant blue nevus: a brief communication. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20100101 |
| The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics. | Journal of neuro-oncology 20100101 |
| The influence of surgical procedure and the effect of chemotherapy on nodal and distant metastases of human malignant melanomas that have been grafted into nude mice. | International journal of oral and maxillofacial surgery 20100101 |
| Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study. | Neurosurgery 20100101 |
| A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100101 |
| Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation. | Cancer research 20100101 |
| Detection of gene pathways with predictive power for breast cancer prognosis. | BMC bioinformatics 20100101 |
| The Diels-Alder-reaction with inverse-electron-demand, a very efficient versatile click-reaction concept for proper ligation of variable molecular partners. | International journal of medical sciences 20100101 |
| Esthesioneuroblastoma (Olfactory Neuroblastoma) with Ectopic ACTH Syndrome: a multidisciplinary case presentation from the Joan Karnell cancer center of Pennsylvania Hospital. | The oncologist 20100101 |
| Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells. | Neoplasia (New York, N.Y.) 20100101 |
| A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma. | PloS one 20100101 |
| A giant mesenteric fibromatosis case presenting with mechanical intestinal obstruction and successfully resected with partial duodeno-jejunectomy and right hemicolectomy. | Clinics (Sao Paulo, Brazil) 20100101 |
| An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo. | Molecular cancer 20100101 |
| Temozolomide in advanced and recurrent uterine leiomyosarcoma and correlation with o6-methylguanine DNA methyltransferase expression: a case series. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20100101 |
| EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis. | Molecular cancer 20100101 |
| O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients. | Neuro-oncology 20100101 |
| Noninvasive detection of temozolomide in brain tumor xenografts by magnetic resonance spectroscopy. | Neuro-oncology 20100101 |
| Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference. | BMC cancer 20100101 |
| Pseudoprogression following chemoradiotherapy for glioblastoma multiforme. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20100101 |
| Increased shedding of HU177 correlates with worse prognosis in primary melanoma. | Journal of translational medicine 20100101 |
| A patient with metastatic melanoma presenting with gastrointestinal perforation after dacarbazine infusion: a case report. | Journal of medical case reports 20100101 |
| Advanced malignant melanoma: immunologic and multimodal therapeutic strategies. | Journal of oncology 20100101 |
| Temozolomide-induced myelodysplasia. | Advances in hematology 20100101 |
| A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy. | Molecular cancer 20100101 |
| MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients. | Neoplasma 20100101 |
| Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications. | Oncology 20100101 |
| Hodgkin's lymphoma masquerading as vertebral osteomyelitis in a man with diabetes: a case report. | Journal of medical case reports 20100101 |
| Postoperative chemo-radiotherapy with temodal in patients with glioblastoma multiforme--survival rates and prognostic factors. | Folia medica 20100101 |
| Dacarbazine as single-agent therapy for relapsed lymphoma in dogs. | Journal of veterinary internal medicine 20100101 |
| Melanoma: a model for testing new agents in combination therapies. | Journal of translational medicine 20100101 |
| Primary nasopharyngeal Hodgkin's disease: case report and literature review. | Journal of medical case reports 20100101 |
| Metastatic gliosarcoma with a unique presentation and progression: case report and review of the literature. | Clinical neuropathology 20100101 |
| Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma. | Tumori 20100101 |
| Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications. | Journal of carcinogenesis 20100101 |
| Tumor angiogenesis: insights and innovations. | Journal of oncology 20100101 |
| Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy. | BMC cancer 20100101 |
| Preoperative chemotherapy for infiltrative low-grade oligoastrocytoma: a useful strategy to maximize surgical resection -case report-. | Neurologia medico-chirurgica 20100101 |
| Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. | PloS one 20100101 |
| Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma. | Sarcoma 20100101 |
| Successful treatment of metastatic malignant fibrous histiocytoma of the kidney. | Urologia internationalis 20100101 |
| Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid. | Molecular cancer 20100101 |
| Fatal malignant melanoma in an adolescent. | Pediatric dermatology 20100101 |
| Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies. | Journal of translational medicine 20100101 |
| Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73. | BMC cancer 20100101 |
| Hemorrhagic cystitis in a patient receiving docetaxel for prostate cancer. | Clinical Medicine Insights. Oncology 20100101 |
| A case of relapsed medulloblastoma treated with intensity-modulated radiotherapy and temozolomide. | Tumori 20100101 |
| Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. | BMC cancer 20100101 |
| Fertility preservation in young cancer patients. | Journal of human reproductive sciences 20100101 |
| CTLA-4 blockade: therapeutic potential in cancer treatments. | OncoTargets and therapy 20100101 |
| Angiogenesis and progression in human melanoma. | Dermatology research and practice 20100101 |
| Genetics of uveal melanoma and cutaneous melanoma: two of a kind? | Dermatology research and practice 20100101 |
| Expression of chemoresistance-related genes and heat shock protein 72 in hyperthermic isolated limb perfusion of malignant melanoma: an experimental study. | Journal of oncology 20100101 |
| Guidelines for the management of soft tissue sarcomas. | Sarcoma 20100101 |
| [Side effects of temozolomide treatment in patient with glioblastoma multiforme--case study]. | Przeglad lekarski 20100101 |
| Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation. | European journal of medical research 20100101 |
| Impact of adjuvant chemotherapy for gliomatosis cerebri. | BMC cancer 20100101 |
| Targeted Therapy Database (TTD): a model to match patient's molecular profile with current knowledge on cancer biology. | PloS one 20100101 |
| The role of spectrophotometry in the diagnosis of melanoma. | BMC dermatology 20100101 |
| Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatment. | Journal of translational medicine 20100101 |
| Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery. | Journal of hematology & oncology 20100101 |
| Low peripheral lymphocyte count before focal radiotherapy plus concomitant temozolomide predicts severe lymphopenia during malignant glioma treatment. | Neurologia medico-chirurgica 20100101 |
| Brain metastasis of undifferentiated sarcoma and response to temozolomide treatment. Case report. | Neurologia medico-chirurgica 20100101 |
| Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial. | BMC cancer 20100101 |
| Dynamic metabolic flux analysis demonstrated on cultures where the limiting substrate is changed from carbon to nitrogen and vice versa. | Journal of biomedicine & biotechnology 20100101 |
| Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma. | PloS one 20100101 |
| Inhibition of melanoma growth by subcutaneous administration of hTERTC27 viral cocktail in C57BL/6 mice. | PloS one 20100101 |
| Molecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancers. | Journal of oncology 20100101 |
| Malignant head and neck paragangliomas: is there an optimal treatment strategy? | Head & neck oncology 20100101 |
| Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report. | BMC cancer 20100101 |
| A cyclic-RGD-BioShuttle functionalized with TMZ by DARinv 'Click Chemistry' targeted to αvβ3 integrin for therapy. | International journal of medical sciences 20100101 |
| Unexpected high response rate to traditional therapy after dendritic cell-based vaccine in advanced melanoma: update of clinical outcome and subgroup analysis. | Clinical & developmental immunology 20100101 |
| Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia. | BMC cancer 20100101 |
| Clinicopathologic characteristics and prognostic factors of ovarian fibrosarcoma: the results of a multi-center retrospective study. | BMC cancer 20100101 |
| Presence of human herpes virus 6 (HHV6) in pediatric lymphomas: impact on clinical course and association with cytomegalovirus infection. | Virology journal 20100101 |
| Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: a brief report and literature review. | Clinical Medicine Insights. Oncology 20100101 |
| Expression of O-Alkylguanine-DNA Alkyltransferase in Normal and Malignant Bladder Tissue of Egyptian Patients. | Journal of nucleic acids 20100101 |
| Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review. | Core evidence 20100101 |
| Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. | TheScientificWorldJournal 20100101 |
| High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study. | Journal of translational medicine 20100101 |
| Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma. | BMC cancer 20100101 |
| Hemophagocytic Syndrome Associated with Hodgkin's Lymphoma First Presenting as Fever and Pancytopenia. | Case reports in medicine 20100101 |
| Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs). | PloS one 20100101 |
| DNA damage induced by alkylating agents and repair pathways. | Journal of nucleic acids 20100101 |
| [Risk factors for hematologic toxicity and multifaceted analysis of blood in Hodgkin's disease: a model for hematologic toxicity]. | Voprosy onkologii 20100101 |
| Treatment of cutaneous melanoma: current approaches and future prospects. | Cancer management and research 20100101 |
| A phase II trial of sorafenib in metastatic melanoma with tissue correlates. | PloS one 20100101 |
| Arsenic trioxide sensitizes cancer stem cells to chemoradiotherapy. A new approach in the treatment of inoperable glioblastoma multiforme. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20100101 |
| Focus on adoptive T cell transfer trials in melanoma. | Clinical & developmental immunology 20100101 |
| The past: what we have learned in the last decade. | Hematology. American Society of Hematology. Education Program 20100101 |
| Treatment of glioblastoma in elderly patients: an overview of current treatments and future perspective. | Tumori 20100101 |
| Chemopotentiation by ultrafractionated radiotherapy in glioblastoma resistant to conventional therapy. | Tumori 20100101 |
| Desmoid tumor treated with polychemotherapy followed by imatinib: a case report and review of the literature. | Case reports in oncology 20100101 |
| Malignant melanoma (metastatic). | BMJ clinical evidence 20100101 |
| Treating glioblastoma multiforme with electrical fields. | World neurosurgery 20100101 |
| Tardy spinal cord tumor following avulsive brachial plexus injury: coincidental or causal? | World neurosurgery 20100101 |
| Immunotoxins: a promising treatment modality for metastatic melanoma? | The Ochsner journal 20100101 |
| Neuroblastoma in a 55-year-old patient: a case report. | Case reports in oncology 20100101 |
| Advances in the treatment of gastroenteropancreatic neuroendocrine tumors. | Clinical and experimental gastroenterology 20100101 |
| Sarcoid Reactions after Chemotherapy for Hodgkin's Lymphoma. | Clinical medicine insights. Case reports 20100101 |
| Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphoma. | Ecancermedicalscience 20100101 |
| Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091220 |
| Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? | Pediatric blood & cancer 20091215 |
| Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide. | Journal of the neurological sciences 20091215 |
| Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group. | Pediatric blood & cancer 20091215 |
| Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected]. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091210 |
| NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091210 |
| Long-term follow-up of survival in Hodgkin's lymphoma. | The New England journal of medicine 20091210 |
| Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. | Neuro-oncology 20091201 |
| Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro. | Neuro-oncology 20091201 |
| Biological reactive intermediates that mediate dacarbazine cytotoxicity. | Cancer chemotherapy and pharmacology 20091201 |
| Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors. | Cancer chemotherapy and pharmacology 20091201 |
| Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells. | Journal of neuro-oncology 20091201 |
| Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy. | Journal of neuro-oncology 20091201 |
| Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones. | The Journal of investigative dermatology 20091201 |
| Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience. | Pediatric blood & cancer 20091201 |
| High-grade glioma mouse models and their applicability for preclinical testing. | Cancer treatment reviews 20091201 |
| Epstein-Barr virus-positive Hodgkin lymphoma-like earlobe lymphoid infiltrate: case report. | The American Journal of dermatopathology 20091201 |
| Pseudoprogression and pseudoresponse in the treatment of gliomas. | Current opinion in neurology 20091201 |
| Primary cutaneous Hodgkin's lymphoma. | Clinical and experimental dermatology 20091201 |
| A novel use of temozolomide in a patient with malignant prolactinoma. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20091201 |
| Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. | International journal of radiation oncology, biology, physics 20091201 |
| Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells. | Molecular cancer research : MCR 20091201 |
| ABT-888 confers broad in vivo activity in combination with temozolomide in diverse tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20091201 |
| The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma. | Clinical lymphoma & myeloma 20091201 |
| Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase. | Molecular cancer therapeutics 20091201 |
| A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells. | Molecular cancer research : MCR 20091201 |
| Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide. | Anticancer research 20091201 |
| Therapeutic windows. | Molecular interventions 20091201 |
| [A pheochromocytoma of urinary bladder treated with neoadjuvant chemotherapy]. | Hinyokika kiyo. Acta urologica Japonica 20091201 |
| IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide. | Neurology 20091124 |
| Antitumor activity of delimotecan against human metastatic melanoma: pharmacokinetics and molecular determinants. | International journal of cancer 20091115 |
| Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma. | Cancer 20091115 |
| The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation. | Clinical cancer research : an official journal of the American Association for Cancer Research 20091115 |
| Synthesis and evaluation of a new generation of orally efficacious benzimidazole-based poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors as anticancer agents. | Journal of medicinal chemistry 20091112 |
| Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091110 |
| Hodgkin's disease of appendix: report of a case. | Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20091101 |
| Primary malignant melanoma of the vagina. | Archives of gynecology and obstetrics 20091101 |
| Preoperative intensity-modulated radiotherapy combined with temozolomide for locally advanced soft-tissue sarcoma. | International journal of radiation oncology, biology, physics 20091101 |
| Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition. | Cancer chemotherapy and pharmacology 20091101 |
| Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20091101 |
| Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas. | Clinical neurology and neurosurgery 20091101 |
| Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant. | The American journal of surgical pathology 20091101 |
| New advances that enable identification of glioblastoma recurrence. | Nature reviews. Clinical oncology 20091101 |
| The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas. | Neurosurgery 20091101 |
| Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma. | Leukemia & lymphoma 20091101 |
| Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme. | Expert review of anticancer therapy 20091101 |
| The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20091101 |
| Neoadjuvant chemoradiation therapy for soft tissue sarcomas of the extremities. | Clinics (Sao Paulo, Brazil) 20091101 |
| [Malignant paraganglioma responsive to CVD therapy and radiation therapy : a case report]. | Hinyokika kiyo. Acta urologica Japonica 20091101 |
| [Metastatic malignant melanoma of the urinary bladder: a case report]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20091101 |
| Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT. | Anticancer research 20091101 |
| [Management of lymphoma with respect to pathologic classification: updates and controversies]. | Zhonghua bing li xue za zhi = Chinese journal of pathology 20091101 |
| [Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma]. | Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20091101 |
| Carney triad in an adult with aggressive behavior: the first case in Korea. | Yonsei medical journal 20091031 |
| Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling. | Cancer letters 20091018 |
| Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma. | Cancer 20091015 |
| Enhancement of cancer chemotherapy by simultaneously altering cell cycle progression and DNA-damage defenses through global modification of the serine/threonine phospho-proteome. | Cell cycle (Georgetown, Tex.) 20091015 |
| DNA ligase IV as a new molecular target for temozolomide. | Biochemical and biophysical research communications 20091002 |
| Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma. | Investigational new drugs 20091001 |
| Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations. | Surgical neurology 20091001 |
| Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model. | Cancer immunology, immunotherapy : CII 20091001 |
| Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma. | Neuro-oncology 20091001 |
| CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma. | Cancer gene therapy 20091001 |
| Early metabolic responses in temozolomide treated low-grade glioma patients. | Journal of neuro-oncology 20091001 |
| Glioma-associated endothelial cells are chemoresistant to temozolomide. | Journal of neuro-oncology 20091001 |
| Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma. | American journal of clinical oncology 20091001 |
| Non-Hodgkin lymphoma following temozolomide. | Pediatric blood & cancer 20091001 |
| The prognostic role of Beclin 1 protein expression in high-grade gliomas. | Autophagy 20091001 |
| The gallium complex KP46 exerts strong activity against primary explanted melanoma cells and induces apoptosis in melanoma cell lines. | Melanoma research 20091001 |
| Management of glioblastoma multiforme in HIV patients: a case series and review of published studies. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20091001 |
| High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease. | European journal of endocrinology 20091001 |
| A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells. | Cancer chemotherapy and pharmacology 20091001 |
| Successful chemotherapy of hepatic metastases in a case of succinate dehydrogenase subunit B-related paraganglioma. | Endocrine 20091001 |
| Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience. | Clinical neurology and neurosurgery 20091001 |
| The translesion polymerase Rev3L in the tolerance of alkylating anticancer drugs. | Molecular pharmacology 20091001 |
| Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy. | European journal of endocrinology 20091001 |
| Insights into pharmacotherapy of malignant glioma in adults. | Expert opinion on pharmacotherapy 20091001 |
| Neurological adverse effects caused by cytotoxic and targeted therapies. | Nature reviews. Clinical oncology 20091001 |
| Promoter methylation and expression analysis of MGMT in advanced pediatric brain tumors. | Oncology reports 20091001 |
| Unintended pregnancy after gonadal failure chemoprevention with gonadotropin-releasing hormone agonist in women with hematologic malignancies. | Fertility and sterility 20091001 |
| Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model. | Cancer biology & therapy 20091001 |
| Dacarbazine induced acute myeloid leukemia in melanoma. | Melanoma research 20091001 |
| Effect of DNA repair host factors on temozolomide or dacarbazine melanoma treatment in Caucasians. | Pharmacogenetics and genomics 20091001 |
| Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen. | Leukemia & lymphoma 20091001 |
| Rituximab maintenance therapy in central nervous system lymphoma? | Leukemia & lymphoma 20091001 |
| Recognition of O6MeG lesions by MGMT and mismatch repair proficiency may be a prerequisite for low-dose radiation hypersensitivity. | Radiation research 20091001 |
| Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy. | The oncologist 20091001 |
| Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly(ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo? | Clinical cancer research : an official journal of the American Association for Cancer Research 20091001 |
| Acquired resistance to combination treatment with temozolomide and ABT-888 is mediated by both base excision repair and homologous recombination DNA repair pathways. | Molecular cancer research : MCR 20091001 |
| Supratentorial, extraventricular choroid plexus carcinoma in an adult: case report. | Neurosurgery 20091001 |
| [Therapeutic strategy for pheochromocytoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091001 |
| p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor. | Anticancer research 20091001 |
| A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomide-refractory high-grade malignant glioma. | Anticancer research 20091001 |
| Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up. | Leukemia & lymphoma 20091001 |
| [Medical management of primary central nervous system lymphoma refractory or resistant to standard of care treatment]. | Brain and nerve = Shinkei kenkyu no shinpo 20091001 |
| [Study on mesenchymal stem cells mediated enzyme-prodrug gene CYP1A2 targeting anti-tumor effect]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20091001 |
| A sinister itch: prurigo nodularis in Hodgkin lymphoma. | The Journal of the Association of Physicians of India 20091001 |
| Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090920 |
| Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). | Cancer chemotherapy and pharmacology 20090901 |
| The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience. | Annals of hematology 20090901 |
| The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment. | Journal of cellular and molecular medicine 20090901 |
| Carbonate and carbamate derivatives of 4-demethylpenclomedine as novel anticancer agents. | Cancer chemotherapy and pharmacology 20090901 |
| Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection. | Journal of neuro-oncology 20090901 |
| Cytomegalovirus associated colonic pseudotumor: a consequence of iatrogenic immunosuppression in a patient with primary brain tumor receiving radiation and temozolomide. | Journal of neuro-oncology 20090901 |
| Clinical utility of temozolomide in the treatment of malignant paraganglioma: a preliminary report. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20090901 |
| Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. | Cancer 20090901 |
| Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20090901 |
| Temozolomide in malignant gliomas: current use and future targets. | Cancer chemotherapy and pharmacology 20090901 |
| Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090901 |
| A rare case of aplastic anemia caused by temozolomide. | Southern medical journal 20090901 |
| Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables. | AAPS PharmSciTech 20090901 |
| Treatment of malignant pheochromocytoma. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20090901 |
| Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters. | AAPS PharmSciTech 20090901 |
| Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts. | International journal of radiation oncology, biology, physics 20090901 |
| Glioblastoma masquerading as a hypertensive putaminal hemorrhage: a diagnostic pitfall. | Neurologia medico-chirurgica 20090901 |
| Population-based study of pseudoprogression after chemoradiotherapy in GBM. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20090901 |
| Recurrent PNET with MGMT methylation responds to temozolomide. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20090901 |
| Six year survival after prolonged temozolomide treatment in a 30-year-old patient with glioblastoma. | Acta neurologica Belgica 20090901 |
| Radiation dose and breast cancer risk in the childhood cancer survivor study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090820 |
| Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. | Cancer letters 20090818 |
| Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study. | British journal of cancer 20090818 |
| Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme. | British journal of cancer 20090818 |
| Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090810 |
| Societal preference values for advanced melanoma health states in the United Kingdom and Australia. | British journal of cancer 20090804 |
| [A multicenter randomized controlled study of temozolomide in 97 patients with malignant brain glioma]. | Zhonghua yi xue za zhi 20090804 |
| Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours. | Clinical endocrinology 20090801 |
| Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology? | Journal of neuro-oncology 20090801 |
| Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression. | Journal of neuro-oncology 20090801 |
| Low-grade gliomas. | Current treatment options in oncology 20090801 |
| IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. | International journal of cancer 20090801 |
| Cancer cell death by design: apoptosis, autophagy and glioma virotherapy. | Autophagy 20090801 |
| A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma. | Cancer investigation 20090801 |
| Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy. | The Journal of clinical endocrinology and metabolism 20090801 |
| Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy. | Cancer 20090801 |
| Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. | Cancer 20090801 |
| Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients. | Melanoma research 20090801 |
| Retrieval of immature oocytes after chemotherapy for Hodgkin's disease and prolonged ovarian down-regulation with gonadotropin-releasing hormone agonist. | Fertility and sterility 20090801 |
| Nodular malignant melanoma and multiple cutaneous neoplasms under immunosuppression with azathioprine. | Melanoma research 20090801 |
| Utility of adjuvant systemic therapy in melanoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20090801 |
| Small molecules and targeted therapies in distant metastatic disease. | Annals of oncology : official journal of the European Society for Medical Oncology 20090801 |
| Immunotherapy of distant metastatic disease. | Annals of oncology : official journal of the European Society for Medical Oncology 20090801 |
| A systematic review of health-related quality of life in cutaneous melanoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20090801 |
| Biomarkers in melanoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20090801 |
| Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090801 |
| Comment re: Temozolomide preferentially depletes cancer stem cells. | Cancer research 20090801 |
| Diagnosis and management of leptomeningeal disease. | Clinical journal of oncology nursing 20090801 |
| Hypersensitivity pneumonitis associated with temozolomide. | The European respiratory journal 20090801 |
| Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20090801 |
| Expressions of uroplakins in the mouse urinary bladder with cyclophosphamide-induced cystitis. | Journal of Korean medical science 20090801 |
| Methionine restriction reduces the chemosensitivity of central nervous system tumour cell lines. | Anticancer research 20090801 |
| First experiences with low-dose anti-angiogenic treatment in gliomatosis cerebri with signs of angiogenic activity. | Anticancer research 20090801 |
| Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity. | Molecular cancer therapeutics 20090801 |
| [Recent trends in the pathophysiology and treatment of pituitary adenomas]. | Brain and nerve = Shinkei kenkyu no shinpo 20090801 |
| Radiotherapy for metastatic brain tumors. | International journal of clinical oncology 20090801 |
| Bilateral adrenal leiomyosarcoma treated with multiple local therapies. | International journal of clinical oncology 20090801 |
| Metastatic pleomorphic sarcoma to left atrium. | Rare tumors 20090722 |
| MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090715 |
| Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. | British journal of cancer 20090707 |
| Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. | Annals of hematology 20090701 |
| Application of prolonged microdialysis sampling in carboplatin-treated cancer patients. | Cancer chemotherapy and pharmacology 20090701 |
| High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. | Journal of neuro-oncology 20090701 |
| Multiple intracranial melanoma metastases: case report and review of the literature. | Journal of neuro-oncology 20090701 |
| Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma. | Pediatric blood & cancer 20090701 |
| Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma. | Cancer 20090701 |
| LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951). | European journal of cancer (Oxford, England : 1990) 20090701 |
| The safety of temozolomide in the treatment of malignancies. | Expert opinion on drug safety 20090701 |
| In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene. | The Journal of clinical investigation 20090701 |
| Effect of IFN-beta on human glioma cell lines with temozolomide resistance. | International journal of oncology 20090701 |
| FEN1 is overexpressed in testis, lung and brain tumors. | Anticancer research 20090701 |
| Pseudoprogression and MGMT status in glioblastoma patients: implications in clinical practice. | Anticancer research 20090701 |
| [Clinicopathological diagnosis of gliomas by genotype analysis]. | Brain and nerve = Shinkei kenkyu no shinpo 20090701 |
| [Treatment of glioma with temozolomide]. | Brain and nerve = Shinkei kenkyu no shinpo 20090701 |
| Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090610 |
| Glioblastoma stem cells resistant to temozolomide-induced autophagy. | Chinese medical journal 20090605 |
| Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro. | Chinese medical journal 20090605 |
| Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts. | Neuro-oncology 20090601 |
| Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model. | Neuro-oncology 20090601 |
| Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma. | Cancer chemotherapy and pharmacology 20090601 |
| Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide. | The Journal of investigative dermatology 20090601 |
| Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies. | International journal of radiation oncology, biology, physics 20090601 |
| Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia. | Journal of neuro-oncology 20090601 |
| Disposition of temozolomide in a patient with glioblastoma multiforme after gastric bypass surgery. | Journal of neuro-oncology 20090601 |
| Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models. | Journal of neuro-oncology 20090601 |
| Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only. | The Journal of clinical endocrinology and metabolism 20090601 |
| Progress of multiple cutaneous and subcutaneous melanoma metastases of the face during imiquimod treatment. | Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20090601 |
| Long-term use of temozolomide: could you use temozolomide safely for life in gliomas? | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20090601 |
| Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma. | Melanoma research 20090601 |
| The history and future of chemotherapy for melanoma. | Hematology/oncology clinics of North America 20090601 |
| Novel therapeutics for melanoma. | Expert review of anticancer therapy 20090601 |
| Ramucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR-2 for the potential treatment of cancer. | Current opinion in investigational drugs (London, England : 2000) 20090601 |
| Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme. | Expert review of pharmacoeconomics & outcomes research 20090601 |
| Biochemotherapy in the treatment of metastatic melanoma in selected patients. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090601 |
| Cell cycle effects and increased adduct formation by temozolomide enhance the effect of cytotoxic and targeted agents in lung cancer cell lines. | Journal of chemotherapy (Florence, Italy) 20090601 |
| Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil. | Clinics (Sao Paulo, Brazil) 20090601 |
| [Central nervous system glioma. Multi-drug chemotherapy including temozolomide]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090601 |
| [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma]. | Ai zheng = Aizheng = Chinese journal of cancer 20090601 |
| [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients]. | Kaku igaku. The Japanese journal of nuclear medicine 20090601 |
| Mapping the literature: role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcoma. | Drugs of today (Barcelona, Spain : 1998) 20090601 |
| Molecular markers of tumor progression in melanoma. | Current genomics 20090601 |
| The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study. | Journal of the Egyptian National Cancer Institute 20090601 |
| EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. | Cancer research 20090515 |
| Folate supplementation limits the aggressiveness of glioma via the remethylation of DNA repeats element and genes governing apoptosis and proliferation. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090515 |
| Hodgkin lymphoma with cutaneous involvement. | Dermatology online journal 20090515 |
| Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain--results of the LEARN Study. | European journal of cancer care 20090501 |
| Efficacy of temozolomide for recurrent embryonal brain tumors in children. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20090501 |
| Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: tumour progression or radionecrosis? | Clinical neurology and neurosurgery 20090501 |
| Rechallenge with temozolomide in patients with recurrent gliomas. | Journal of neurology 20090501 |
| Sunitinib, a novel therapy for anthracycline- and cisplatin-refractory malignant pheochromocytoma. | Japanese journal of clinical oncology 20090501 |
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. | The Lancet. Oncology 20090501 |
| The combination topotecan, temozolomide and dexamethasone associated with radiotherapy as treatment of central nervous system myeloma relapse. | International journal of hematology 20090501 |
| Endogenous Noxa Determines the Strong Proapoptotic Synergism of the BH3-Mimetic ABT-737 with Chemotherapeutic Agents in Human Melanoma Cells. | Translational oncology 20090501 |
| Antifolate activity of pyrimethamine enhances temozolomide-induced cytotoxicity in melanoma cells. | Molecular cancer research : MCR 20090501 |
| Carboplatin and vinorelbine combined with subcutaneous interleukin-2 in metastatic melanoma with poor prognosis. | Anticancer research 20090501 |
| Novel therapeutics for the treatment of metastatic melanoma. | Future oncology (London, England) 20090501 |
| [Prescription guidebook for temozolomide usage in brain tumors]. | Bulletin du cancer 20090501 |
| A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma. | British journal of cancer 20090421 |
| O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib. | British journal of cancer 20090421 |
| Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article. | Molecules (Basel, Switzerland) 20090416 |
| G3139, an anti-Bcl-2 antisense oligomer that binds heparin-binding growth factors and collagen I, alters in vitro endothelial cell growth and tubular morphogenesis. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090415 |
| Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo. | British journal of cancer 20090407 |
| Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis. | Blood 20090402 |
| Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells. | Neuro-oncology 20090401 |
| Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131. | Neuro-oncology 20090401 |
| Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases. | Neuro-oncology 20090401 |
| Prolonged and severe thrombocytopenia with pancytopenia induced by radiation-combined temozolomide therapy in a patient with newly diagnosed glioblastoma--analysis of O6-methylguanine-DNA methyltransferase status. | Journal of neuro-oncology 20090401 |
| Possible leukemogenic potential of temozolomide. | Pediatric blood & cancer 20090401 |
| Combined magnetic resonance and fluorescence imaging of the living mouse brain reveals glioma response to chemotherapy. | NeuroImage 20090401 |
| Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20090401 |
| Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma. | Oncology reports 20090401 |
| Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090401 |
| Hypersensitivity pneumonitis associated with the use of temozolomide. | The European respiratory journal 20090401 |
| BNIP3 (Bcl-2 19 kDa interacting protein) acts as transcriptional repressor of apoptosis-inducing factor expression preventing cell death in human malignant gliomas. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20090401 |
| Use of temozolomide in aggressive pituitary tumors: case report. | Neurosurgery 20090401 |
| Hodgkin lymphoma presenting as a vulvar mass in a patient with crohn disease: a case report and literature review. | Journal of lower genital tract disease 20090401 |
| Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial. | Clinical lymphoma & myeloma 20090401 |
| Malignant melanoma therapy by chemotherapy and autoimmunity induced by cytokine. | Cancer biotherapy & radiopharmaceuticals 20090401 |
| Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090315 |
| Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090310 |
| Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090310 |
| Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090310 |
| Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090310 |
| Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090310 |
| The side story of stem-like glioma cells. | Cell stem cell 20090306 |
| PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. | Cell stem cell 20090306 |
| Melanocytoma in the orbital apex. | Journal of neuro-oncology 20090301 |
| Tuberculosis in a patient on temozolomide: a case report. | Journal of neuro-oncology 20090301 |
| ACNU-based chemotherapy for recurrent glioma in the temozolomide era. | Journal of neuro-oncology 20090301 |
| Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model. | Journal of neuro-oncology 20090301 |
| Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma. | Journal of neuro-oncology 20090301 |
| Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. | Journal of neurosurgery 20090301 |
| O(6)-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment? | Cancer 20090301 |
| Unintended pregnancy during radiotherapy for cancer. | Nature clinical practice. Oncology 20090301 |
| Inverse-electron-demand Diels-Alder reaction as a highly efficient chemoselective ligation procedure: synthesis and function of a BioShuttle for temozolomide transport into prostate cancer cells. | Journal of peptide science : an official publication of the European Peptide Society 20090301 |
| Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells. | Cancer research 20090301 |
| [Evaluation of stability of temozolomide in solutions after opening the capsule]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20090301 |
| Management of temozolomide toxicity by nurse practitioners in neuro-oncology. | Oncology nursing forum 20090301 |
| Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy. | Molecular cancer therapeutics 20090301 |
| [A case of sarcomatoid malignant peritoneal mesothelioma responding to combination chemotherapy of cyclophosphamide, vincristine, adriamycin and dacarbazine(CYVADIC)]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090301 |
| Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide. | Cancer biology & therapy 20090301 |
| [Association of radiotherapy and chemotherapy-targeted therapies in glioblastomas]. | Bulletin du cancer 20090301 |
| [Biological basis of chemo-radiotherapy associations]. | Bulletin du cancer 20090301 |
| [Predictive molecular pathological testing in the diagnosis of high-grade tumors of glial origin]. | Magyar onkologia 20090301 |
| Chemotherapy for Langerhans cell sarcoma. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20090301 |
| [Research and therapeutic trials on gliomas]. | Soins; la revue de reference infirmiere 20090301 |
| Efficacy of temozolomide treatment in patients with high-grade glioma. | Anticancer research 20090301 |
| [ABVD chemotherapy scheme at day 1 and 8 for treatment of primary Hodgkin's lymphomas]. | Zhonghua nei ke za zhi 20090301 |
| Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090215 |
| ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090210 |
| Integrating BRAF/MEK inhibitors into combination therapy for melanoma. | British journal of cancer 20090210 |
| Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy. | British journal of cancer 20090210 |
| Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells. | Biochemical and biophysical research communications 20090206 |
| Leser-Trelat sign in metastasized malignant melanoma. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20090201 |
| Brazilian marine sponge Polymastia janeirensis induces apoptotic cell death in human U138MG glioma cell line, but not in a normal cell culture. | Investigational new drugs 20090201 |
| Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis. | International journal of radiation oncology, biology, physics 20090201 |
| Quality of life in low-grade glioma patients receiving temozolomide. | Neuro-oncology 20090201 |
| New (alternative) temozolomide regimens for the treatment of glioma. | Neuro-oncology 20090201 |
| The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivity. | Neuro-oncology 20090201 |
| Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. | International journal of radiation oncology, biology, physics 20090201 |
| Concomitant (without adjuvant) temozolomide and radiation to treat glioblastoma: a retrospective study. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20090201 |
| Stability of antineoplastic agents in use for home-based intravenous chemotherapy. | Pharmacy world & science : PWS 20090201 |
| Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201 |
| Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse. | Melanoma research 20090201 |
| Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines. | Molecular cancer therapeutics 20090201 |
| The surgical and systemic management of neuroendocrine tumors of the pancreas. | The Surgical clinics of North America 20090201 |
| Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma. | Molecular cancer therapeutics 20090201 |
| Editorial: on the road to multi-modal and pluri-disciplinary treatment of glioblastomas. | Acta neurochirurgica 20090201 |
| Impressive regression of visceral and cerebral melanoma metastases under combination treatment including dacarbacine, radiotherapy and celecoxib. | International journal of dermatology 20090201 |
| [Primary multifocal osseous Hodgkin lymphoma]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20090201 |
| Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines. | International journal of radiation biology 20090201 |
| Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease. | Anticancer research 20090201 |
| A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence. | Melanoma research 20090201 |
| Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53. | British journal of cancer 20090127 |
| Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. | Journal of medicinal chemistry 20090122 |
| Genomic and molecular profiling predicts response to temozolomide in melanoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090115 |
| In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090115 |
| Activation of KATP channels increases anticancer drug delivery to brain tumors and survival. | European journal of pharmacology 20090114 |
| A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma. | British journal of cancer 20090113 |
| Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases. | Brain pathology (Zurich, Switzerland) 20090101 |
| A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20090101 |
| Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. | Journal of neuro-oncology 20090101 |
| Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients. | Journal of neuro-oncology 20090101 |
| Bone marrow transplantation for severe aplastic anemia secondary to temozolomide. | Journal of neuro-oncology 20090101 |
| Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients. | International journal of cancer 20090101 |
| Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs. | DNA repair 20090101 |
| Independent association of extent of resection with survival in patients with malignant brain astrocytoma. | Journal of neurosurgery 20090101 |
| MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. | European journal of cancer (Oxford, England : 1990) 20090101 |
| Treatment of Nelson's syndrome with temozolomide. | European journal of endocrinology 20090101 |
| Management of aggressive pituitary adenomas: current treatment strategies. | Pituitary 20090101 |
| Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation. | Acta oncologica (Stockholm, Sweden) 20090101 |
| Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy. | Oncology 20090101 |
| [Diagnostic and treatment delays do not modify the treatment outcome of patients with multiform glioblastoma]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20090101 |
| A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients. | Cancer research 20090101 |
| Phase II study of protracted daily temozolomide for low-grade gliomas in adults. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090101 |
| O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090101 |
| Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields). | BMC medical physics 20090101 |
| Continuous administration of daily low-dose temozolomide in pretreated patients with advanced non-small cell lung cancer: a phase II study. | Oncology 20090101 |
| Recent approaches to improve the antitumor efficacy of temozolomide. | Current medicinal chemistry 20090101 |
| Synchronously diagnosed eosinophilic granuloma and Hodgkin's disease in a 12-year-old boy: a case report. | Journal of medical case reports 20090101 |
| [Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases]. | Journal de radiologie 20090101 |
| Drugs targeting the mitochondrial pore act as cytotoxic and cytostatic agents in temozolomide-resistant glioma cells. | Journal of translational medicine 20090101 |
| Nodular melanoma presenting with rapid progression and widespread metastases: a case report. | Journal of medical case reports 20090101 |
| Modulation of the efficacy of temozolomide and dacarbazine melanoma treatment by DNA-repair factors in vivo and in vitro. | International journal of clinical pharmacology and therapeutics 20090101 |
| Localized BCNU chemotherapy and the multimodal management of malignant glioma. | Current medical research and opinion 20090101 |
| Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors. | PloS one 20090101 |
| Thymic hyperplasia following successful chemotherapy for Hodgkin's lymphoma: report of a case. | Chang Gung medical journal 20090101 |
| Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation. | BMC cancer 20090101 |
| HIV-associated Hodgkin lymphoma. | Current opinion in HIV and AIDS 20090101 |
| Current concepts and newer developments in the treatment of malignant gliomas. | Indian journal of cancer 20090101 |
| Treatment of early uterine sarcomas: disentangling adjuvant modalities. | World journal of surgical oncology 20090101 |
| Effects of fotemustine or dacarbasine on a melanoma cell line pretreated with therapeutic proton irradiation. | Journal of experimental & clinical cancer research : CR 20090101 |
| Evidence of gamma-tocotrienol as an apoptosis-inducing, invasion-suppressing, and chemotherapy drug-sensitizing agent in human melanoma cells. | Nutrition and cancer 20090101 |
| Myxoid liposarcoma: a rare soft-tissue tumor with a misleading benign appearance. | World journal of surgical oncology 20090101 |
| Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: a retrospective analysis. | Chemotherapy 20090101 |
| Combined modality treatment of Hodgkin's lymphoma. | Cancer journal (Sudbury, Mass.) 20090101 |
| Role of chemotherapy in Hodgkin's lymphoma. | Cancer journal (Sudbury, Mass.) 20090101 |
| Role of radiation therapy in Hodgkin's lymphoma. | Cancer journal (Sudbury, Mass.) 20090101 |
| Primary diffuse leptomeningeal gliomatosis. | European neurology 20090101 |
| Adult-generated hippocampal neurons allow the flexible use of spatially precise learning strategies. | PloS one 20090101 |
| Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma. | Chemotherapy 20090101 |
| CTLA4 blockade increases Th17 cells in patients with metastatic melanoma. | Journal of translational medicine 20090101 |
| Management of malignant melanoma: best practices. | Journal of cutaneous medicine and surgery 20090101 |
| Temozolomide and cisplatin in relapsed/refractory acute leukemia. | Journal of hematology & oncology 20090101 |
| Stevens-Johnson Syndrome and toxic epidermal necrolysis overlap due to oral temozolomide and cranial radiotherapy. | American journal of clinical dermatology 20090101 |
| Temozolomide: a safe and effective treatment for malignant digestive endocrine tumors. | Neuroendocrinology 20090101 |
| Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis. | Radiation oncology (London, England) 20090101 |
| Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis. | Tumori 20090101 |
| Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases. | PloS one 20090101 |
| Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma. | BMC cancer 20090101 |
| Prognostic factors other than the performance status and age for glioblastoma multiforme: a single-institution experience. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101 |
| Diffuse anorectal melanoma; review of the current diagnostic and treatment aspects based on a case report. | World journal of surgical oncology 20090101 |
| RNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway. | PloS one 20090101 |
| Three-dimensional conformal radiotherapy, temozolomide chemotherapy, and high-dose fractionated stereotactic boost in a protocol-driven, postoperative treatment schedule for high-grade gliomas. | Tumori 20090101 |
| Long-term pegylated interferon-alpha and its potential in the treatment of melanoma. | Biologics : targets & therapy 20090101 |
| Dacarbazine as single-agent therapy for relapsed lymphoma in dogs. | Journal of veterinary internal medicine 20090101 |
| Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs. | Journal of experimental & clinical cancer research : CR 20090101 |
| Primary cardiac angiosarcoma: a fatal disease. | Case reports in medicine 20090101 |
| RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study. | BMC cancer 20090101 |
| Long-term survival of patients treated for Hodgkin's disease in 1971-1996 depending on the clinical stage of the disease, patient's fertility after therapy and cause of death analysis. | Neoplasma 20090101 |
| [Primary pulmonary sarcomas]. | Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20090101 |
| Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine. | Hepato-gastroenterology 20090101 |
| Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers. | Biologics : targets & therapy 20090101 |
| Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting. | Journal of experimental & clinical cancer research : CR 20090101 |
| Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells. | Molecular cancer 20090101 |
| Drugs associated with more suicidal ideations are also associated with more suicide attempts. | PloS one 20090101 |
| Familial adenomatous polyposis. | Orphanet journal of rare diseases 20090101 |
| Nasal mucosal melanoma presenting as central type vertigo: a case report. | Cases journal 20090101 |
| Sarcoidosis mimicking lymphoma on positron emission tomography-computed tomography in two patients treated for lymphoma: two case reports. | Journal of medical case reports 20090101 |
| Two Cases of Retroperitoneal Liposarcoma Diagnosed Using Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA). | Diagnostic and therapeutic endoscopy 20090101 |
| Bleomycin induced urethral stricture in Hodgkin's disease. | Indian journal of urology : IJU : journal of the Urological Society of India 20090101 |
| [Evaporation of selected cytotoxic drugs and permeation of protective gloves--research into the occupational risks of health care personnel handling hazardous cytotoxic drugs (CYTO project)]. | Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20090101 |
| Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network. | BMC cancer 20090101 |
| [Serious cutaneous toxicity following ifosfamide, gemcitabine and vinorelbine therapy in a patient with relapsed Hodgkin lymphoma and ichthyosis]. | Casopis lekaru ceskych 20090101 |
| Preparation and the influencing factors of timozolomide liposomes. | Artificial cells, blood substitutes, and immobilization biotechnology 20090101 |
| Effective palliative radiotherapy in primary malignant melanoma of the esophagus: a case report. | Cases journal 20090101 |
| Primary leiomyosarcoma of the male urethra: a case report. | Cases journal 20090101 |
| Metastatic Melanoma presenting 24 years after surgical resection: a case report and review of the literature. | Cases journal 20090101 |
| High-resolution flow cytometry: a suitable tool for monitoring aneuploid prostate cancer cells after TMZ and TMZ-BioShuttle treatment. | International journal of medical sciences 20090101 |
| Standard therapy of advanced Hodgkin lymphoma. | Hematology. American Society of Hematology. Education Program 20090101 |
| Congenital desmoid tumor of the cheek: a clinicopathological case report. | Eplasty 20090101 |
| Postirradiation sarcoma: clinicopathologic features and role of chemotherapy in the treatment strategy. | Sarcoma 20090101 |
| Hodgkin's lymphoma presenting with markedly elevated IgE: a case report. | Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20090101 |
| Effect of temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma. | Hormones (Athens, Greece) 20090101 |
| Targeted therapy in melanoma. | Biologics : targets & therapy 20090101 |
| Antiangiogenic therapy in the treatment of recurrent medulloblastoma in the adult: case report and review of the literature. | Journal of oncology 20090101 |
| Metastatic melanoma: case report of a patient with seventeen months of complete remission, five years survival and review of the literature. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101 |
| A small interference RNA screen revealed proteasome inhibition as strategy for glioblastoma therapy. | Clinical neurosurgery 20090101 |
| Tumor lysis syndrome associated with chemotherapy in primary retroperitoneal soft tissue sarcoma by ex vivo ATP-based tumor chemo-sensitivity assay (ATP-TCA). | International journal of general medicine 20090101 |
| Role of trabectedin in the treatment of soft tissue sarcoma. | OncoTargets and therapy 20090101 |
| Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy. | Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20090101 |
| Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron. | Cancer management and research 20090101 |
| Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations. | Cancer management and research 20090101 |
| Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy. | Cancer management and research 20090101 |
| Pleural epithelioid hemangioendothelioma. | Yonsei medical journal 20081231 |
| Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group. | Cancer 20081215 |
| Current management of metastatic melanoma. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081215 |
| Targeting metastatic melanoma. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081215 |
| p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts. | Cancer research 20081215 |
| Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081210 |
| Assessment of the inhibitory effects of different radiation qualities or chemotherapeutic agents on a human melanoma cell line. | Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) 20081201 |
| Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic disease. | Investigational new drugs 20081201 |
| Enhancement of survival of 9L gliosarcoma bearing rats following intracerebral delivery of drugs in combination with microbeam radiation therapy. | European journal of radiology 20081201 |
| A novel tool to analyze MRI recurrence patterns in glioblastoma. | Neuro-oncology 20081201 |
| Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas. | Journal of neuro-oncology 20081201 |
| Biochemotherapy in patients with advanced head and neck mucosal melanoma. | Head & neck 20081201 |
| Silencing DNA methyltransferase (DNMT) enhances glioma chemosensitivity. | Oligonucleotides 20081201 |
| Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib. | Nature clinical practice. Oncology 20081201 |
| Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081201 |
| Differential effects of imatinib mesylate against uveal melanoma in vitro and in vivo. | Melanoma research 20081201 |
| Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanoma. | Oncology reports 20081201 |
| LED phototherapy to prevent mucositis: a case report. | Photomedicine and laser surgery 20081201 |
| Breast cancer after treatment of Hodgkin's lymphoma: general review. | International journal of radiation oncology, biology, physics 20081201 |
| Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens: is the survival really so impressive?: in regard to Combs et al. (Int J Radiat Oncol Biol Phys 2008;71:999-1005). | International journal of radiation oncology, biology, physics 20081201 |
| Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression. | Clinical cancer research : an official journal of the American Association for Cancer Research 20081201 |
| Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20081201 |
| Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model. | Neoplasia (New York, N.Y.) 20081201 |
| Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells. | Molecular cancer therapeutics 20081201 |
| IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression. | Molecular cancer therapeutics 20081201 |
| Radiotherapy followed by adjuvant temozolomide treatment of malignant glioma. | Surgical neurology 20081201 |
| Pituitary carcinoma presenting with multiple metastases: case report. | Journal of child neurology 20081201 |
| Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide. | Acta neurologica Belgica 20081201 |
| Systems biology: a therapeutic target for tumor therapy. | Cancer microenvironment : official journal of the International Cancer Microenvironment Society 20081201 |
| Novel microtubule-targeting agents - the epothilones. | Biologics : targets & therapy 20081201 |
| [Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?]. | Orvosi hetilap 20081123 |
| Proapoptotic receptor agonists, targeted radionuclide therapy, and the treatment of central nervous system malignancies: in regard to Fiveash et Al. (Int J Radiat Oncol Biol Phys 2008;71:507-516). | International journal of radiation oncology, biology, physics 20081115 |
| Hodgkin lymphoma in older patients: an uncommon disease in need of study. | Oncology (Williston Park, N.Y.) 20081115 |
| Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081110 |
| Antitumor efficacy testing in rodents. | Journal of the National Cancer Institute 20081105 |
| Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20081101 |
| Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. | Journal of neuro-oncology 20081101 |
| Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study. | Human reproduction (Oxford, England) 20081101 |
| Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts. | Neurological research 20081101 |
| Disseminated salmonellosis in a patient treated with temozolomide. | The Journal of infection 20081101 |
| Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery. | Molecular therapy : the journal of the American Society of Gene Therapy 20081101 |
| Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases. | Cancer 20081101 |
| Characterization of a side population of astrocytoma cells in response to temozolomide. | Journal of neurosurgery 20081101 |
| [Combined treatment with dacarbazine, nimustine, cisplatin, and tamoxifen plus interferon-beta in a patient with advanced anorectal malignant melanoma]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20081101 |
| Treatment-related myelodysplastic syndrome after temozolomide use in a child: first report. | Journal of pediatric hematology/oncology 20081101 |
| Methylation status of MGMT gene promoter in meningiomas. | Cancer genetics and cytogenetics 20081101 |
| Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide. | Molecular cancer therapeutics 20081101 |
| Erythropoietin augments survival of glioma cells after radiation and temozolomide. | International journal of radiation oncology, biology, physics 20081101 |
| Assessment of ovarian reserve following ovarian tissue banking and/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin's disease. | Journal of assisted reproduction and genetics 20081101 |
| Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20081101 |
| Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081020 |
| Validated hydrophilic interaction LC-MS/MS method for simultaneous quantification of dacarbazine and 5-amino-4-imidazole-carboxamide in human plasma. | Talanta 20081019 |
| An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitors. | Analytical biochemistry 20081015 |
| Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the 'rescue' approach. | Cancer 20081015 |
| Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients. | Cancer 20081015 |
| Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study. | Cancer 20081015 |
| DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081010 |
| Temozolomide for high grade glioma. | The Cochrane database of systematic reviews 20081008 |
| Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials. | Annals of oncology : official journal of the European Society for Medical Oncology 20081001 |
| Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomide. | Pediatric blood & cancer 20081001 |
| A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma. | Cancer 20081001 |
| Effects, in an in-vivo model system, of 1,2,3,4-tetrahydroisoquinoline on glioma. | Anti-cancer drugs 20081001 |
| Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma. | International journal of radiation oncology, biology, physics 20081001 |
| PARP inhibitors and cancer therapy - early results and potential applications. | The British journal of radiology 20081001 |
| A multicenter phase I trial of interferon-beta and temozolomide combination therapy for high-grade gliomas (INTEGRA Study). | Japanese journal of clinical oncology 20081001 |
| Potentiation of temozolomide cytotoxicity by poly(ADP)ribose polymerase inhibitor ABT-888 requires a conversion of single-stranded DNA damages to double-stranded DNA breaks. | Molecular cancer research : MCR 20081001 |
| [Orthogonal experiments for optimizing the formulation and preparation conditions of temozolomide solid lipid nanoparticles]. | Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20081001 |
| [A case of premalignant melanosis of the vagina recurring urethral orifice and intrapelvic retroperitoneum with malignant transformation]. | Hinyokika kiyo. Acta urologica Japonica 20081001 |
| [The story about Hodgkin's lymphoma]. | Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20081001 |
| Survival from melanoma of the skin in England and Wales up to 2001. | British journal of cancer 20080923 |
| Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080920 |
| Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study. | Cancer 20080915 |
| In vitro and in vivo anticancer efficacy of unconjugated humanized anti-CEA monoclonal antibodies. | British journal of cancer 20080902 |
| Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas. | Surgical neurology 20080901 |
| Topical CpG enhances the response of murine malignant melanoma to dacarbazine. | The Journal of investigative dermatology 20080901 |
| Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas. | Journal of neuro-oncology 20080901 |
| Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. | Journal of neuro-oncology 20080901 |
| CPT-11 for recurrent temozolomide-refractory 1p19q co-deleted anaplastic oligodendroglioma. | Journal of neuro-oncology 20080901 |
| Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate. | Journal of dermatological science 20080901 |
| Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells. | Gene therapy 20080901 |
| Temozolomide for recurrent low-grade spinal cord gliomas in adults. | Cancer 20080901 |
| Treatment of Hodgkin lymphoma: the past, present, and future. | Nature clinical practice. Oncology 20080901 |
| Role of the primary care physician in Hodgkin lymphoma. | American family physician 20080901 |
| Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers. | Annals of oncology : official journal of the European Society for Medical Oncology 20080901 |
| Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20080901 |
| [Alveolo-interstitial pneumonia due to Temozolamide]. | Revue des maladies respiratoires 20080901 |
| Expression and function of bcl-2 proteins in melanoma. | Current genomics 20080901 |
| Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme. | Cancer 20080815 |
| Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability. | International journal of radiation oncology, biology, physics 20080801 |
| Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20080801 |
| Low grade astrocytoma presenting with visual loss. | Journal of neuro-oncology 20080801 |
| Cryptococcal meningitis in patients with glioma: a report of two cases. | Journal of neuro-oncology 20080801 |
| Multifocal glioblastoma multiforme with synchronous spontaneous hemorrhage: case report. | Journal of neuro-oncology 20080801 |
| Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide. | Molecular pharmacology 20080801 |
| A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood. | Neuro-oncology 20080801 |
| Mechanisms of disease: temozolomide and glioblastoma--look to the future. | Nature clinical practice. Oncology 20080801 |
| Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma. | Neuro-oncology 20080801 |
| Different initial steps of apoptosis induced by two types of antineoplastic drugs. | Biochemical pharmacology 20080801 |
| Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080801 |
| [Hepatic intra-arterial bio-chemotherapy for the treatment of melanoma patients with liver metastasis: a phase II clinical study]. | Ai zheng = Aizheng = Chinese journal of cancer 20080801 |
| Isolated neutropenia during ABVD chemotherapy for Hodgkin lymphoma does not require growth factor support. | Leukemia & lymphoma 20080801 |
| Adjuvant fermented wheat germ extract (Avemar) nutraceutical improves survival of high-risk skin melanoma patients: a randomized, pilot, phase II clinical study with a 7-year follow-up. | Cancer biotherapy & radiopharmaceuticals 20080801 |
| Optimizing radiotherapy of brain tumours by a combination of temozolomide & lonidamine. | The Indian journal of medical research 20080801 |
| [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080801 |
| In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs. | British journal of cancer 20080722 |
| Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens. | International journal of radiation oncology, biology, physics 20080715 |
| Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. | Cancer 20080715 |
| Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. | Bioorganic & medicinal chemistry 20080715 |
| Temozolomide preferentially depletes cancer stem cells in glioblastoma. | Cancer research 20080715 |
| Long-term follow-up after cancer rehabilitation using high-intensity resistance training: persistent improvement of physical performance and quality of life. | British journal of cancer 20080708 |
| Polymorphs and polymorphic cocrystals of temozolomide. | Chemistry, an Asian journal 20080707 |
| Temozolomide in combination with fotemustine in patients with metastatic melanoma. | Cancer chemotherapy and pharmacology 20080701 |
| Local therapy of cancer with free IL-2. | Cancer immunology, immunotherapy : CII 20080701 |
| A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients. | Journal of neuro-oncology 20080701 |
| AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition. | Molecular pharmacology 20080701 |
| Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance. | Molecular pharmacology 20080701 |
| Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma. | British journal of haematology 20080701 |
| Treatment and prognosis of malignant melanoma of the oral cavity: preoperative surgical procedure increases risk of distant metastasis. | Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080701 |
| Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience. | Anti-cancer drugs 20080701 |
| Modern treatment of Hodgkin lymphoma. | Current opinion in hematology 20080701 |
| Individual adjuvant therapy for malignant gliomas based on O6-methylguanine-DNA methyltransferase messenger RNA quantitation by real-time reverse-transcription polymerase chain-reaction. | Oncology reports 20080701 |
| Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal. | Journal of the American College of Surgeons 20080701 |
| Metastatic melanoma: scientific rationale for sorafenib treatment and clinical results. | Onkologie 20080701 |
| [Novel anticancer compounds induce apoptosis in human tumor cells]. | Ai zheng = Aizheng = Chinese journal of cancer 20080701 |
| [In vitro drug sensitivity profiling in melanoma]. | Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20080701 |
| Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results. | Neurological research 20080701 |
| Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20080701 |
| Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma. | Journal of pediatric hematology/oncology 20080701 |
| Stem cell-related 'self-renewal' signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080620 |
| Novel anticancer compounds induce apoptosis in melanoma cells. | Cell cycle (Georgetown, Tex.) 20080615 |
| Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis. | Annals of oncology : official journal of the European Society for Medical Oncology 20080601 |
| Evidence of galectin-1 involvement in glioma chemoresistance. | Toxicology and applied pharmacology 20080601 |
| Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma. | Cancer treatment reviews 20080601 |
| Complete response after one cycle of temozolomide in an elderly patient with glioblastoma and poor performance status. | Journal of neuro-oncology 20080601 |
| Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma. | Neuro-oncology 20080601 |
| Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults. | Neuro-oncology 20080601 |
| Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5. | International journal of radiation oncology, biology, physics 20080601 |
| Multidisciplinary management of metastatic sarcoma. | The Surgical clinics of North America 20080601 |
| Treatment of lymphocyte-predominant Hodgkin lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20080601 |
| Management of malignant glioma--quo vadis? | Onkologie 20080601 |
| Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment. | Onkologie 20080601 |
| The role of temozolomide in newly-diagnosed glioblastoma multiforme. | British journal of neurosurgery 20080601 |
| Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. | Annals of nuclear medicine 20080601 |
| [Current topics of treatment for glioma and mechanism of drug resistance]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080601 |
| A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer. | British journal of cancer 20080520 |
| Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. | Cancer research 20080515 |
| Phase II study of extended-dose temozolomide in patients with melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080510 |
| Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study. | Cancer chemotherapy and pharmacology 20080501 |
| Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20080501 |
| Effects of the VEGFR inhibitor ZD6474 in combination with radiotherapy and temozolomide in an orthotopic glioma model. | Journal of neuro-oncology 20080501 |
| The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma. | Journal of neuro-oncology 20080501 |
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. | Journal of neuro-oncology 20080501 |
| Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity. | International journal of pharmaceutics 20080501 |
| Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. | Autophagy 20080501 |
| Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival? | Journal of neuro-oncology 20080501 |
| Salvage chemotherapy with CPT-11 for recurrent temozolomide-refractory anaplastic astrocytoma. | Cancer 20080501 |
| Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanoma. | Molecular therapy : the journal of the American Society of Gene Therapy 20080501 |
| The European approach to in-transit melanoma lesions. | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20080501 |
| Focus on FOCIS: interleukin 2 treatment associated autoimmunity. | Clinical immunology (Orlando, Fla.) 20080501 |
| Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. | Journal of neuropathology and experimental neurology 20080501 |
| Modulatory effects of acetazolomide and dexamethasone on temozolomide-mediated apoptosis in human glioblastoma T98G and U87MG cells. | Cancer investigation 20080501 |
| Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501 |
| MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501 |
| Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system. | Cancer research 20080501 |
| Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. | The Lancet. Oncology 20080501 |
| Adjuvant temozolomide: how long and how much? | Expert review of anticancer therapy 20080501 |
| Combi-targeting concept: an optimized single-molecule dual-targeting model for the treatment of chronic myelogenous leukemia. | Molecular cancer therapeutics 20080501 |
| When temozolomide alone fails: adding procarbazine in salvage therapy of glioma. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20080501 |
| Noninvasive imaging of apoptosis and its application in cancer therapeutics. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080415 |
| A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation. | Cancer chemotherapy and pharmacology 20080401 |
| Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients. | Journal of neuro-oncology 20080401 |
| The apoptosome: emerging insights and new potential targets for drug design. | Pharmaceutical research 20080401 |
| The 'old drug' dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas. | Investigational new drugs 20080401 |
| Evaluation of twenty-one human adenovirus types and one infectivity-enhanced adenovirus for the treatment of malignant melanoma. | The Journal of investigative dermatology 20080401 |
| An orthotopic skull base model of malignant meningioma. | Brain pathology (Zurich, Switzerland) 20080401 |
| Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG). | Annals of oncology : official journal of the European Society for Medical Oncology 20080401 |
| ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study. | Annals of oncology : official journal of the European Society for Medical Oncology 20080401 |
| Influence of therapy on the antioxidant status in patients with melanoma. | Journal of clinical pharmacy and therapeutics 20080401 |
| Temozolomide associated with PEG-interferon in patients with metastatic melanoma: a multicenter prospective phase I/II study. | Melanoma research 20080401 |
| Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases. | Melanoma research 20080401 |
| Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080401 |
| The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma. | Oncology reports 20080401 |
| [Genetic diagnoses and individualized treatment of gliomas]. | No shinkei geka. Neurological surgery 20080401 |
| A rare case of melanoma recurring as subcutaneous metastatic melanoma with overlying ecchymoses. | Archives of dermatology 20080401 |
| Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline. | Current oncology (Toronto, Ont.) 20080401 |
| Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline. | Current oncology (Toronto, Ont.) 20080401 |
| Metastatic malignant teratoma arising from mediastinal nonseminomatous germ cell tumor: a case report. | Military medicine 20080401 |
| A multivariate analysis of patients with glioma: a treatment outcome and prognostic factor for survival. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080401 |
| Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival. | Journal of immunotoxicology 20080401 |
| Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. | International journal of radiation oncology, biology, physics 20080315 |
| Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study. | Cancer 20080315 |
| Dose-intensive chemotherapy with growth factor or autologous bone marrow/stem cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a systematic review. | Cancer 20080315 |
| Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma. | Pediatric blood & cancer 20080301 |
| Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. | Cancer chemotherapy and pharmacology 20080301 |
| Mechanism of UVA-dependent DNA damage induced by an antitumor drug dacarbazine in relation to its photogenotoxicity. | Pharmaceutical research 20080301 |
| A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases. | Journal of neuro-oncology 20080301 |
| Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma. | Journal of neuro-oncology 20080301 |
| Plitidepsin has a dual effect inhibiting cell cycle and inducing apoptosis via Rac1/c-Jun NH2-terminal kinase activation in human melanoma cells. | The Journal of pharmacology and experimental therapeutics 20080301 |
| Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas. | Cancer 20080301 |
| Temozolomide-induced desquamative skin rash in a patient with metastatic melanoma. | Pharmacotherapy 20080301 |
| Dacarbazine-Doxorubicin therapy ameliorated an extremely aggressive mesenteric desmoid tumor associated with familial adenomatous polyposis: report of a case. | Japanese journal of clinical oncology 20080301 |
| Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells. | Haematologica 20080301 |
| Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080301 |
| Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma. | Cancer research 20080301 |
| [Temozolomide: Temodal]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080301 |
| Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies. | Expert review of anticancer therapy 20080301 |
| Glioblastoma in a patient with a hereditary cancer syndrome. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20080301 |
| [The sodium pump could constitute a new target to combat glioblastomas]. | Bulletin du cancer 20080301 |
| Clinical uses of GM-CSF, a critical appraisal and update. | Biologics : targets & therapy 20080301 |
| Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080220 |
| Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri. | Neurology 20080219 |
| Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation. | Cancer 20080215 |
| Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. | The New England journal of medicine 20080214 |
| Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma. | Pediatric blood & cancer 20080201 |
| MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy. | Acta neuropathologica 20080201 |
| Defining the standard of care for high-grade glioma--a NICE deal for patients. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20080201 |
| Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases. | Gynecologic oncology 20080201 |
| Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma. | Anti-cancer drugs 20080201 |
| In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080201 |
| [Chemotherapy for brain tumors in adult patients]. | Der Nervenarzt 20080201 |
| Detection of photogenotoxicity in skin and eye in rat with the photo comet assay. | Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20080201 |
| [Recent advances in chemotherapy for malignant gliomas]. | No shinkei geka. Neurological surgery 20080201 |
| [Interferon-alpha can improve the prognosis in high-risk melanoma. Combination of surgery, cytostatics and natural IFN-alpha doubled the survival rate]. | Lakartidningen 20080201 |
| Trabectedin and its potential in the treatment of soft tissue sarcoma. | Therapeutics and clinical risk management 20080201 |
| Thymic 18F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult. | AIDS (London, England) 20080102 |
| Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms. | Leukemia research 20080101 |
| Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy. | Cancer immunology, immunotherapy : CII 20080101 |
| Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. | International journal of radiation oncology, biology, physics 20080101 |
| Adjuvant use of interferon alpha 2b is not justified in patients with stage IIb/III melanoma. | Nature clinical practice. Oncology 20080101 |
| Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors. | Surgical neurology 20080101 |
| Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study. | Neuro-oncology 20080101 |
| Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. | The Lancet. Oncology 20080101 |
| Temozolomide and resistant glioma cells. | Journal of neurosurgery 20080101 |
| Nomograms as clinicobiological predictors of survival in glioblastoma. | The Lancet. Oncology 20080101 |
| Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization. | Molecular cancer therapeutics 20080101 |
| Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate. | European journal of nuclear medicine and molecular imaging 20080101 |
| [Treatment of marignant brain tumor: today and tomorrow]. | No shinkei geka. Neurological surgery 20080101 |
| [Molecular genetic analysis for malignant gliomas: clinical implications and future directions]. | No shinkei geka. Neurological surgery 20080101 |
| Overcoming therapeutic resistance in malignant gliomas: current practices and future directions. | Cancer treatment and research 20080101 |
| Regression of sporadic intra-abdominal desmoid tumour following administration of non-steroidal anti-inflammatory drug. | World journal of surgical oncology 20080101 |
| The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward. | Journal of translational medicine 20080101 |
| Langerhans cell sarcoma emanating from the upper arm skin: successful treatment by MAID regimen. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20080101 |
| Astroblastoma with rhabdoid features and favorable long-term outcome: report of a case with a 12-year follow-up. | Pathology, research and practice 20080101 |
| Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs. | Journal of veterinary internal medicine 20080101 |
| Stage IV primitive-appearing sinus and orbital rhabdomyosarcoma presenting in a 68-year-old female previously treated for breast cancer. | Orbit (Amsterdam, Netherlands) 20080101 |
| Primary biliary cirrhosis following chemotherapy for Hodgkin's lymphoma. | Internal medicine (Tokyo, Japan) 20080101 |
| Hodgkin lymphoma as a complication of primary Sjögren's syndrome. | Modern rheumatology 20080101 |
| A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma. | Cancer investigation 20080101 |
| Extensive necrosis of visceral melanoma metastases after immunotherapy. | World journal of surgical oncology 20080101 |
| Transient T cell depletion causes regression of melanoma metastases. | Journal of translational medicine 20080101 |
| Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20080101 |
| Dihydroartemisinin potentiates the cytotoxic effect of temozolomide in rat C6 glioma cells. | Pharmacology 20080101 |
| Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells. | Respiratory research 20080101 |
| Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer. | Breast cancer research : BCR 20080101 |
| Morphologically and immunohistochemically undifferentiated gastric neoplasia in a patient with multiple metastatic malignant melanomas: a case report. | Journal of medical case reports 20080101 |
| Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma. | Journal of translational medicine 20080101 |
| Extra central nervous system metastases from cerebral glioblastoma multiforme in elderly patients. Clinico-pathological remarks on our series of seven cases and critical review of the literature. | Tumori 20080101 |
| Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases. | Sarcoma 20080101 |
| Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma. | Anticancer research 20080101 |
| [Adjuvant chemotherapy as a component of complex treatment for skin melanoma]. | Voprosy onkologii 20080101 |
| [Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease]. | Voprosy onkologii 20080101 |
| [Therapeutic strategies for the management of gliomas]. | Revue neurologique 20080101 |
| Bcl-2 expression is not associated with survival in metastatic cutaneous melanoma: a historical cohort study. | World journal of surgical oncology 20080101 |
| Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations. | Journal of experimental & clinical cancer research : CR 20080101 |
| Aggressive juvenile fibromatosis of the paranasal sinuses: case report and brief review. | Journal of hematology & oncology 20080101 |
| Effects of palliative treatment with temozolomide in patients with high-grade gliomas. | Neurologia i neurochirurgia polska 20080101 |
| Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system. | World journal of surgical oncology 20080101 |
| Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape. | American journal of clinical dermatology 20080101 |
| Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alkylating agents on human glioblastoma cells. | Journal of experimental therapeutics & oncology 20080101 |
| [Multivariate analysis of prognostic factors and survival in patients with 'glioblastoma multiforme']. | La Clinica terapeutica 20080101 |
| Tyrosinase overexpression promotes ATM-dependent p53 phosphorylation by quercetin and sensitizes melanoma cells to dacarbazine. | Cellular oncology : the official journal of the International Society for Cellular Oncology 20080101 |
| TMZ-BioShuttle--a reformulated temozolomide. | International journal of medical sciences 20080101 |
| Aggressive papillary glioneuronal tumor: case report and literature review. | Clinical neuropathology 20080101 |
| Concomitant radiochemotherapy in a patient with multiple sclerosis and glioblastoma. | Clinical neuropathology 20080101 |
| Orally administered rapamycin, dacarbazine or both for treatment of human melanoma evaluated in severe combined immunodeficiency mice. | Pharmacology 20080101 |
| The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group. | Radiation oncology (London, England) 20080101 |
| Gliosarcomas in the elderly: analysis of 7 cases and clinico-pathological remarks. | Tumori 20080101 |
| Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines. | Journal of translational medicine 20080101 |
| Short-term effective treatment of CNS metastasis of sarcomatoid renal cell carcinoma with temozolomide and pegylated liposomal doxorubicin: A case report. | Cases journal 20080101 |
| Giant retroperitoneal liposarcoma. | World journal of surgical oncology 20080101 |
| Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with tremelimumab (CP-675,206). | The oncologist 20080101 |
| Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010). | The oncologist 20080101 |
| Delayed malignant melanoma recurrence simulating primary ovarian cancer: case report. | World journal of surgical oncology 20080101 |
| Intra-axial brainstem malignant melanoma mimicking cavernous angioma--case report. | Neurologia medico-chirurgica 20080101 |
| The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivo. | Anticancer research 20080101 |
| Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic Leiomyosarcoma. | Sarcoma 20080101 |
| Leiomyosarcoma of the prostate: case report and review of 54 previously published cases. | Sarcoma 20080101 |
| Prolonged hemophagocytic lymphohistiocytosis syndrome as an initial presentation of Hodgkin lymphoma: a case report. | Journal of medical case reports 20080101 |
| Limited-stage disease: optimal use of chemotherapy and radiation treatment. | Hematology. American Society of Hematology. Education Program 20080101 |
| Challenging problems: coincident pregnancy, HIV infection, and older age. | Hematology. American Society of Hematology. Education Program 20080101 |
| EBV-Associated Smooth Muscle Neoplasms: Solid Tumors Arising in the Presence of Immunosuppression and Autoimmune Diseases. | Sarcoma 20080101 |
| Carboplatin and oral cyclophosphamide combination after temozolomide failure in malignant gliomas. | Tumori 20080101 |
| Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway. | Journal of experimental & clinical cancer research : CR 20080101 |
| MSH6 inactivation and emergent temozolomide resistance in human glioblastomas. | Clinical neurosurgery 20080101 |
| Serum cytokine in response to chemo-radiotherapy for Hodgkin's disease. | Tumori 20080101 |
| Disappearance of gadolinium enhancement in a chemoresistant astrocytoma of the tectum after high-dose interferon beta. | Tumori 20080101 |
| Nanoemulsion preparations of the anticancer drug dacarbazine significantly increase its efficacy in a xenograft mouse melanoma model. | Molecular pharmaceutics 20080101 |
| Malignant melanoma (metastatic). | BMJ clinical evidence 20080101 |
| Extravasational side effects of cytotoxic drugs: A preventable catastrophe. | Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India 20080101 |
| Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics. | Gene regulation and systems biology 20080101 |
| Malignant melanoma - cutaneous metastases. | Indian journal of dermatology 20080101 |
| Amelanotic esophageal malignant melanoma: case report and short review of the literature. | Case reports in gastroenterology 20080101 |
| [Efficiency of radiation or chemoradiation therapy for diffusely growing brainstem tumors in children]. | Vestnik rentgenologii i radiologii 20080101 |
| Primary fibrosarcoma of the liver: we don't know much: a case report. | Case reports in gastroenterology 20080101 |
| A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response. | Ecancermedicalscience 20080101 |
| Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis. | British journal of cancer 20071217 |
| Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cells. | International journal of cancer 20071215 |
| Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. | Cancer research 20071215 |
| Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma. | Immunology 20071201 |
| Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis. | Carcinogenesis 20071201 |
| Treatments for metastatic melanoma: synthesis of evidence from randomized trials. | Cancer treatment reviews 20071201 |
| Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation. | Cancer investigation 20071201 |
| Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood. | Human reproduction (Oxford, England) 20071201 |
| Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination. | International journal of laboratory hematology 20071201 |
| Management of glioblastoma. | Expert opinion on pharmacotherapy 20071201 |
| Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20071201 |
| Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study. | Clinical cancer research : an official journal of the American Association for Cancer Research 20071201 |
| Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy. | Cancer investigation 20071201 |
| Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma. | Current treatment options in oncology 20071201 |
| Acquired hypopigmentation (leukoderma) as a presenting feature of metastatic amelanotic melanoma with brain involvement. | Archives of neurology 20071201 |
| Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience. | British journal of neurosurgery 20071201 |
| [Responses of 109 adult soft tissue sarcoma patients to chemotherapy]. | Ai zheng = Aizheng = Chinese journal of cancer 20071201 |
| Management of metastatic melanoma. | Seminars in oncology 20071201 |
| Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide. | Japanese journal of clinical oncology 20071201 |
| Primary malignant melanoma of the female urethra. | Urology 20071201 |
| Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. | The oncologist 20071201 |
| [Dacarbazine: deticene]. | Annales de dermatologie et de venereologie 20071201 |
| Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20071201 |
| Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma. | Clinical lymphoma & myeloma 20071201 |
| Palonosetron as an anti-emetic and anti-nausea agent in oncology. | Therapeutics and clinical risk management 20071201 |
| Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients. | British journal of cancer 20071119 |
| Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines. | International journal of radiation oncology, biology, physics 20071115 |
| Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report. | Clinical cancer research : an official journal of the American Association for Cancer Research 20071115 |
| AMG 102, a fully human anti-hepatocyte growth factor/scatter factor neutralizing antibody, enhances the efficacy of temozolomide or docetaxel in U-87 MG cells and xenografts. | Clinical cancer research : an official journal of the American Association for Cancer Research 20071115 |
| Temozolomide induces senescence but not apoptosis in human melanoma cells. | British journal of cancer 20071105 |
| O (4)-benzylfolic acid inactivates O (6)-alkylguanine-DNA alkyltransferase in brain tumor cell lines. | Cancer chemotherapy and pharmacology 20071101 |
| Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature. | Journal of neuro-oncology 20071101 |
| Temozolomide in pediatric low-grade glioma. | Pediatric blood & cancer 20071101 |
| The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. | Biomaterials 20071101 |
| Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinoma. | Anti-cancer drugs 20071101 |
| Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly. | Journal of neuro-oncology 20071101 |
| Molecular targeted therapies and chemotherapy in malignant gliomas. | Current opinion in oncology 20071101 |
| A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy. | European journal of haematology 20071101 |
| Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo. | International journal of oncology 20071101 |
| Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20071101 |
| Systemic therapy of disseminated malignant melanoma: an evidence-based overview of the state-of-the-art in daily routine. | Journal of the European Academy of Dermatology and Venereology : JEADV 20071101 |
| Diagnosis and treatment of high-grade astrocytoma. | Neurologic clinics 20071101 |
| Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071101 |
| CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma. | European journal of clinical investigation 20071101 |
| [Adefovir in reactivation of chemotherapy-induced hepatitis B in an anti-Hbc-positive patient]. | Gastroenterologia y hepatologia 20071101 |
| The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. | Health technology assessment (Winchester, England) 20071101 |
| FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity. | Haematologica 20071101 |
| Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. | Neurosurgery 20071101 |
| [The effect of oxygenation on the biological behaviour of tumours]. | Orvosi hetilap 20071028 |
| Potential biochemical therapy of glioma cancer. | Biochemical and biophysical research communications 20071019 |
| The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. | Cancer research 20071015 |
| Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20071015 |
| Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. | Cancer chemotherapy and pharmacology 20071001 |
| Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. | The Journal of investigative dermatology 20071001 |
| Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide. | Journal of neuro-oncology 20071001 |
| Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice. | The Journal of investigative dermatology 20071001 |
| Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20071001 |
| MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas. | Laboratory investigation; a journal of technical methods and pathology 20071001 |
| Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group. | Cancer 20071001 |
| Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20071001 |
| Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. | The Journal of clinical endocrinology and metabolism 20071001 |
| Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20071001 |
| What approach will lead to cure of glioblastoma multiforme? In regard to Barani et al. (Int J Radiat Oncol Biol Phys 2007;68:324-333) and Jones and Sanghera (Int J Radiat Oncol Biol Phys 2007;68:441-448). | International journal of radiation oncology, biology, physics 20071001 |
| Successful management of multiple liver metastases from pancreatic neuroendocrine tumor by hepatic arterial administration of cisplatin powder. | Pancreas 20071001 |
| Triazene compounds: mechanism of action and related DNA repair systems. | Pharmacological research 20071001 |
| Pharmacokinetic study of temozolomide on a daily-for-5-days schedule in Japanese patients with relapsed malignant gliomas: first study in Asians. | International journal of clinical oncology 20071001 |
| O6-methylguanine-DNA-methyltransferase promoter demethylation is involved in basic fibroblast growth factor induced resistance against temozolomide in human melanoma cells. | Molecular cancer therapeutics 20071001 |
| [A case of liver metastasis from anorectal malignant melanoma on hemodialysis treated by chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20071001 |
| Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244). | The British journal of radiology 20071001 |
| [Cutaneous melanoma]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20071001 |
| [Description of a peculiar form of Hodgkin's disease associated with Epstein-Barr virus infection]. | Bulletin de la Societe de pathologie exotique (1990) 20071001 |
| [Tracheal involvement revealing Hodgkin's disease. A case report]. | Revue de pneumologie clinique 20071001 |
| Oblimersen for the treatment of patients with chronic lymphocytic leukemia. | Therapeutics and clinical risk management 20071001 |
| Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases. | Cancer 20070915 |
| Targeting methylguanine-DNA methyltransferase in the treatment of neuroblastoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070915 |
| Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide. | Journal of neuro-oncology 20070901 |
| [What type of adjuvant chemotherapy should be proposed for the initial treatment of glioblastoma?]. | Presse medicale (Paris, France : 1983) 20070901 |
| Thymosin alpha 1: from bench to bedside. | Annals of the New York Academy of Sciences 20070901 |
| Defining the standard of care for high-grade glioma--a NICE deal for UK patients? | Clinical oncology (Royal College of Radiologists (Great Britain)) 20070901 |
| Impact of combination therapy with repeat surgery and temozolomide for recurrent or progressive glioblastoma multiforme: a prospective trial. | Surgical neurology 20070901 |
| Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070901 |
| Temozolomide treatment of an adult with a relapsing medulloblastoma. | Cancer investigation 20070901 |
| Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy. | Journal of neurosurgery 20070901 |
| Temozolomide for the treatment of metastatic melanoma: a systematic review. | The oncologist 20070901 |
| Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070820 |
| The photo comet assay--a fast screening assay for the determination of photogenotoxicity in vitro. | Mutation research 20070815 |
| Efficacy of temozolomide or dacarbazine in combination with an anthracycline for rescue chemotherapy in dogs with lymphoma. | Journal of the American Veterinary Medical Association 20070815 |
| Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070810 |
| The fallacy of single-agent chemotherapy for cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070810 |
| Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. | Pediatric blood & cancer 20070801 |
| The contribution of Gianni Bonadonna to the history of chemotherapy. | Cancer chemotherapy and pharmacology 20070801 |
| Temozolomide in glioblastoma: results of administration at first relapse and in newly diagnosed cases. Is still proposable an alternative schedule to concomitant protocol? | Journal of neuro-oncology 20070801 |
| Novel role of triazenes in haematological malignancies: pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia. | DNA repair 20070801 |
| Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo. | Cancer gene therapy 20070801 |
| Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival. | Gastrointestinal endoscopy 20070801 |
| Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070801 |
| [Vascular endothelial growth factor and interleukin 6 production by Hodgkin lymphoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070801 |
| The economics of temozolomide in brain cancer. | Expert opinion on pharmacotherapy 20070801 |
| The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity. | Molecular cancer therapeutics 20070801 |
| Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor. | Journal of pediatric surgery 20070801 |
| Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline. | Current oncology (Toronto, Ont.) 20070801 |
| [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab]. | Deutsche medizinische Wochenschrift (1946) 20070801 |
| Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages? | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20070801 |
| Efficacy of temozolomide is correlated with 1p loss and methylation of the deoxyribonucleic acid repair gene MGMT in malignant gliomas. | Neurologia medico-chirurgica 20070801 |
| Predicting human tumor drug concentrations from a preclinical pharmacokinetic model of temozolomide brain disposition. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070715 |
| Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding. | Cancer research 20070715 |
| Prophylactic radiotherapy for glioblastoma in the elderly. | The New England journal of medicine 20070712 |
| Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents. | British journal of cancer 20070702 |
| Salvage therapy for primary central nervous system lymphoma with (90)Y-Ibritumomab and Temozolomide. | Journal of neuro-oncology 20070701 |
| Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group. | Journal of cancer research and clinical oncology 20070701 |
| Anaplastic astrocytoma in adults. | Critical reviews in oncology/hematology 20070701 |
| In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab. | International journal of radiation oncology, biology, physics 20070701 |
| Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells. | Journal of neuro-oncology 20070701 |
| Radiochemotherapy for brain metastasis: how to define a role for temozolomide. | Onkologie 20070701 |
| Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. | Onkologie 20070701 |
| [Pharmacokinetic and molecular biological approaches to achieve the safety and effective management of drug therapies]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20070701 |
| Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070701 |
| Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer. | The oncologist 20070701 |
| Is BEACOPP better than ABVD? | Current hematologic malignancy reports 20070701 |
| Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070620 |
| Mathematical modeling of brain tumors: effects of radiotherapy and chemotherapy. | Physics in medicine and biology 20070607 |
| Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma. | International journal of radiation oncology, biology, physics 20070601 |
| Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines. | The journal of gene medicine 20070601 |
| Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. | Annals of oncology : official journal of the European Society for Medical Oncology 20070601 |
| G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. | British journal of haematology 20070601 |
| Molecular classification of patients with malignant melanoma for new therapeutic strategies. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601 |
| Oblimersen in the treatment of metastatic melanoma. | Future oncology (London, England) 20070601 |
| Temozolomide-associated organizing pneumonitis. | Mayo Clinic proceedings 20070601 |
| Primary gastric Hodgkin's lymphoma expressing a B-Cell profile including Oct-2 and Bob-1 proteins. | International journal of hematology 20070601 |
| Contributing factors of temozolomide resistance in MCF-7 tumor xenograft models. | Cancer biology & therapy 20070601 |
| A phase I study of thalidomide, capecitabine and temozolomide in advanced cancer. | Cancer biology & therapy 20070601 |
| Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. | Cancer investigation 20070601 |
| Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE). | The Journal of pharmacy and pharmacology 20070601 |
| Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors. | Endocrine-related cancer 20070601 |
| Hemorrhagic cystitis in a patient receiving conventional doses of dacarbazine for metastatic malignant melanoma: case report and review of the literature. | Clinical therapeutics 20070601 |
| Microphthalmos associated with Dartmouth combination chemotherapy in pregnancy: a case report. | The Journal of reproductive medicine 20070601 |
| Metastatic medulloblastoma in an adult; treatment with temozolomide. | Acta neurologica Belgica 20070601 |
| Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors. | Therapeutics and clinical risk management 20070601 |
| An overview of the clinical use of ondansetron in preschool age children. | Therapeutics and clinical risk management 20070601 |
| Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. | Neurology 20070522 |
| Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070520 |
| Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070515 |
| Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070515 |
| Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation. | British journal of cancer 20070507 |
| Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas. | Journal of neuro-oncology 20070501 |
| Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice. | Carcinogenesis 20070501 |
| Malignant transformation of conus medullaris ganglioglioma: case report. | Journal of neuro-oncology 20070501 |
| The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents. | Journal of molecular medicine (Berlin, Germany) 20070501 |
| Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines. | Cancer chemotherapy and pharmacology 20070501 |
| A small proportion of glioblastoma patients are probably eligible for concomitant/adjuvant temozolomide. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20070501 |
| Dynamic history of low-grade gliomas before and after temozolomide treatment. | Annals of neurology 20070501 |
| Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070501 |
| Presentation of Hodgkin's lymphoma with Ophelia syndrome. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070501 |
| Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir. | Cancer research 20070501 |
| Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents. | Molecular cancer therapeutics 20070501 |
| [Chemotherapy for malignant gliomas]. | No shinkei geka. Neurological surgery 20070501 |
| Adjuvant therapy in glioblastomas: false steps and real advances. | Expert review of anticancer therapy 20070501 |
| Complete response to temozolomide treatment in an elderly patient with recurrent primary central nervous system lymphoma--case report. | Neurologia medico-chirurgica 20070501 |
| Expression of O6-methylguanine-deoxyribose nucleic acid methyltransferase and temozolomide response in a patient with a malignant spinal cord astrocytoma. Case report. | Journal of neurosurgery. Spine 20070501 |
| Improved median survival for glioblastoma multiforme following introduction of adjuvant temozolomide chemotherapy. | Annals of the Academy of Medicine, Singapore 20070501 |
| Salvage chemotherapy in progressive high-grade astrocytoma. | Annals of the Academy of Medicine, Singapore 20070501 |
| Cross-priming by temozolomide enhances antitumor immunity of dendritic cell vaccination in murine brain tumor model. | Vaccine 20070430 |
| Methylguanine methyltransferase testing in glioblastoma: when and how? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070420 |
| Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070420 |
| Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070420 |
| [Our experiences in treating patients with Hodgkin disease in the last decade]. | Orvosi hetilap 20070415 |
| Fatal reactivation of hepatitis B with temozolomide. | The New England journal of medicine 20070412 |
| Taming a mutinous mutant: an errant receptor becomes a prime cancer target. | Journal of the National Cancer Institute 20070404 |
| [Establishment of a multi drug-resistant human lung adenocarcinoma cell line and biological characteristics there of]. | Zhonghua yi xue za zhi 20070403 |
| MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. | Pediatric blood & cancer 20070401 |
| A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma. | Journal of neuro-oncology 20070401 |
| A phase II study of temozolomide therapy for poor-risk patients aged >or=60 years with acute myeloid leukemia: low levels of MGMT predict for response. | Leukemia 20070401 |
| Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation. | Annals of surgical oncology 20070401 |
| Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens. | The Journal of pharmacology and experimental therapeutics 20070401 |
| Clinical review: Current treatment of malignant pheochromocytoma. | The Journal of clinical endocrinology and metabolism 20070401 |
| The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation. | Oncology reports 20070401 |
| Temozolomide in children with progressive low-grade glioma. | Neuro-oncology 20070401 |
| [Glioma therapy up-date]. | Neurologia (Barcelona, Spain) 20070401 |
| Profound neutropenia resulting from interaction between antiretroviral therapy and vinblastine in a patient with HIV-associated Hodgkin's disease. | European journal of haematology 20070401 |
| Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070401 |
| Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells. | Journal of neurosurgery 20070401 |
| Primary alveolar soft part sarcoma of the lung. | Journal of Korean medical science 20070401 |
| Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). | Hematology (Amsterdam, Netherlands) 20070401 |
| Doxorubicin pharmacokinetics in lymphoma patients treated with doxorubicin-loaded eythrocytes. | Haematologica 20070401 |
| Diagnosis and treatment of cutaneous melanoma: state of the art 2006. | Melanoma research 20070401 |
| Temozolomide as salvage treatment in primary brain lymphomas. | British journal of cancer 20070326 |
| Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma. | British journal of cancer 20070326 |
| Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note. | Neurology 20070320 |
| Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. | Journal of neuro-oncology 20070301 |
| DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. | Cell death and differentiation 20070301 |
| Local recurrence and distant metastasis of supratentorial primitive neuro-ectodermal tumor in an adult patient successfully treated with intensive induction chemotherapy and maintenance temozolomide. | Journal of neuro-oncology 20070301 |
| Local intracerebral administration of O(6)-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma. | Journal of neuro-oncology 20070301 |
| Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. | Hematological oncology 20070301 |
| Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy. | Fertility and sterility 20070301 |
| Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. | European journal of haematology 20070301 |
| Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. | Acta neurochirurgica 20070301 |
| Immunotherapy of melanoma: a critical review of current concepts and future strategies. | Expert opinion on biological therapy 20070301 |
| Combined treatment with temozolomide and methoxyamine: blocking apurininc/pyrimidinic site repair coupled with targeting topoisomerase IIalpha. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070301 |
| Fatal outcome related to carmustine implants in glioblastoma multiforme. | Acta neurochirurgica 20070301 |
| [Long-term survival of malignant fibrous histiocytoma of the chest wall by multidisciplinary treatment]. | Kyobu geka. The Japanese journal of thoracic surgery 20070301 |
| [Weekly paclitaxel therapy is curative for patients with retroperitoneal liposarcoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070301 |
| Emerging drugs for the treatment of soft tissue sarcomas. | Expert opinion on emerging drugs 20070301 |
| Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial. | Molecular cancer therapeutics 20070301 |
| Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit? | Japanese journal of clinical oncology 20070301 |
| [Hodgkin lymphoma in Chile: experience of the national adult cancer program]. | Revista medica de Chile 20070301 |
| Hodgkin lymphoma among patients infected with HIV in post-HAART era. | Clinical lymphoma & myeloma 20070301 |
| Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma. | Neurology 20070227 |
| Socioeconomic inequality and short-term outcome in Hodgkin's lymphoma. | International journal of cancer 20070215 |
| Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. | Journal of the National Cancer Institute 20070207 |
| Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma. | Pediatric blood & cancer 20070201 |
| Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas. | Cancer chemotherapy and pharmacology 20070201 |
| Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro. | International journal of pharmaceutics 20070201 |
| Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme. | Journal of neuro-oncology 20070201 |
| A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. | Journal of neuro-oncology 20070201 |
| Ganglioglioma occurring with glioblastoma multiforme: separate lesions or the same lesion? | Clinical neurology and neurosurgery 20070201 |
| Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20070201 |
| ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors. | Annals of oncology : official journal of the European Society for Medical Oncology 20070201 |
| Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity. | International journal of oncology 20070201 |
| A review of the current clinical trials for gastroenteropancreatic neuroendocrine tumours. | Expert opinion on investigational drugs 20070201 |
| Induction of peptide-specific immune response in patients with primary malignant melanoma of the esophagus after immunotherapy using dendritic cells pulsed with MAGE peptides. | Japanese journal of clinical oncology 20070201 |
| American Society of Hematology--48th Annual Meeting and Exposition. Therapeutic approaches for hematological cancers. 9-12 December 2006 Orlando, FL, USA. | IDrugs : the investigational drugs journal 20070201 |
| Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma. | Haematologica 20070201 |
| Surgical treatment of primary malignant melanoma of the esophagus: a case report. | Journal of Korean medical science 20070201 |
| [Molecular pharmacology on DNA methylating agent temozolomide]. | No shinkei geka. Neurological surgery 20070201 |
| [Case of caesarian section in a patient with a giant mediastinal tumor]. | Masui. The Japanese journal of anesthesiology 20070201 |
| Malignant fibrous histiocytoma following radiation therapy and chemotherapy for Hodgkin's lymphoma. | International journal of clinical oncology 20070201 |
| Single-agent interleukin-2 in the treatment of metastatic melanoma. | Current oncology (Toronto, Ont.) 20070201 |
| Temozolomide for the treatment of metastatic melanoma. | Current oncology (Toronto, Ont.) 20070201 |
| [Temozolomide, an oral chemotherapeutic agent with potential severe toxicity]. | Nederlands tijdschrift voor geneeskunde 20070127 |
| A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma. | British journal of cancer 20070115 |
| Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation? | Cancer 20070115 |
| Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. | Oncogene 20070111 |
| Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: Morphological findings. | Human pathology 20070101 |
| Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions. | Amino acids 20070101 |
| Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in vivo. | Fertility and sterility 20070101 |
| The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. | Neuro-oncology 20070101 |
| Interindividual differences in anticancer drug cytotoxicity in primary human glioblastoma cells. | Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20070101 |
| Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070101 |
| Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. | BMC cancer 20070101 |
| New [1,2,4]triazolo[4,3-c]quinazoline enhances cisplatin- and temozolomide-induced growth inhibition and apoptosis in HL-60 cells. | Neoplasma 20070101 |
| Case of metastatic melanoma in an epitrochlear lymph node arising in a pregnant woman. | The Journal of dermatology 20070101 |
| Human monocytes, but not dendritic cells derived from them, are defective in base excision repair and hypersensitive to methylating agents. | Cancer research 20070101 |
| Resection in the popliteal fossa for metastatic melanoma. | World journal of surgical oncology 20070101 |
| Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life. | BMC cancer 20070101 |
| The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization. | Journal of translational medicine 20070101 |
| Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF. | Journal of carcinogenesis 20070101 |
| [Primary malignant melanoma of the vagina--case report and review of the literature]. | Gynakologisch-geburtshilfliche Rundschau 20070101 |
| Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists. | Pituitary 20070101 |
| Giant cell tumor of the uterus: case report and response to chemotherapy. | BMC cancer 20070101 |
| A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk. | Radiation oncology (London, England) 20070101 |
| Viability of a human melanoma cell after single and combined treatment with fotemustine, dacarbazine, and proton irradiation. | Annals of the New York Academy of Sciences 20070101 |
| Colon-available raspberry polyphenols exhibit anti-cancer effects on in vitro models of colon cancer. | Journal of carcinogenesis 20070101 |
| Carbon ion radiotherapy for vaginal malignant melanoma: a case report. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101 |
| Efficacy of different regimens of adjuvant radiochemotherapy for treatment of glioblastoma. | Tumori 20070101 |
| A phase I study of cisplatin, temozolomide and thalidomide in patients with malignant brain tumors. | Anticancer research 20070101 |
| Temozolomide and thalidomide in the treatment of glioblastoma multiforme. | Anticancer research 20070101 |
| Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades. | Anticancer research 20070101 |
| Successful treatment of palmar-plantar erythrodysesthesia possibly due to temozolomide with dexamethasone. | Journal of postgraduate medicine 20070101 |
| Atrial and placental melanoma metastasis: a case report and literature review. | Journal of medical case reports 20070101 |
| [Evolution in 18F-FDG-PET of a case of Hodgkin disease, nodular sclerosis variety, after treatment and autotrasplant]. | Revista espanola de medicina nuclear 20070101 |
| O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies. | Molecular cancer 20070101 |
| Serum VEGF-C is associated with metastatic site in patients with malignant melanoma. | Acta oncologica (Stockholm, Sweden) 20070101 |
| Delirium likely caused by interaction between phenytoin and temozolomide. | Psychosomatics 20070101 |
| Osteomalacia as a late metabolic complication of Ifosfamide chemotherapy in young adults: illustrative cases and review of the literature. | Sarcoma 20070101 |
| The expression of Ki-67 and Bcl-2 in Hodgkin's lymphoma: correlation with the International Prognostic Score and bulky disease: a study by the Serbian Lymphoma Study Group (SLG). | Medical oncology (Northwood, London, England) 20070101 |
| Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide. | Tumori 20070101 |
| Epidermal growth factor receptor serum levels and prognostic value in malignant gliomas. | Tumori 20070101 |
| Medical treatment and other combination regimens. | Tumori 20070101 |
| Medical treatment of uveal melanoma. | Tumori 20070101 |
| Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. | BMC cancer 20070101 |
| Combination therapy with thalidomide, temozolomide and tamoxifen improves quality of life in patients with malignant astrocytomas. | Anticancer research 20070101 |
| Analysis of long-term survivors of glioblastoma multiforme in a single institution with aggressive local retreatment protocol. | Anticancer research 20070101 |
| Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium. | Drugs in R&D 20070101 |
| Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth. | Acta oncologica (Stockholm, Sweden) 20070101 |
| How useful are housekeeping genes? Variable expression in melanoma metastases. | Clinical chemistry and laboratory medicine 20070101 |
| Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme. | Cancer journal (Sudbury, Mass.) 20070101 |
| Genasense: it ain't over till the fat lady sings. | Oligonucleotides 20070101 |
| Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast. | The breast journal 20070101 |
| Risk, cure and complications in advanced hodgkin disease. | Hematology. American Society of Hematology. Education Program 20070101 |
| Tissue is the issue-sarcoidosis following ABVD chemotherapy for Hodgkin's lymphoma: a case report. | Journal of medical case reports 20070101 |
| Chemoradiotherapy in high-grade gliomas. | Tumori 20070101 |
| Laparoscopic cholecystectomy for melanoma metastatic to the gallbladder: is it an adequate surgical procedure? Report of a case and review of the literature. | World journal of surgical oncology 20070101 |
| [Dicarbamin--an effective protector of myelodepression in combined treatment for Hodgkin's disease]. | Voprosy onkologii 20070101 |
| PEComa of the Upper Extremity: A Unique Case and Description of an Initial Response to Neoadjuvant Chemotherapy. | Sarcoma 20070101 |
| Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study. | Oncology 20070101 |
| Interleukin-2-based biochemotherapy for patients with stage IV melanoma: long-term survivors outside a clinical trial setting. | Oncology 20070101 |
| [Glioblastomas are resistant to apoptosis but less resistant to the autophagic process]. | Bulletin et memoires de l'Academie royale de medecine de Belgique 20070101 |
| Synchronous Hodgkin's disease and gastric adenocarcinoma. | Oncology 20070101 |
| Cell cycle, melanin contents and apoptosis processes in B16 and Cloudman S91 mouse melanoma cells after exposure to cytostatic drugs. | Acta poloniae pharmaceutica 20070101 |
| The relationship of arginine deprivation, argininosuccinate synthetase and cell death in melanoma. | Drug target insights 20070101 |
| Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20061201 |
| Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies. | European journal of cancer (Oxford, England : 1990) 20061201 |
| Anti-CD20 monoclonal antibody (rituximab) for therapy of CD20-positive nodular lymphocyte-predominant Hodgkin lymphoma in an 10-year-old girl. | Pediatric hematology and oncology 20061201 |
| Potentiation of antiglioma effect with combined temozolomide and interferon-beta. | Oncology reports 20061201 |
| Nodular sclerosing Hodgkin disease presenting as a sternal mass. | British journal of haematology 20061201 |
| Hematoma-like metastases. | Journal of the American Academy of Dermatology 20061201 |
| Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model. | Melanoma research 20061201 |
| [Temozolomide in the treatment of recurrent malignant glioma]. | No shinkei geka. Neurological surgery 20061201 |
| [Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases]. | Ai zheng = Aizheng = Chinese journal of cancer 20061201 |
| [Routine chemotherapeutic drug treatment effectiveness predictive molecules and chemotherapeutic drug selection]. | Ai zheng = Aizheng = Chinese journal of cancer 20061201 |
| MGMT methylation: a marker of response to temozolomide in low-grade gliomas. | Annals of neurology 20061201 |
| [Recent advances in the medical treatment of glioma-temozolomide]. | No to shinkei = Brain and nerve 20061201 |
| Recurrent hypoglycemia and hypothermia in a patient with Hodgkin's disease. | Haematologica 20061201 |
| Multiple gangliogliomas of the optic pathway. | British journal of neurosurgery 20061201 |
| [Malignant melanoma--diagnosis and treatment]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20061130 |
| Skin delivery potency and antitumor activities of temozolomide ester prodrugs. | Cancer letters 20061128 |
| Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061120 |
| Irinotecan plus temozolomide for relapsed or refractory neuroblastoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061120 |
| From natural products to bioorganic chemistry. What's next? | Journal of medicinal chemistry 20061116 |
| Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO). | British journal of cancer 20061106 |
| A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas. | British journal of cancer 20061106 |
| Simulating chemotherapeutic schemes in the individualized treatment context: the paradigm of glioblastoma multiforme treated by temozolomide in vivo. | Computers in biology and medicine 20061101 |
| Radical surgery after chemotherapy: a new therapeutic strategy to envision in grade II glioma. | Journal of neuro-oncology 20061101 |
| In vivo selection of transduced hematopoietic stem cells and little evidence of their conversion into hepatocytes in vivo. | Journal of hepatology 20061101 |
| Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis. | European journal of haematology 20061101 |
| Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients. | European journal of haematology 20061101 |
| Targeted therapies in melanoma. | Cancer treatment reviews 20061101 |
| Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma. | European journal of cancer (Oxford, England : 1990) 20061101 |
| A pilot study of metronomic temozolomide treatment in patients with recurrent temozolomide-refractory glioblastoma. | Oncology reports 20061101 |
| Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group. | European journal of cancer (Oxford, England : 1990) 20061101 |
| Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? | Critical reviews in oncology/hematology 20061101 |
| Adjuvant therapy for extremity sarcomas. | Current treatment options in oncology 20061101 |
| Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma. | Onkologie 20061101 |
| Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. | Clinical cancer research : an official journal of the American Association for Cancer Research 20061101 |
| The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity. | Molecular cancer therapeutics 20061101 |
| Glioma therapy in adults. | The neurologist 20061101 |
| Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas. | Expert review of anticancer therapy 20061101 |
| Genotoxic risks to nurses from contamination of the work environment with antineoplastic drugs in Japan. | Journal of occupational health 20061101 |
| European Academy of Paediatrics, Barcelona, Spain, October 7-10, 2006. Abstracts. | European journal of pediatrics 20061101 |
| [Cerebral tumours in the adult. A real increase]. | La Revue du praticien 20061031 |
| [Pattern of care of high-grade gliomas]. | La Revue du praticien 20061031 |
| Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102). | Cancer 20061015 |
| Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061010 |
| Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061010 |
| The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study. | British journal of cancer 20061009 |
| Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status. | Journal of neuro-oncology 20061001 |
| Complications of a temozolomide overdose: a case report. | Journal of neuro-oncology 20061001 |
| Radiotherapy plus concomitant and adjuvant temozolomide for leptomeningeal pilomyxoid astrocytoma: a case study. | Journal of neuro-oncology 20061001 |
| Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma. | Cancer treatment reviews 20061001 |
| Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy. | International journal of radiation oncology, biology, physics 20061001 |
| 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. | European journal of cancer (Oxford, England : 1990) 20061001 |
| A single cycle of treatment with temozolomide, alone or combined with O(6)-benzylguanine, induces strong chemoresistance in melanoma cell clones in vitro: role of O(6)-methylguanine-DNA methyltransferase and the mismatch repair system. | International journal of oncology 20061001 |
| Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm. | Clinical endocrinology 20061001 |
| Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study. | Annals of oncology : official journal of the European Society for Medical Oncology 20061001 |
| Unusual manifestation of Hodgkin disease. | American journal of clinical oncology 20061001 |
| Spanish co-operative group of Medical Neuro-oncology (GENOM). | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061001 |
| Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001 |
| [Malignant fibrous histiocytoma of the retroperitoneum--review of clinical course and histopathology]. | Hinyokika kiyo. Acta urologica Japonica 20061001 |
| Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060920 |
| Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. | Cancer 20060915 |
| Dacarbazine induces genotoxic and cytotoxic germ cell damage with concomitant decrease in testosterone and increase in lactate dehydrogenase concentration in the testis. | Mutation research 20060905 |
| Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. | British journal of cancer 20060904 |
| A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours. | British journal of cancer 20060904 |
| A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma. | Journal of cancer research and clinical oncology 20060901 |
| Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study. | Annals of oncology : official journal of the European Society for Medical Oncology 20060901 |
| Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12. | Brain : a journal of neurology 20060901 |
| Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial. | Journal of neuro-oncology 20060901 |
| Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours. | European journal of cancer (Oxford, England : 1990) 20060901 |
| Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma. | International journal of radiation oncology, biology, physics 20060901 |
| [Therapy of malignant melanoma. First-, second- and pathogenesis-oriented third-line therapies]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20060901 |
| Intralesional therapy of metastatic spreading melanoma with beta-interferon. | Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20060901 |
| Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme. | Anti-cancer drugs 20060901 |
| Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060901 |
| [Efficacy and safety of monotherapy with temozolomide in patients with anaplastic astrocytoma at first relapse--a phase II clinical study]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060901 |
| Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival. | Onkologie 20060901 |
| Genetic alterations associated with acquired temozolomide resistance in SNB-19, a human glioma cell line. | Molecular cancer therapeutics 20060901 |
| Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma. | Leukemia & lymphoma 20060901 |
| Temozolomide as prophylaxis for brain metastasis in non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060901 |
| Current status of clinical trials for glioblastoma. | Reviews on recent clinical trials 20060901 |
| Treatment of Hodgkin's disease: a twenty-year follow-up of patients at a center in Korea. | Yonsei medical journal 20060831 |
| Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide. | Cancer letters 20060808 |
| Is protracted low-dose temozolomide feasible in glioma patients? | Neurology 20060808 |
| Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells. | European journal of pharmacology 20060807 |
| Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy. | Current opinion in pharmacology 20060801 |
| Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20060801 |
| Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma. | Melanoma research 20060801 |
| Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma. | Melanoma research 20060801 |
| Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma. | Melanoma research 20060801 |
| The course of melanoma-associated vitiligo: report of a case. | Melanoma research 20060801 |
| MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients. | European journal of radiology 20060801 |
| Craniofacial fibrous dysplasia and hypophysial microadenoma with Hodgkin's lymphoma: unusual involution of an extensive case. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20060801 |
| Temozolomide chemotherapy in patients with recurrent malignant gliomas. | Journal of Korean medical science 20060801 |
| In vitro drug response and molecular markers associated with drug resistance in malignant gliomas. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060801 |
| Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060801 |
| Hypoxia-inducible factor-1 inhibition in combination with temozolomide treatment exhibits robust antitumor efficacy in vivo. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060801 |
| A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomide. | IEEE transactions on bio-medical engineering 20060801 |
| Temozolomide: a milestone in neuro-oncology and beyond? | Expert review of anticancer therapy 20060801 |
| [Haemorrhagic complications in obstetrics]. | Hamostaseologie 20060801 |
| [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. | Ai zheng = Aizheng = Chinese journal of cancer 20060801 |
| [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma]. | Ai zheng = Aizheng = Chinese journal of cancer 20060801 |
| High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only. | Leukemia & lymphoma 20060801 |
| Comparison of outcomes in studies of advanced Hodgkin's lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060710 |
| Nuclear ING2 expression is reduced in human cutaneous melanomas. | British journal of cancer 20060703 |
| Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas. | Pediatric blood & cancer 20060701 |
| Temozolomide in resistant or relapsed pediatric solid tumors. | Pediatric blood & cancer 20060701 |
| Role of temozolomide in pediatric brain tumors. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20060701 |
| Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial. | Journal of neuro-oncology 20060701 |
| Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma. | Neuro-oncology 20060701 |
| Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature. | Neuro-oncology 20060701 |
| Hodgkin's disease presenting with osseous involvement. | American journal of hematology 20060701 |
| Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas. | Oncology reports 20060701 |
| Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060701 |
| [A case of malignant melanoma from the esophagus responding to weekly paclitaxel therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060701 |
| [Glioma]. | Nihon rinsho. Japanese journal of clinical medicine 20060701 |
| Primary intradural extraarachnoid hodgkin lymphoma of the cervical spine. Case report. | Journal of neurosurgery. Spine 20060701 |
| Combined biodifferentiating and antiangiogenic oral metronomic therapy is feasible and effective in relapsed solid tumors in children: single-center pilot study. | Onkologie 20060701 |
| Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database. | Cancer control : journal of the Moffitt Cancer Center 20060701 |
| Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma. | Epilepsia 20060701 |
| The effects of the oral, pan-VEGF-R kinase inhibitor CEP-7055 and chemotherapy in orthotopic models of glioblastoma and colon carcinoma in mice. | Molecular cancer therapeutics 20060701 |
| Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study. | British journal of cancer 20060619 |
| [Lymph node tuberculosis as primary manifestation of Hodgkin's disease]. | Medizinische Klinik (Munich, Germany : 1983) 20060615 |
| Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review. | The Journal of laryngology and otology 20060601 |
| Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG). | Annals of oncology : official journal of the European Society for Medical Oncology 20060601 |
| Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma. | Cancer 20060601 |
| A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. | Melanoma research 20060601 |
| Hodgkin's lymphoma in adolescents. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601 |
| Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601 |
| Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents. | Experimental biology and medicine (Maywood, N.J.) 20060601 |
| Temozolomide: a novel treatment for pituitary carcinoma. | The Lancet. Oncology 20060601 |
| Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide. | Nature clinical practice. Oncology 20060601 |
| POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group. | Journal of pediatric hematology/oncology 20060601 |
| Implications of tissue transglutaminase expression in malignant melanoma. | Molecular cancer therapeutics 20060601 |
| Gliomatosis cerebri treatment in 11 elderly patients. | Journal of experimental & clinical cancer research : CR 20060601 |
| Chemotherapy for malignant gliomas. | Wiener medizinische Wochenschrift (1946) 20060601 |
| Re-evaluation of the cost effectiveness of temozolomide for malignant gliomas in British Columbia. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20060601 |
| [Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060601 |
| [Malignant pheochromocytoma]. | Nihon rinsho. Japanese journal of clinical medicine 20060528 |
| Autophagy: is it cancer's friend or foe? | Science (New York, N.Y.) 20060526 |
| Surgery, radiotherapy and temozolomide in treating high-grade gliomas. | Frontiers in bioscience : a journal and virtual library 20060501 |
| Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. | European journal of nuclear medicine and molecular imaging 20060501 |
| Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model. | Oncology reports 20060501 |
| Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions. | Proteomics 20060501 |
| [Systemic therapy of malignant adrenal tumors]. | Der Urologe. Ausg. A 20060501 |
| Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide. | The Lancet. Oncology 20060501 |
| Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275. | Molecular cancer therapeutics 20060501 |
| The role of chemotherapy in the treatment of malignant astrocytomas. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20060501 |
| Primitive neuroectodermal tumor (PNET) as second malignancy after treatment of Hodgkin's disease. | Indian journal of pediatrics 20060501 |
| Cardiac metastasis from uterine leiomyosarcoma. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060501 |
| [Phototoxicity of dacarbazine (Deticene) not reinduced by temozolomide (Temodal)]. | Annales de dermatologie et de venereologie 20060501 |
| Radiation therapy in the management of brain metastases from renal cell carcinoma. | Oncology (Williston Park, N.Y.) 20060501 |
| [Temozolomide--a new antitumor preparation in the treatment of central nervous system malignant tumors]. | Georgian medical news 20060501 |
| Temozolomide for recurrent or progressive high-grade malignant glioma: results of an Austrian multicenter observational study. | Wiener klinische Wochenschrift 20060501 |
| [Male patient with Hodgkin's disease with exanthema of the gall bladder with symmetric distribution in hands after chemotherapy treatment]. | Anales de medicina interna (Madrid, Spain : 1984) 20060501 |
| The safety of the temozolomide in patients with malignant glioma. | Current drug safety 20060501 |
| Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression. | Cancer 20060415 |
| A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. | Cancer research 20060415 |
| Treatment options for glioblastoma. | Neurosurgical focus 20060415 |
| Enhancement of glioblastoma cell killing by combination treatment with temozolomide and tamoxifen or hypericin. | Neurosurgical focus 20060415 |
| New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy. | Neurosurgical focus 20060415 |
| Autophagy, the Trojan horse to combat glioblastomas. | Neurosurgical focus 20060415 |
| Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield. | British journal of cancer 20060410 |
| Higher dosing of temozolomide? Regression of an anaplastic oligoastrocytoma over more than three years. | Journal of neuro-oncology 20060401 |
| O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro. | Pharmacological research 20060401 |
| Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. | Annals of oncology : official journal of the European Society for Medical Oncology 20060401 |
| Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20060401 |
| Noninvasive 1H/13C magnetic resonance spectroscopic imaging of the intratumoral distribution of temozolomide. | Magnetic resonance in medicine 20060401 |
| Mutagenic potential of temozolomide in bone marrow cells in vivo. | Blood 20060401 |
| EBV-associated recurrent Hodgkin's disease after renal transplantation. | Transplant international : official journal of the European Society for Organ Transplantation 20060401 |
| Chemotherapy and targeted therapy combinations in advanced melanoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060401 |
| [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma]. | Ai zheng = Aizheng = Chinese journal of cancer 20060401 |
| Acute myocardial infarction induced by cisplatin-based combination chemotherapy for malignant melanoma: a case report. | Journal of cardiology 20060401 |
| Whole brain irradiation and temozolomide based chemotherapy in melanoma brain metastases. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060401 |
| Hodgkin lymphoma in a child with Diamond Blackfan anemia. | Journal of pediatric hematology/oncology 20060401 |
| Successful treatment via chemotherapy and surgical resection of a femoral hemangiopericytoma with pulmonary metastasis. | Journal of pediatric hematology/oncology 20060401 |
| Mitoxantrone, vinblastine and CCNU: long-term follow-up of patients treated for advanced and poor-prognosis Hodgkin's disease. | Leukemia & lymphoma 20060401 |
| Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy. | Leukemia & lymphoma 20060401 |
| Evaluation of acute and early cardiotoxicity in survivors of Hodgkin's disease treated with ABVD or BEACOPP regimens. | Journal of chemotherapy (Florence, Italy) 20060401 |
| [Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy]. | Vnitrni lekarstvi 20060401 |
| Recent advances in the treatment of malignant astrocytoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060310 |
| More from PHARMAC on temozolomide: feedback needed. | The New Zealand medical journal 20060310 |
| O(6)-methylguanine DNA-methyltransferase (MGMT) overexpression in melanoma cells induces resistance to nitrosoureas and temozolomide but sensitizes to mitomycin C. | Toxicology and applied pharmacology 20060301 |
| APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial. | Pediatric blood & cancer 20060301 |
| Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial. | International journal of radiation oncology, biology, physics 20060301 |
| Phase II trial of temozolomide in children with recurrent high-grade glioma. | Journal of neuro-oncology 20060301 |
| Recent developments in the use of chemotherapy in brain tumours. | European journal of cancer (Oxford, England : 1990) 20060301 |
| Catalase activity in Candida albicans exposed to antineoplastic drugs. | Journal of medical microbiology 20060301 |
| Management of advanced stage Hodgkin lymphoma. | Journal of the National Comprehensive Cancer Network : JNCCN 20060301 |
| Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060301 |
| Oral regimen for metastatic neuroendocrine tumours. | The Lancet. Oncology 20060301 |
| Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine. | Molecular cancer therapeutics 20060301 |
| [Management of malignant gliomas diagnosed during pregnancy]. | Revue neurologique 20060301 |
| Therapeutic and palliative options for diffuse neuroendocrine metastatic disease. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20060301 |
| Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment. | Clinical lymphoma & myeloma 20060301 |
| [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy]. | Vnitrni lekarstvi 20060301 |
| [Spinal involvement as first presentation of Hodgkin's disease]. | Anales de medicina interna (Madrid, Spain : 1984) 20060301 |
| [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060301 |
| Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060301 |
| Is protracted low-dose temozolomide feasible in glioma patients? | Neurology 20060214 |
| Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. | Journal of neuro-oncology 20060201 |
| Role of temozolomide in spinal cord low grade astrocytomas: results in two paediatric patients. | Acta neurochirurgica 20060201 |
| A new approach to modeling covariate effects and individualization in population pharmacokinetics-pharmacodynamics. | Journal of pharmacokinetics and pharmacodynamics 20060201 |
| O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. | Journal of neurochemistry 20060201 |
| Chemotherapy for glioblastoma multiforme (GBM). | Surgical neurology 20060201 |
| Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-alpha in patients with metastatic melanoma. | Melanoma research 20060201 |
| A biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, temozolomide (Temodal), interferon-alfa and interleukin-2 for metastatic melanoma: a phase II study. | Melanoma research 20060201 |
| Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201 |
| Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201 |
| A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy. | American journal of clinical oncology 20060201 |
| Glioblastoma--more questions than answers? | Nature clinical practice. Oncology 20060201 |
| [Hypersensitivity to dacarbazine in patients with metastatic malignant melanoma]. | Annales de dermatologie et de venereologie 20060201 |
| Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120 |
| Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma. | Cancer 20060115 |
| Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060110 |
| Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication. | Journal of the National Cancer Institute 20060104 |
| Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours. | Cancer chemotherapy and pharmacology 20060101 |
| The P140K mutant of human O(6)-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O(6)-(4-bromothenyl)guanine. | The journal of gene medicine 20060101 |
| Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. | Journal of neuro-oncology 20060101 |
| Phase I study of temozolomide and lomustine in the treatment of high grade malignant glioma. | Frontiers in bioscience : a journal and virtual library 20060101 |
| Hodgkin's disease in Indian children: outcome with chemotherapy alone. | Pediatric blood & cancer 20060101 |
| Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma. | Cancer 20060101 |
| [Chemotherapy of sarcomas: optimization of existing drugs and new molecules]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20060101 |
| Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model. | International journal of oncology 20060101 |
| Combination celecoxib and temozolomide in C6 rat glioma orthotopic model. | Oncology reports 20060101 |
| Desmoid tumors respond to chemotherapy: defying the dogma in oncology. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060101 |
| Phase II study of two-weekly temozolomide in patients with high-grade gliomas. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20060101 |
| Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060101 |
| Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytotoxicity. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060101 |
| Echocardiographic evaluation of early and chronic cardiotoxicity in adult patients treated for Hodgkin's disease with ABVD regimen. | Neoplasma 20060101 |
| High-dose idarubicin, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma responsive to DAV chemotherapy: comparison with a historical control. | Acta haematologica 20060101 |
| Differential competitive resistance to methylating versus chloroethylating agents among five O6-alkylguanine DNA alkyltransferases in human hematopoietic cells. | Molecular cancer therapeutics 20060101 |
| Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. | Neuro-oncology 20060101 |
| [Update on cerebral tumors]. | Bulletin du cancer 20060101 |
| Advances in the treatment of primary brain tumors: dawn of a new era? | Current oncology reports 20060101 |
| The evolution of chemoradiation for glioblastoma: a modern success story. | Current oncology reports 20060101 |
| Merkel cell carcinoma. | World journal of surgical oncology 20060101 |
| [A case of primary leiomyosarcoma of the ureter]. | Hinyokika kiyo. Acta urologica Japonica 20060101 |
| Search for optimal coupling reagent in multiple peptide synthesizer. | Biopolymers 20060101 |
| Normocalcemic parathyroid carcinoma: an unusual clinical presentation. | World journal of surgical oncology 20060101 |
| Primary malignant melanoma of the lung: a case report and review of the literature. | Clinical lung cancer 20060101 |
| Current trends in the management of extra-abdominal desmoid tumours. | World journal of surgical oncology 20060101 |
| Pyoderma gangrenosum related to a new granulocyte colony-stimulating factor. | Skinmed 20060101 |
| Solitary pulmonary metastasis from primary melanoma of the oesophagus 5 years after resection of the primary tumor. | World journal of surgical oncology 20060101 |
| [Management of corneo-conjunctival malignant melanoma with 'no touch technique' surgical excision and corneoscleral lamellar keratoplasty]. | [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20060101 |
| Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol. | BMC cancer 20060101 |
| Adjuvant therapy of cutaneous melanoma -- current status. | Acta oncologica (Stockholm, Sweden) 20060101 |
| Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial. | Acta oncologica (Stockholm, Sweden) 20060101 |
| Primary malignant melanoma of the middle ear mucosa: a case report. | Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat 20060101 |
| Recurrent endometrial stromal sarcoma after treatment with high-dose chemotherapy and autologous stem-cell support: A case report. | European journal of gynaecological oncology 20060101 |
| High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy. | Anticancer research 20060101 |
| Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report. | BMC urology 20060101 |
| Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study. | Cancer investigation 20060101 |
| [Limphomatous meningitis as recurrence site in Hodgkin's disease]. | Medicina 20060101 |
| Temozolomide and radiotherapy as first-line treatment of high-grade gliomas. | Tumori 20060101 |
| The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane. | Sarcoma 20060101 |
| [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy]. | Terapevticheskii arkhiv 20060101 |
| Retroperitoneal synovial sarcoma. | Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 20060101 |
| [Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis]. | Voprosy onkologii 20060101 |
| Selected hypoxic stop-flow perfusions: indication and limits. | Tumori 20060101 |
| Gardner's syndrome in a 40-year-old woman: successful treatment of locally aggressive desmoid tumors with cytotoxic chemotherapy. | World journal of surgical oncology 20060101 |
| [Results of radical removal of malignant cerebral gliomas, by using computer-assisted navigation, followed by adjuvant therapy]. | Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 20060101 |
| A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia. | In vivo (Athens, Greece) 20060101 |
| Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation. | Anticancer research 20060101 |
| Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas. | Anticancer research 20060101 |
| Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS). | Sarcoma 20060101 |
| Primary cardiac angiosarcoma. | Sarcoma 20060101 |
| Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair. | Clinical neurosurgery 20060101 |
| A retrospective analysis of vinorelbine chemotherapy for patients with previously treated soft-tissue sarcomas. | Sarcoma 20060101 |
| Late-onset meningeal metastases in liposarcoma: a case report and review of the literature. | Sarcoma 20060101 |
| Combined modality treatment of glioblastoma multiforme: the role of temozolomide. | Reviews on recent clinical trials 20060101 |
| Familial paragangliomas. | Hereditary cancer in clinical practice 20060101 |
| ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220 |
| Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220 |
| Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220 |
| Evidence, economics, and emotions: the case for temozolomide. | The New Zealand medical journal 20051216 |
| PHARMAC's response on temozolomide and funding costly medicines that prolong life shortly. | The New Zealand medical journal 20051216 |
| Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051210 |
| Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051210 |
| Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure. | International journal of radiation oncology, biology, physics 20051201 |
| Salvage temozolomide for prior temozolomide responders. | Cancer 20051201 |
| Combination hepatic arterial infusion therapy is effective for ocular melanoma metastasis to the liver. | Oncology reports 20051201 |
| Artesunate in the treatment of metastatic uveal melanoma--first experiences. | Oncology reports 20051201 |
| Treatment of astrocytomas. | Current opinion in neurology 20051201 |
| Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide. | European journal of cancer (Oxford, England : 1990) 20051201 |
| Radiotherapy and Hodgkin's lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051201 |
| Decline in angiogenic factors, such as interleukin-8, indicates response to chemotherapy of metastatic melanoma. | Melanoma research 20051201 |
| Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trial. | Melanoma research 20051201 |
| Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease. | American journal of clinical oncology 20051201 |
| Health-related quality of life in patients with glioblastoma: a randomised controlled trial. | The Lancet. Oncology 20051201 |
| Temozolomide in the treatment of recurrent malignant glioma in Chinese patients. | Hong Kong medical journal = Xianggang yi xue za zhi 20051201 |
| Interleukin-2 for the treatment of melanoma. | Current opinion in investigational drugs (London, England : 2000) 20051201 |
| Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. | Molecular cancer therapeutics 20051201 |
| [Concomitant radiotherapy with chemotherapy in patients with glioblastoma]. | Bulletin du cancer 20051201 |
| Clinical analysis of primary malignant melanoma of the cervix. | Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20051201 |
| Extended continuous oral temozolomide in patients with progressive metastatic renal cell carcinoma not responding to interferon alpha 2b. | Journal of chemotherapy (Florence, Italy) 20051201 |
| Temozolomide: a milestone in the pharmacotherapy of brain tumors. | Future oncology (London, England) 20051201 |
| Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trial. | Nature clinical practice. Neurology 20051201 |
| Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase. | Cancer research 20051115 |
| O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts. | British journal of cancer 20051114 |
| Relapse of primary CNS lymphoma after more than 10 years in complete remission. | Journal of neurology 20051101 |
| Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group. | International journal of radiation oncology, biology, physics 20051101 |
| Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study. | Lung cancer (Amsterdam, Netherlands) 20051101 |
| Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: a Gynecologic Oncology Group study. | Gynecologic oncology 20051101 |
| A Phase I trial of protracted oral fixed-dose temozolomide. | Cancer 20051101 |
| Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma. | The British journal of dermatology 20051101 |
| Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051101 |
| Avoiding glucocorticoid administration in a neurooncological case. | Cancer biology & therapy 20051101 |
| Systemic temozolomide combined with loco-regional mitoxantrone in treating recurrent glioblastoma. | Journal of neuro-oncology 20051101 |
| 10 questions about temozolomide and the treatment of brain tumors. | The neurologist 20051101 |
| A congenital brain tumor associated with assisted in vitro fertilization. Case report. | Journal of neurosurgery 20051101 |
| Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020 |
| Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020 |
| Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumors. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020 |
| A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas. | Cancer 20051015 |
| [Standards and new developments in the chemotherapy of glioblastomas]. | Deutsche medizinische Wochenschrift (1946) 20051007 |
| Secondary Ph+ acute lymphoblastic leukemia after temozolomide. | Annals of hematology 20051001 |
| Primary angiosarcoma of the ovary: a case report of Stage I disease. | Gynecologic oncology 20051001 |
| Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma. | Cancer 20051001 |
| Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. | International journal of radiation oncology, biology, physics 20051001 |
| Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001 |
| A low rate of central nervous system progression in a phase II trial of outpatient chemobiologic therapy with cisplatin, temozolomide, interleukin-2, and interferon alfa 2-B for metastatic malignant melanoma. | American journal of clinical oncology 20051001 |
| Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. | Clinical cancer research : an official journal of the American Association for Cancer Research 20051001 |
| Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment. | Neoplasia (New York, N.Y.) 20051001 |
| Gastrin exerts pleiotropic effects on human melanoma cell biology. | Neoplasia (New York, N.Y.) 20051001 |
| A retrospective study of biochemotherapy for metastatic melanoma: the importance of dose intensity. | Cancer biotherapy & radiopharmaceuticals 20051001 |
| A case of epidermotropic metastatic malignant melanoma with multiple nodular lesions of the scalp. | The Journal of dermatology 20051001 |
| Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050920 |
| State-of-the-art therapeutics: Hodgkin's lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050910 |
| Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies. | British journal of cancer 20050905 |
| [Radiotherapy for glioblastomas: from radiobiology to concomitant chemotherapy]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20050901 |
| Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF. | Japanese journal of clinical oncology 20050901 |
| Alveolar soft part sarcoma: a rare and enigmatic entity. | Clinical orthopaedics and related research 20050901 |
| Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901 |
| IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. | Cancer research 20050901 |
| Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma. | Haematologica 20050901 |
| Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. | Molecular cancer therapeutics 20050901 |
| Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft. | Molecular cancer therapeutics 20050901 |
| Inactivation of p53 sensitizes astrocytic glioma cells to BCNU and temozolomide, but not cisplatin. | Journal of neuro-oncology 20050901 |
| [Role of extracellular matrix degradation enzyme for glioma invasion]. | Nihon rinsho. Japanese journal of clinical medicine 20050901 |
| [Chemotherapy for gliomas in children]. | Nihon rinsho. Japanese journal of clinical medicine 20050901 |
| [Treatment of malignant gliomas in the elderly]. | Nihon rinsho. Japanese journal of clinical medicine 20050901 |
| [Chemotherapy for brain metastases]. | Nihon rinsho. Japanese journal of clinical medicine 20050901 |
| Sarcomatoid renal cell carcinoma with a chromophobe component producing beta-human chorionic gonadotropin. | International journal of urology : official journal of the Japanese Urological Association 20050901 |
| The role of chemotherapy in the treatment of low-grade glioma. A review of the literature. | Acta neurologica Belgica 20050901 |
| Efficiency, quality and bureaucracy: not always in the same bag!! | European journal of cancer (Oxford, England : 1990) 20050901 |
| A case of Werner syndrome with three primary lesions of malignant melanoma. | The Journal of dermatology 20050901 |
| Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide. | International journal of cancer 20050820 |
| Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo. | Cancer research 20050815 |
| [Guideline 'Melanoma' (3rd revision)]. | Nederlands tijdschrift voor geneeskunde 20050813 |
| Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy. | Oncogene 20050804 |
| Lack of response of a metastatic renal perivascular epithelial cell tumor (PEComa) to successive courses of DTIC based-therapy and imatinib mesylate. | Pediatric blood & cancer 20050801 |
| Risk management of extravasation of cytostatic drugs at the Adult Chemotherapy Outpatient Clinic of a university hospital. | Journal of clinical nursing 20050801 |
| Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. | International journal of oncology 20050801 |
| Research on the anti-tumour effect of steroid lactam alkylator (NSC-294859) in comparison with conventional chemotherapeutics in malignant melanoma. | Melanoma research 20050801 |
| Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma. | Melanoma research 20050801 |
| Cardiac metastasis of melanoma. | Melanoma research 20050801 |
| Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801 |
| Medullary thyroid carcinoma in Hong Kong Chinese patients. | Hong Kong medical journal = Xianggang yi xue za zhi 20050801 |
| Thalidomide enhances the anti-tumor activity of standard chemotherapy in a human melanoma xenotransplatation model. | The Journal of investigative dermatology 20050801 |
| Author comments on drug-dispensing change. | Clinical journal of oncology nursing 20050801 |
| [Spinal and cerebral leptomeningeal seeding from a melanocytoma of the cerebello-pontine angle]. | Wiener medizinische Wochenschrift (1946) 20050801 |
| Endocrine tumours of the gastrointestinal tract: Chemotherapy. | Best practice & research. Clinical gastroenterology 20050801 |
| Specific binding of dacarbazine to DNA bases and oligonucleotides based on gold nanoparticles. | Journal of nanoscience and nanotechnology 20050801 |
| Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050720 |
| Chemotherapy alone for early Hodgkin's lymphoma: an emerging option. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050720 |
| The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death. | Cancer research 20050715 |
| [Primary pulmonary Hodgkin's disease]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20050710 |
| Low-grade primary meningeal lymphoma: case report and review of the literature. | Neurosurgical review 20050701 |
| Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme. | Annals of oncology : official journal of the European Society for Medical Oncology 20050701 |
| Chemopotentiation by PARP inhibitors in cancer therapy. | Pharmacological research 20050701 |
| Temozolomide in uterine leiomyosarcomas. | Gynecologic oncology 20050701 |
| Artificial tumor model suitable for monitoring 31P and 13C NMR spectroscopic changes during chemotherapy-induced apoptosis in human glioma cells. | Magnetic resonance in medicine 20050701 |
| Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis. | Journal of neuro-oncology 20050701 |
| Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma? | European journal of haematology. Supplementum 20050701 |
| Clinical trials in North America. | European journal of haematology. Supplementum 20050701 |
| Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy. | Leukemia & lymphoma 20050701 |
| Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: results of a phase II trial. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20050701 |
| Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620 |
| How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620 |
| [Temozolomide in patients with a glioblastoma multiforme: new developments]. | Nederlands tijdschrift voor geneeskunde 20050618 |
| [Favourable result for temozolomide in recurrent high-grade glioma]. | Nederlands tijdschrift voor geneeskunde 20050618 |
| Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study. | Cancer 20050615 |
| Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. | Journal of the National Cancer Institute 20050615 |
| Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. | British journal of cancer 20050606 |
| Treatment of brain tumors. | The New England journal of medicine 20050602 |
| Treatment of brain tumors. | The New England journal of medicine 20050602 |
| Management of pilocytic astrocytoma with diffuse leptomeningeal spread: two cases and review of the literature. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20050601 |
| Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20050601 |
| Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20050601 |
| Engineering 3-alkyltriazenes to block bcr-abl kinase: a novel strategy for the therapy of advanced bcr-abl expressing leukemias. | Leukemia research 20050601 |
| Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide. | Annals of oncology : official journal of the European Society for Medical Oncology 20050601 |
| Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts. | International journal of oncology 20050601 |
| Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest. | International journal of oncology 20050601 |
| Combined chemoimmunotherapy of metastatic melanoma: a single institution experience. | Melanoma research 20050601 |
| Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20050601 |
| Variant lymphoproliferative disorder of granular lymphocytes (LDGL) following Hodgkin lymphoma. | American journal of hematology 20050601 |
| Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence. | Cancer research 20050601 |
| Clusterin regulates drug-resistance in melanoma cells. | The Journal of investigative dermatology 20050601 |
| Maintenance of fertility following treatment with temozolomide for a high grade astrocytoma. | Journal of neuro-oncology 20050601 |
| ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do? | Clinical lymphoma 20050601 |
| Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy. | International journal of clinical oncology 20050601 |
| Modeling antitumor activity in xenograft tumor treatment. | Biometrical journal. Biometrische Zeitschrift 20050601 |
| Development of a pharmacokinetic limited sampling model for temozolomide and its active metabolite MTIC. | Cancer chemotherapy and pharmacology 20050501 |
| Treatment of brain metastases from melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050501 |
| Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute. | European journal of cancer (Oxford, England : 1990) 20050501 |
| Systemic therapy for advanced uterine sarcoma: a systematic review of the literature. | Gynecologic oncology 20050501 |
| Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme. | Current neurology and neuroscience reports 20050501 |
| Optimal role of temozolomide in the treatment of malignant gliomas. | Current neurology and neuroscience reports 20050501 |
| Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050501 |
| Treatment of metastatic malignant melanoma. | Current treatment options in oncology 20050501 |
| Temozolomide and radiation for aggressive pediatric central nervous system malignancies. | Journal of pediatric hematology/oncology 20050501 |
| Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma. | British journal of cancer 20050425 |
| Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells. | Glia 20050415 |
| Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents. | Cancer research 20050415 |
| Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401 |
| O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050401 |
| A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma. | International journal of radiation oncology, biology, physics 20050401 |
| Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death. | Neuro-oncology 20050401 |
| Melanoma treatment update. | Dermatologic clinics 20050401 |
| Adjuvant chemotherapy in the treatment of high grade gliomas. | Cancer treatment reviews 20050401 |
| [Highly quality-controlled radiation therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050401 |
| Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts. | Journal of neurosurgery 20050401 |
| [New place of the chemotherapy in gliomas]. | Bulletin du cancer 20050401 |
| [Interdigitating dendritic cell sarcoma-a case report with literature review]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20050401 |
| [Rhabdomyolysis, disseminated intravascular coagulation and acute renal failure after severe narcotics intoxication (MDMA, THC, amphetamine)]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050401 |
| Does addition of temozolomide to whole brain radiotherapy improve outcome in patients with brain metastases? | Nature clinical practice. Oncology 20050401 |
| Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations. | British journal of cancer 20050328 |
| PARP inhibitors for cancer therapy. | Expert reviews in molecular medicine 20050315 |
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. | The New England journal of medicine 20050310 |
| MGMT gene silencing and benefit from temozolomide in glioblastoma. | The New England journal of medicine 20050310 |
| Chemotherapy for brain tumors--a new beginning. | The New England journal of medicine 20050310 |
| Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. | Neurology 20050308 |
| Hodgkin's lymphoma and tuberculosis coexistence in cervical lymph nodes. | Leukemia & lymphoma 20050301 |
| Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050301 |
| Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease. | Annals of oncology : official journal of the European Society for Medical Oncology 20050301 |
| Temozolomide in the treatment of solid tumours: current results and rationale for dosing/scheduling. | Critical reviews in oncology/hematology 20050301 |
| Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes. | Journal of surgical oncology 20050301 |
| Expression of ABC-1 transporter is elevated in human glioma cells under irradiation and temozolomide treatment. | Amino acids 20050301 |
| Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease. | British journal of haematology 20050301 |
| Functional erythropoietin autocrine loop in melanoma. | The American journal of pathology 20050301 |
| Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20050301 |
| [Malignant melanoma of nasal fossae: clinical and therapeutic considerations about three cases]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20050301 |
| Local control of primary oropharyngeal malignant melanomas with limited tissue excision: a report of three cases. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20050201 |
| Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. | Blood 20050201 |
| Brain distribution and efficacy as chemosensitizer of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumors. | International journal of oncology 20050201 |
| Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050201 |
| Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma. | Journal of neuro-oncology 20050201 |
| Successful treatment of a chemoresistant tumor with temozolomide in an adult patient: report of a recurrent intracranial mesenchymal chondrosarcoma. | Journal of neuro-oncology 20050201 |
| Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa. | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20050201 |
| [Primary treatment of advanced Hodgkin's disease]. | Orvosi hetilap 20050130 |
| The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors. | Bioorganic & medicinal chemistry letters 20050117 |
| Repeated-measures models with constrained parameters for incomplete data in tumour xenograft experiments. | Statistics in medicine 20050115 |
| [Primary treatment of early stage Hodgkin's disease]. | Orvosi hetilap 20050109 |
| Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme. | Journal of cancer research and clinical oncology 20050101 |
| Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). | Cancer 20050101 |
| A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly). | Annals of oncology : official journal of the European Society for Medical Oncology 20050101 |
| Chemotherapeutic induced fascial oedema. | Annals of the rheumatic diseases 20050101 |
| The effect of antitumor drugs on oxidative stress in B16 and S91 melanoma cells in vitro. | Medical science monitor : international medical journal of experimental and clinical research 20050101 |
| Neuro-oncology: the growing role of chemotherapy in glioma. | The Lancet. Neurology 20050101 |
| Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy. | The Annals of thoracic surgery 20050101 |
| Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease. | International journal of radiation oncology, biology, physics 20050101 |
| Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. | International journal of radiation oncology, biology, physics 20050101 |
| Research news and notes. | Surgical neurology 20050101 |
| Neoadjuvant temozolomide followed by complete resection of a 1p- and 19q-deleted anaplastic oligoastrocytoma: case study. | Neuro-oncology 20050101 |
| Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study. | Journal of neuro-oncology 20050101 |
| Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanoma. | Cancer investigation 20050101 |
| Spermatogenesis after cancer treatment: damage and recovery. | Journal of the National Cancer Institute. Monographs 20050101 |
| Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome. | Neoplasma 20050101 |
| Response to temozolomide in second-line treatment of recurrent nonsmall cell lung carcinoma: case report. | Cancer investigation 20050101 |
| Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life. | Cancer investigation 20050101 |
| Improving outcomes in advanced malignant melanoma: update on systemic therapy. | Drugs 20050101 |
| Total reconstruction of the upper lip after resection of a malignant melanoma. | Scandinavian journal of plastic and reconstructive surgery and hand surgery 20050101 |
| Temozolomide and cisplatin in avdanced malignant melanoma. | Anticancer research 20050101 |
| ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease. | Annals of oncology : official journal of the European Society for Medical Oncology 20050101 |
| Phenytoin may increase the efficacy of temozolomide by methylating DNA-repair enzyme, O6-methylguanine-DNA methyltransferase in patients with glioblastoma. | Medical hypotheses 20050101 |
| Analysis of 7-methylguanine using isotope dilution and gas chromatography/electron-capture negative chemical ionization mass spectrometry. | Rapid communications in mass spectrometry : RCM 20050101 |
| Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme. | PharmacoEconomics 20050101 |
| A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSF. | Cancer investigation 20050101 |
| Primary malignant melanoma of the common bile duct: a case report and literature review. | Gastroenterologia y hepatologia 20050101 |
| Electrochemical detection of single a-g mismatch using biosensing surface based on gold nanoparticles. | Genomics, proteomics & bioinformatics 20050101 |
| Intracranial involvement in Hodgkin's disease. | Pediatric hematology and oncology 20050101 |
| A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT). | Breast cancer research : BCR 20050101 |
| 518A2 melanoma cells are protected by G3139 and other antineoplastic agents against the cytotoxic effects of DTIC. | Oligonucleotides 20050101 |
| New drug extends lives of brain cancer patients. | FDA consumer 20050101 |
| Targeted therapy against Bcl-2-related proteins in breast cancer cells. | Breast cancer research : BCR 20050101 |
| Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma. | Dermatology (Basel, Switzerland) 20050101 |
| Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives. | BMC cancer 20050101 |
| Evolving approaches to primary treatment of Hodgkin lymphoma. | Hematology. American Society of Hematology. Education Program 20050101 |
| Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy. | Hematology. American Society of Hematology. Education Program 20050101 |
| Treatment of unresectable glioblastoma multiforme. | Anticancer research 20050101 |
| B16 and cloudman S91 mouse melanoma cells susceptibility to apoptosis after dacarbazine treatment. | Acta poloniae pharmaceutica 20050101 |
| Synthesis and antitumor activity of methyltriazene prodrugs simultaneously releasing DNA-methylating agents and the antiresistance drug O(6)-benzylguanine. | Journal of medicinal chemistry 20041230 |
| Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population. | Cancer 20041215 |
| Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas. | Cancer 20041215 |
| Synchronous cancer and metastatic melanoma of the breasts. | Archives of gynecology and obstetrics 20041201 |
| Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. | Blood 20041201 |
| Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20041201 |
| The piperidine nitroxide Tempol potentiates the cytotoxic effects of temozolomide in human glioblastoma cells. | International journal of oncology 20041201 |
| Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study. | Annals of oncology : official journal of the European Society for Medical Oncology 20041201 |
| Breast metastases from cutaneous malignant melanoma. | Breast (Edinburgh, Scotland) 20041201 |
| Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041201 |
| Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma. | Cancer research 20041201 |
| The prognostic role of CD4+ and CD8+ lymphocytes during chemoimmunotherapy in metastatic melanoma. | Melanoma research 20041201 |
| Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma. | Melanoma research 20041201 |
| Serum bcl-2 and survivin levels in melanoma. | Melanoma research 20041201 |
| Pharmacokinetic model-predicted anticancer drug concentrations in human tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041201 |
| Significance of splenomegaly in childhood Hodgkin disease. | Journal of pediatric hematology/oncology 20041201 |
| Relevance and necessity of studies on second-line chemotherapy in melanoma. | Onkologie 20041201 |
| A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy. | Molecular cancer therapeutics 20041201 |
| Response of low-grade oligodendroglial tumors to temozolomide. | Journal of neuro-oncology 20041201 |
| Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM). | Journal of neuro-oncology 20041201 |
| Malignant retroperitoneal paraganglioma: case report and review of the literature. | Pediatric hematology and oncology 20041201 |
| Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas. | Ideggyogyaszati szemle 20041120 |
| Phase I clinical trial of fixed-dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation. | Cancer 20041115 |
| Inhibition of O6-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors: comparison with nonconjugated inhibitors and effect on fotemustine and temozolomide-induced cell death. | The Journal of pharmacology and experimental therapeutics 20041101 |
| Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death. | Cancer 20041101 |
| Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease. | International journal of radiation oncology, biology, physics 20041101 |
| Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group. | British journal of cancer 20041101 |
| Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4. | Molecular therapy : the journal of the American Society of Gene Therapy 20041101 |
| Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma. | American journal of surgery 20041101 |
| Hierarchical models for tumor xenograft experiments in drug development. | Journal of biopharmaceutical statistics 20041101 |
| Making inferences about projected completors in longitudinal studies. | Journal of biopharmaceutical statistics 20041101 |
| Apoptosis, Bcl-2 antisense, and cancer therapy. | Oncology (Williston Park, N.Y.) 20041101 |
| Innovative therapy for patients with brain metastases: oral treatments. | Journal of chemotherapy (Florence, Italy) 20041101 |
| Endothelin-1 and cardiac function in anthracycline-treated patients: a 1-year follow-up. | Journal of cardiovascular pharmacology 20041101 |
| Axillary swelling and a reduced general condition in a middle-aged man. | Nature clinical practice. Oncology 20041101 |
| No adverse effect of ABVD chemotherapy in a patient with chronic hepatitis C and Hodgkin's disease. | Wiener klinische Wochenschrift 20041030 |
| Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphoma. | Leukemia & lymphoma 20041001 |
| Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. | International journal of radiation oncology, biology, physics 20041001 |
| Alkylating benzamides with melanoma cytotoxicity. | Melanoma research 20041001 |
| The role of taxanes in the treatment of metastatic melanoma. | Melanoma research 20041001 |
| Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. | Cancer research 20041001 |
| Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase. | Molecular cancer therapeutics 20041001 |
| Temozolomide for the treatment of recurrent supratentorial glioma: results of a compassionate use program in Belgium. | Journal of neuro-oncology 20041001 |
| Intracranial metastatic esthesioneuroblastoma responsive to temozolomide. | Journal of neuro-oncology 20041001 |
| Phase II study of concurrent continuous Temozolomide (TMZ) and Tamoxifen (TMX) for recurrent malignant astrocytic gliomas. | Journal of neuro-oncology 20041001 |
| New (1-deaza)purine derivatives via efficient C-2 nitration of the (1-deaza)purine ring. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Management of metastatic cutaneous melanoma. | Oncology (Williston Park, N.Y.) 20041001 |
| Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma. | Cancer research 20040915 |
| Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. | Neurology 20040914 |
| Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas. | Neurology 20040914 |
| Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line. | British journal of cancer 20040913 |
| Procarbazine in haematology: an old drug with a new life? | European journal of cancer (Oxford, England : 1990) 20040901 |
| DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system. | Molecular pharmacology 20040901 |
| A Phase II trial of gemcitabine for metastatic neuroendocrine tumors. | Cancer 20040901 |
| [Soft tissue sarcoma: postoperative chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040901 |
| The impact of conventional and high-dose therapy for lymphoma on fertility. | Clinical lymphoma 20040901 |
| Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide. | The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 20040901 |
| Current therapies for glioblastoma. | Clinical advances in hematology & oncology : H&O 20040901 |
| Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. | Neurology 20040810 |
| Temozolomide in paediatric high-grade glioma: a key for combination therapy? | British journal of cancer 20040802 |
| Consolidation radiotherapy may improve outcomes in people with Hodgkin's disease achieving complete remission after combination chemotherapy. | Cancer treatment reviews 20040801 |
| Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma. | Cancer 20040801 |
| Extraskeletal Ewing sarcoma of the diaphragm presenting with hemothorax. | The Annals of thoracic surgery 20040801 |
| Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040801 |
| Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years? | European journal of cancer (Oxford, England : 1990) 20040801 |
| CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040801 |
| Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells. | Molecular cancer therapeutics 20040801 |
| Intravascular metastatic melanoma of the vena saphena magna. | International journal of dermatology 20040801 |
| The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma. | Melanoma research 20040801 |
| Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma Intergroup. | Melanoma research 20040801 |
| Lentivirus-mediated expression of mutant MGMTP140K protects human CD34+ cells against the combined toxicity of O6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomide. | Human gene therapy 20040801 |
| Gliomatosis cerebri: better definition, better treatment. | Neurology 20040727 |
| Initial chemotherapy in gliomatosis cerebri. | Neurology 20040727 |
| Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide. | Neurology 20040727 |
| Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma. | British journal of cancer 20040719 |
| Phase I trial of the novel taxane BMS-184476 administered in combination with carboplatin every 21 days. | British journal of cancer 20040719 |
| ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040715 |
| Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors. | International journal of radiation oncology, biology, physics 20040715 |
| Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma. | Cancer research 20040715 |
| Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease. | Annals of hematology 20040701 |
| Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol. | Pediatric blood & cancer 20040701 |
| Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma. | International journal of radiation oncology, biology, physics 20040701 |
| Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas. | Cancer 20040701 |
| Distinct responses of xenografted gliomas to different alkylating agents are related to histology and genetic alterations. | Cancer research 20040701 |
| Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial. | European journal of cancer (Oxford, England : 1990) 20040701 |
| Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review. | European journal of cancer (Oxford, England : 1990) 20040701 |
| Temozolomide and interferon alpha 2b in metastatic melanoma stage IV. | The British journal of dermatology 20040701 |
| Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy. | Neuro-oncology 20040701 |
| Cyclooxygenase-2 (Cox-2) expression in lymphomas. | Leukemia & lymphoma 20040701 |
| Oblimersen sodium (Genasense bcl-2 antisense oligonucleotide): a rational therapeutic to enhance apoptosis in therapy of lung cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040615 |
| [Disseminated melanoma treatment]. | La Revue du praticien 20040615 |
| One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. | Neurology 20040608 |
| Chemotherapy for melanoma: the resultant of conflicting vectors. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601 |
| Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601 |
| ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis. | British journal of haematology 20040601 |
| DNA repair pathways in drug resistance in melanoma. | Anti-cancer drugs 20040601 |
| Preliminary study on pharmacokinetics of dacarbazine and fotemustine in glioblastoma multiforme patients does not indicate gender-specific differences. | Anti-cancer drugs 20040601 |
| Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers. | Anti-cancer drugs 20040601 |
| Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601 |
| Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040601 |
| In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. | Melanoma research 20040601 |
| A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer. | Gynecologic oncology 20040601 |
| Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide. | Journal of neurosurgery 20040601 |
| Activity of irinotecan, cisplatin and dacarbazine (CPD) combination in previously treated patients with advanced colorectal carcinoma. | Experimental oncology 20040601 |
| Evaluation of temozolomide in patients with myelodysplastic syndrome. | Leukemia & lymphoma 20040601 |
| Long-term outcome of oligodendrogliomas. | Neurology 20040525 |
| Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors. | Bioorganic & medicinal chemistry letters 20040517 |
| Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. | Cancer 20040515 |
| Modeling antitumor activity by using a non-linear mixed-effects model. | Mathematical biosciences 20040501 |
| BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20040501 |
| Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma. | Journal of the American Academy of Dermatology 20040501 |
| First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040501 |
| Synthesis and in vitro antileukemic activity of new 4-triazenopyrazole derivatives. | Farmaco (Societa chimica italiana : 1989) 20040501 |
| Irinotecan-induced interstitial pneumonia. | The Lancet. Oncology 20040501 |
| Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines. | The Journal of clinical endocrinology and metabolism 20040501 |
| Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age. | Acta paediatrica (Oslo, Norway : 1992). Supplement 20040501 |
| Disposition and pharmacokinetics of temozolomide in rat. | Xenobiotica; the fate of foreign compounds in biological systems 20040501 |
| Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice. | British journal of cancer 20040419 |
| Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group. | Cancer 20040415 |
| A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study. | Cancer 20040415 |
| Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial. | Cancer 20040415 |
| How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040415 |
| Temozolomide for treatment-resistant recurrent meningioma. | Neurology 20040413 |
| Unusual and severe symptomatic impairment of neutrophil function after one cycle of temozolomide in patients with malignant glioma. | Annals of hematology 20040401 |
| Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. | Cell death and differentiation 20040401 |
| Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors. | Investigational new drugs 20040401 |
| Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations. | DNA repair 20040401 |
| Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways. | Journal of immunology (Baltimore, Md. : 1950) 20040401 |
| Biochemotherapy in patients with metastatic anorectal mucosal melanoma. | Cancer 20040401 |
| Role of chemotherapy in patients with soft tissue sarcomas. | Expert review of anticancer therapy 20040401 |
| Update on the systemic treatment of malignant melanoma. | Seminars in oncology 20040401 |
| Complete response of multiple melanoma brain metastases after treatment with temozolomide. | Onkologie 20040401 |
| [Survival analysis following the addition of temozolomide to surgery and radiotherapy in patients with glioblastoma multiforme]. | Neurocirugia (Asturias, Spain) 20040401 |
| Cutaneous involvement in Hodgkin's lymphoma: report of two cases. | The Journal of dermatology 20040401 |
| [Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation]. | Medicina clinica 20040327 |
| Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group. | International journal of radiation oncology, biology, physics 20040315 |
| Extended total sacrectomy and reconstruction for sacral tumor. | Spine 20040315 |
| Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040315 |
| Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme. | Cancer 20040315 |
| Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040315 |
| Primary cultures of microglial cells for testing toxicity of anticancer drugs. | Toxicology letters 20040314 |
| Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers. | British journal of cancer 20040308 |
| Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. | Pediatric blood & cancer 20040301 |
| Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma. | Journal of cutaneous pathology 20040301 |
| Enzyme-catalyzed activation of anticancer prodrugs. | Pharmacological reviews 20040301 |
| A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasms. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040301 |
| Correspondence re: DC Lev et al., Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy. Mol Cancer Ther, 2003;2(8):753-63. | Molecular cancer therapeutics 20040301 |
| Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease. | Annals of hematology 20040301 |
| Pediatric Hodgkin's disease. | The Journal of the Kentucky Medical Association 20040301 |
| Management of brain metastases in patients with melanoma. | Current opinion in oncology 20040301 |
| Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy. | British journal of cancer 20040223 |
| Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040215 |
| Temozolomide for melanoma: new toxicities and new opportunities. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040215 |
| Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. | British journal of cancer 20040209 |
| Temozolomide in the treatment of recurrent malignant glioma. | Cancer 20040201 |
| Temozolomide in combination with irinotecan for treatment of recurrent malignant glioma. | American journal of clinical oncology 20040201 |
| Second malignancies after chemotherapy and radiotherapy for Hodgkin disease. | American journal of clinical oncology 20040201 |
| Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease. | Annals of oncology : official journal of the European Society for Medical Oncology 20040201 |
| Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20040201 |
| Angiomatoid metastatic melanoma. | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20040201 |
| Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040201 |
| Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040201 |
| Dual repair modulation reverses Temozolomide resistance in vitro. | Molecular cancer therapeutics 20040201 |
| Metastatic malignant melanoma presenting as a cavernous sinus syndrome. | Journal of neurology 20040201 |
| Bony metastases of anaplastic oligodendroglioma respond to temozolomide. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20040201 |
| [Therapy of malignant melanoma at the stage of distant metastasis]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20040201 |
| Temozolomide as prophylaxis for melanoma brain metastases. | Melanoma research 20040201 |
| Second primary breast cancer after Hodgkin's disease. | British journal of cancer 20040126 |
| Apoptosis triggered by DNA damage O6-methylguanine in human lymphocytes requires DNA replication and is mediated by p53 and Fas/CD95/Apo-1. | Oncogene 20040115 |
| Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361. | Journal of the National Cancer Institute 20040107 |
| Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trial. | Blood 20040101 |
| Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101 |
| Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors. | Annals of oncology : official journal of the European Society for Medical Oncology 20040101 |
| What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP? | Current hematology reports 20040101 |
| Uncommon presentations of Hodgkin's disease. Case 2. Hodgkin's disease of the nasopharynx. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101 |
| Uncommon presentations of Hodgkin's disease. Case 3. Hodgkin's disease: rectal presentation. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101 |
| Temozolomide in patients with advanced cancer: phase I and pharmacokinetic study. | Pharmacotherapy 20040101 |
| Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. | Journal of neurosurgery 20040101 |
| Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study. | Neuro-oncology 20040101 |
| Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme. | Neuro-oncology 20040101 |
| A phase II trial of temozolomide and IFN-alpha in patients with advanced renal cell carcinoma. | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20040101 |
| Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients. | Journal of neuro-oncology 20040101 |
| [A case of extra-adrenal pheochromocytoma presenting with lung metastasis]. | Hinyokika kiyo. Acta urologica Japonica 20040101 |
| Temozolomide as first-line agent in treating high-grade gliomas: phase II study. | Journal of neuro-oncology 20040101 |
| Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme. | Journal of neuro-oncology 20040101 |
| The effect of sequential radiochemotherapy in preirradiated malignant gliomas in a phase II study. | Journal of neuro-oncology 20040101 |
| The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies. | Klinische Padiatrie 20040101 |
| [Chemoimmunotherapy with dacarbazine and aranose combined with interferon-alpha in disseminated cutaneous melanoma]. | Voprosy onkologii 20040101 |
| Comparison of viability of B16 and Cl S91 cells in three cytotoxicity tests: cells counting, MTT and flow cytometry after cytostatic drug treatment. | Acta poloniae pharmaceutica 20040101 |
| Effect of association of temozolomide with other chemotherapic agents on cell growth inhibition in glioma cell lines. | Oncology research 20040101 |
| Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20040101 |
| B-Raf specific antibody responses in melanoma patients. | BMC cancer 20040101 |
| Temozolomide treatment in glioma--experiences in two university hospitals in Finland. | Acta oncologica (Stockholm, Sweden) 20040101 |
| Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case report. | BMC cancer 20040101 |
| Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. | Molecular cancer 20040101 |
| [Influence of age on treatment results in children and adolescents with Hodgkin's disease]. | Przeglad lekarski 20040101 |
| [Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications]. | Przeglad lekarski 20040101 |
| Intermediate stage Hodgkin's disease: preliminary results on 210 patients treated with four ABVD chemotherapy cycles plus extended versus involved field radiotherapy. | Anticancer research 20040101 |
| Clinical response following adjuvant Temozolomide in a patient with primary cerebral lymphoma. | Anticancer research 20040101 |
| Dacarbazine. | Report on carcinogens : carcinogen profiles 20040101 |
| A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas. | Cancer 20031215 |
| Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors. | Cancer chemotherapy and pharmacology 20031201 |
| Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients. | Cancer chemotherapy and pharmacology 20031201 |
| Response to low dose temozolomide in radiation induced gliomatosis cerebri. | Medical and pediatric oncology 20031201 |
| Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy. | International journal of radiation oncology, biology, physics 20031201 |
| Promises and controversies in the management of low-grade glioma. | Annals of oncology : official journal of the European Society for Medical Oncology 20031201 |
| Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. | Annals of oncology : official journal of the European Society for Medical Oncology 20031201 |
| Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. | Annals of oncology : official journal of the European Society for Medical Oncology 20031201 |
| Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary. | Expert opinion on pharmacotherapy 20031201 |
| Systemic chemotherapy in the treatment of malignant melanoma. | Expert opinion on pharmacotherapy 20031201 |
| Novel chemotherapeutic agents for the treatment of glioblastoma multiforme. | Expert opinion on investigational drugs 20031201 |
| PET scan assessment of chemotherapy response in metastatic paraganglioma. | American journal of clinical oncology 20031201 |
| Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. | Journal of neurosurgery 20031201 |
| Benefits of adjuvant chemotherapy in high-grade gliomas. | Seminars in oncology 20031201 |
| Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies. | Seminars in oncology 20031201 |
| Should radiotherapy be standard therapy for brain tumors in the elderly? Cons. | Seminars in oncology 20031201 |
| [Hodgkin lymphoma of the nasopharynx associated with a pituitary adenoma]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20031201 |
| New approach in delivering chemotherapy: locoregional treatment for recurrent glioblastoma (rGBM). | Journal of experimental & clinical cancer research : CR 20031201 |
| A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma. | British journal of cancer 20031117 |
| Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. | British journal of cancer 20031103 |
| A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomas. | Mathematical biosciences 20031101 |
| Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis. | Surgical neurology 20031101 |
| A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma. | Cancer 20031101 |
| Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20031101 |
| Correspondence re: M. Provencio, et al. the topoisomerase IIa expression correlates with survival in patients with advanced Hodgkin's lymphoma. Clin. Cancer Res., 9: 1406-1411, 2003. | Clinical cancer research : an official journal of the American Association for Cancer Research 20031101 |
| Temozolomide: realizing the promise and potential. | Current opinion in oncology 20031101 |
| [Pulmonary rhabdomyosarcoma generated during treatment of testicular tumor]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20031101 |
| Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration. | Magnetic resonance imaging 20031101 |
| Bibliography. Current world literature. Therapeutic modalities. | Current opinion in oncology 20031101 |
| O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma. | British journal of cancer 20031020 |
| MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine. | Oncogene 20031016 |
| Spin labeled antioxidants protect bacteria against the toxicity of alkylating antitumor drug CCNU. | Toxicology letters 20031015 |
| Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin. | Neurology 20031014 |
| Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031001 |
| Temozolomide: too early for definitive conclusions. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031001 |
| Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins. | Melanoma research 20031001 |
| Effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on B16-F10 murine melanoma. | Melanoma research 20031001 |
| [Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20031001 |
| The role of chemotherapy in brain metastases. | European journal of cancer (Oxford, England : 1990) 20031001 |
| [Hematologic tumors]. | Gan to kagaku ryoho. Cancer & chemotherapy 20031001 |
| A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme. | International journal of clinical oncology 20031001 |
| Primary malignant melanoma of the oral mucosa. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20031001 |
| [Malignant pheochromocytoma responsive to multimodal therapy: a case report]. | Hinyokika kiyo. Acta urologica Japonica 20031001 |
| Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo. | DNA repair 20030918 |
| Chemotherapy for Hodgkin's disease. | The New England journal of medicine 20030918 |
| Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030915 |
| [Asplenia in the Hodgkin's patient]. | Presse medicale (Paris, France : 1983) 20030906 |
| Repopulating defect of mismatch repair-deficient hematopoietic stem cells. | Blood 20030901 |
| Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide. | British journal of cancer 20030901 |
| Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity. | Cancer 20030901 |
| Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030901 |
| Unusual locations of involvement by malignancies: Case 2. Metastatic pheochromocytoma to the colon. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030901 |
| Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline. | Annals of oncology : official journal of the European Society for Medical Oncology 20030901 |
| TT-232: a somatostatin structural derivative as a potent antitumor drug candidate. | Anti-cancer drugs 20030901 |
| Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030901 |
| Myxoid endometrial stromal sarcoma of the uterus. | Pathology international 20030901 |
| Treatment of early clinically staged Hodgkin's disease with a combination of ABVD chemotherapy plus limited field radiotherapy. | Leukemia & lymphoma 20030901 |
| Treatment of glioblastoma multiforme in the elderly in functionally non-critical areas. Clinical remarks on 22 patients. | Journal of experimental & clinical cancer research : CR 20030901 |
| On the effect of biochemotherapy in metastatic malignant melanoma: an immunopathological evaluation. | Melanoma research 20030801 |
| Primary jejunal malignant melanoma first noticed because of the presence of parotid lymph node metastasis. | Journal of the American Academy of Dermatology 20030801 |
| Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy. | Molecular cancer therapeutics 20030801 |
| Treatment of advanced Hodgkin's disease: EBVD versus intensive brief chemotherapy. | Leukemia & lymphoma 20030801 |
| Hodgkin's disease associated cholestasis in a man with thymoma. | Pathology 20030801 |
| Inhibition of angiogenesis by non-toxic doses of temozolomide. | Anti-cancer drugs 20030801 |
| Recurrent bilateral spontaneous pneumothorax complicating chemotherapy for metastatic sarcoma. | Southern medical journal 20030801 |
| Investing in new technology: the PET experience. | British journal of cancer 20030721 |
| Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas. | British journal of cancer 20030721 |
| Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells. | Blood 20030715 |
| Experimental design and sample size determination for testing synergism in drug combination studies based on uniform measures. | Statistics in medicine 20030715 |
| Has 'MAID' made it in the management of high-risk soft-tissue sarcoma? | International journal of radiation oncology, biology, physics 20030715 |
| Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. | International journal of radiation oncology, biology, physics 20030715 |
| Radiation therapy in the treatment of Hodgkin's disease--do you see what I see? | Journal of the National Cancer Institute 20030702 |
| Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells. | Cancer chemotherapy and pharmacology 20030701 |
| Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030701 |
| Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030701 |
| Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme. | Anti-cancer drugs 20030701 |
| Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. | European journal of cancer (Oxford, England : 1990) 20030701 |
| Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030701 |
| Revascularization for acute coronary occlusion in a young woman following radiation. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20030701 |
| Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center. | Wiener klinische Wochenschrift 20030624 |
| Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615 |
| High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615 |
| Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. | The New England journal of medicine 20030612 |
| Pharmacodynamic-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models. | The Journal of pharmacology and experimental therapeutics 20030601 |
| Spontaneous regression of Hodgkin's disease: two case reports and a review of the literature. | Hematology (Amsterdam, Netherlands) 20030601 |
| Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965). | European journal of cancer (Oxford, England : 1990) 20030601 |
| Phase I-II study on isolation antiblastic fotemustine perfusion after dacarbazine chemosensitization for advanced melanoma of the extremities. | Melanoma research 20030601 |
| Phase II evaluation of temozolomide in metastatic choroidal melanoma. | Melanoma research 20030601 |
| Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model. | The Journal of investigative dermatology 20030601 |
| Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030601 |
| Formation of DNA adducts and induction of lacI mutations in Big Blue Rat-2 cells treated with temozolomide: implications for the treatment of low-grade adult and pediatric brain tumors. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20030601 |
| Mucosal metastases in malignant melanoma. | Onkologie 20030601 |
| Pericardial synovial sarcoma. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20030601 |
| Metabolic activation of temozolomide measured in vivo using positron emission tomography. | Cancer research 20030515 |
| The emerging role of irinotecan (CPT-11) in the treatment of malignant glioma in brain tumors. | Cancer 20030501 |
| Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. | Cancer 20030501 |
| Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma. | European journal of cancer (Oxford, England : 1990) 20030501 |
| Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas. | Journal of pediatric hematology/oncology 20030501 |
| [Malignant melanoma of the alimentary tract]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030501 |
| Phase I. Trial of irinotecan and temozolomide in patients with solid tumors. | Oncology (Williston Park, N.Y.) 20030501 |
| Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma. | Cancer 20030415 |
| Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules. | British journal of cancer 20030407 |
| Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. | Annals of oncology : official journal of the European Society for Medical Oncology 20030401 |
| The management of benign and malignant pheochromocytoma and abdominal paraganglioma. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20030401 |
| Recent developments in the molecular characterization and treatment of oligodendroglial tumors. | Neuro-oncology 20030401 |
| O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030401 |
| Low-dose continuous chemotherapy for metastatic melanoma: a phase II trial. | Melanoma research 20030401 |
| Bilateral spontaneous pneumothorax during cytotoxic chemotherapy for angiosarcoma of the scalp: a case report. | Journal of Korean medical science 20030401 |
| Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor. | Molecular cancer therapeutics 20030401 |
| Bilateral renal artery stenosis after abdominal radiotherapy for Hodgkin's disease. | International journal of clinical practice 20030401 |
| Immunotherapy of malignant melanoma. | The Surgical clinics of North America 20030401 |
| DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system. | Journal of chemotherapy (Florence, Italy) 20030401 |
| Treatment of brain metastases: a short review of current therapies and the emerging role of temozolomide. | Clinical advances in hematology & oncology : H&O 20030401 |
| Interobserver variability in the radiological assessment of response to chemotherapy in glioma. | Neurology 20030311 |
| HIV-related Hodgkin's disease with central nervous system involvement and association with Epstein-Barr virus. | American journal of hematology 20030301 |
| Topical imiquimod in the treatment of metastatic melanoma to skin. | Archives of dermatology 20030301 |
| Metastatic melanoma presenting as cardiac mass and hemobilia. | The American journal of the medical sciences 20030301 |
| Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity. | Journal of neurosurgery 20030301 |
| Antitumor activity of Virulizin, a novel biological response modifier (BRM) in a panel of human pancreatic cancer and melanoma xenografts. | Cancer chemotherapy and pharmacology 20030301 |
| Gastroduodenal metastases in a clear cell sarcoma patient. | Journal of experimental & clinical cancer research : CR 20030301 |
| Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme. | British journal of cancer 20030224 |
| Pharmacokinetic, biochemical and clinical effects of dimethyltriazenoimidazole-4-carboxamide-bischloroethylnitrosourea combination therapy in patients with advanced breast cancer. | International journal of cancer 20030220 |
| Advanced Hodgkin's disease: ABVD is better, yet is not good enough! | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215 |
| Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215 |
| Phase II trial of temozolomide in patients with progressive low-grade glioma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215 |
| Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids. | British journal of cancer 20030210 |
| Increased risk of chronic hepatitis in children with cancer. | Medical and pediatric oncology 20030201 |
| The effect of O6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells to temozolomide, 1,3-bis(2-chloroethyl)1-nitrosourea, and cisplatin. | The Journal of pharmacology and experimental therapeutics 20030201 |
| A prospective study on glioblastoma in the elderly. | Cancer 20030201 |
| Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up. | Annals of oncology : official journal of the European Society for Medical Oncology 20030201 |
| Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study. | Melanoma research 20030201 |
| Effects of interferon-alpha, verapamil and dacarbazine in the treatment of advanced malignant melanoma. | Melanoma research 20030201 |
| Low molecular weight heparin treatment for malignant melanoma: a pilot clinical trial. | Thrombosis and haemostasis 20030201 |
| [Foliculitis in a patient with Hodkins disease]. | Enfermedades infecciosas y microbiologia clinica 20030201 |
| Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates. | Journal of neuro-oncology 20030201 |
| Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results. | Journal of neuro-oncology 20030201 |
| [Relapse of Hodgkin disease after 17 years of complete remission. A case report]. | Revista medica de Chile 20030201 |
| [Effect of bcl-2 antisense oligonucleotides on multidrug resistance of cultured uveal melanoma cells]. | [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20030201 |
| Chemotherapy for malignant pleural mesothelioma: past results and recent developments. | British journal of cancer 20030127 |
| Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma. | British journal of cancer 20030127 |
| Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy. | British journal of cancer 20030127 |
| Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. | Journal of medicinal chemistry 20030116 |
| Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma. | British journal of cancer 20030113 |
| [Treatment of melanoma]. | Presse medicale (Paris, France : 1983) 20030111 |
| Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy. | AIDS (London, England) 20030103 |
| Identification of novel enzyme-prodrug combinations for use in cytochrome P450-based gene therapy for cancer. | Archives of biochemistry and biophysics 20030101 |
| Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor. | Molecular pharmacology 20030101 |
| Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study. | Cancer 20030101 |
| Farnesyl thiosalicylic acid chemosensitizes human melanoma in vivo. | The Journal of investigative dermatology 20030101 |
| [A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030101 |
| Complete remission of metastatic clear cell sarcoma with DAV chemotherapy. | Clinical and experimental dermatology 20030101 |
| Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer. | The oncologist 20030101 |
| Chemotherapy of soft tissue sarcoma--a clinical evaluation of treatment over ten years. | Acta oncologica (Stockholm, Sweden) 20030101 |
| Pharmacokinetics of radiolabelled anticancer drugs for positron emission tomography. | Current pharmaceutical design 20030101 |
| [Hodgkin's disease in pregnancy--case report and literature review]. | Zeitschrift fur Geburtshilfe und Neonatologie 20030101 |
| Biochemotherapy for metastatic melanoma with limited central nervous system involvement. | Oncology 20030101 |
| De novo uterine sarcoma with good response to neo-adjuvant chemotherapy. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101 |
| Trace elements improve survival of DTIC-treated mice with overt liver metastases of Lewis lung carcinoma. | Pathology oncology research : POR 20030101 |
| [Chemotherapy in combination with laser coagulation or interstitial hyperthermia--effective combined therapy for disseminated skin melanoma]. | Voprosy onkologii 20030101 |
| Current chemotherapy for glioblastoma. | Cancer journal (Sudbury, Mass.) 20030101 |
| Survival of patients with recurrent malignant glioma treated with temozolomide: a retrospective observational study. | Drugs in R&D 20030101 |
| Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy. | Health and quality of life outcomes 20030101 |
| [Novel pharmacologic form of ondansetron (Zofran)--lingual tablets in the prevention of cytostatic chemotherapy-induced loss of appetite, nausea and vomiting]. | Voprosy onkologii 20030101 |
| Adjuvant chemotherapy following surgery in the management of uterine sarcomas. | European journal of gynaecological oncology 20030101 |
| Etoposide, vinblastine, adriamycin and prednisolone (EVAP) combination chemotherapy as first-line treatment for Hodgkin's disease. | The National medical journal of India 20030101 |
| Clinicopathologic and molecular features of Hodgkin's lymphoma. | Cancer biology & therapy 20030101 |
| IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC. | Clinical & experimental metastasis 20030101 |
| Pharmacology of oral chemotherapy agents. | Clinical journal of oncology nursing 20030101 |
| Medication sheets for patients. Oral chemotherapy. | Clinical journal of oncology nursing 20030101 |
| Health-related quality of life in patients with advanced metastatic melanoma: results of a randomized phase III study comparing temozolomide with dacarbazine. | Cancer investigation 20030101 |
| Quality of life, at what cost? | Cancer investigation 20030101 |
| Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. | Anticancer research 20030101 |
| High-dose tamoxifen modulates drug resistance to doxorubicin, dacarbazine and ifosfamide in metastatic uterine leiomyosarcoma. | Anticancer research 20030101 |
| Preclinical evaluation of the homo-aza-steroid ester 13beta-hydroxy-13alpha-amino-13,17- seco-5alpha-androstan-17-oic-13,17-lactam-p-bis(2-chloroethyl)aminophenoxy acetate for the treatment of malignant melanoma. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20030101 |
| Fine-needle aspiration of bilateral breast metastases from malignant melanoma: a case report. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20030101 |
| Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001. | Journal of the National Cancer Institute 20021218 |
| An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease. | Cancer 20021215 |
| Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021215 |
| Immunophenotypical markers, ultrastructure and chemosensitivity profile of metastatic melanoma cells. | Cancer letters 20021205 |
| Antitumor imidazotetrazines. 40. Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studies. | Journal of medicinal chemistry 20021205 |
| Antitumor imidazotetrazines. 41. Conjugation of the antitumor agents mitozolomide and temozolomide to peptides and lexitropsins bearing DNA major and minor groove-binding structural motifs. | Journal of medicinal chemistry 20021205 |
| BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens. | Blood 20021201 |
| Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma. | Cancer 20021201 |
| Phase I/II study of sequential chemoimmunotherapy (SCIT) for metastatic melanoma: outpatient treatment with dacarbazine, granulocyte-macrophage colony-stimulating factor, low-dose interleukin-2, and interferon-alpha. | Cancer immunology, immunotherapy : CII 20021201 |
| Ifosfamide, doxorubicin and dacarbazine chemotherapy, and adjunctive laparoscopic cystoprostatectomy and external beam radiotherapy for prostatic embryonal rhabdomyosarcoma. | The Journal of urology 20021201 |
| Combined heart and lung transplantation for unresectable primary cardiac sarcoma. | The Journal of thoracic and cardiovascular surgery 20021201 |
| Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20021201 |
| Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20021201 |
| Developing therapeutic pharmaceuticals for the treatment of soft-tissue sarcomas. | Expert opinion on investigational drugs 20021201 |
| Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20021201 |
| Misleading Ga-67 uptake in a patient with Hodgkin's disease, mediastinal deviation, and pulmonary compression. | Clinical nuclear medicine 20021201 |
| [Construction of an angiostatin eukaryotic expression vector and characterization of its inhibitory efficiency in B16 melanoma bearing mice]. | Shi yan sheng wu xue bao 20021201 |
| [Complete response of cerebral metastasic melanoma after a combined treatment of radiotherapy and temozolomide]. | Medicina clinica 20021130 |
| Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-A/B Multicenter Randomized Trial. | Cancer 20021115 |
| Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure. | Journal of medicinal chemistry 20021107 |
| Biochemotherapy of metastatic malignant melanoma. On down-regulation of CD28. | Cancer immunology, immunotherapy : CII 20021101 |
| Two spin labeled triazenes: relationship between biochemical and biological activities. | International journal of pharmaceutics 20021024 |
| Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. | British journal of cancer 20021007 |
| Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response. | Cancer immunology, immunotherapy : CII 20021001 |
| Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells. | Glia 20021001 |
| Effect of cancer therapy on pituitary-testicular axis. | International journal of andrology 20021001 |
| [Temozolomide as therapeutic option for patients with metastatic melanoma and poor prognosis]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20021001 |
| A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. | Neuro-oncology 20021001 |
| Treatment of leptomeningeal relapse of medulloblastoma with temozolomide. | Journal of pediatric hematology/oncology 20021001 |
| A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20021001 |
| Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience). | Annals of oncology : official journal of the European Society for Medical Oncology 20021001 |
| Chemotherapy for the treatment of metastatic brain tumors. | Expert review of anticancer therapy 20021001 |
| Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study. | American journal of clinical oncology 20021001 |
| Hemorrhagic cystitis as an unexpected adverse reaction to temozolomide: case report. | American journal of clinical oncology 20021001 |
| Systemic chemotherapy for the treatment of metastatic melanoma. | Seminars in oncology 20021001 |
| Metastatic melanoma: chemotherapy. | Seminars in oncology 20021001 |
| The treatment of brain metastases from malignant melanoma. | Seminars in oncology 20021001 |
| Malignant and benign pheochromocytoma: chromaffin granule transmitters and the response to medical and surgical treatment. | Annals of the New York Academy of Sciences 20021001 |
| Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. | The Journal of biological chemistry 20020906 |
| [Endemic celiac sprue and Hodgkin's disease in a 72-year-old patient]. | Deutsche medizinische Wochenschrift (1946) 20020906 |
| Stanford V and radiotherapy for Hodgkin's disease. | Current oncology reports 20020901 |
| Induction of chromosomal aberrations by dacarbazine in somatic and germinal cells of mice. | Mutagenesis 20020901 |
| Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020901 |
| Small-sample inference for incomplete longitudinal data with truncation and censoring in tumor xenograft models. | Biometrics 20020901 |
| Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020901 |
| Base excision repair as a therapeutic target in colon cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020901 |
| Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020901 |
| The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020901 |
| Case report: a patient with primary CNS lymphoma treated with temozolomide to complete response. | Journal of neuro-oncology 20020901 |
| [Pilot study of an alternative CYVADIC + CBDCA protocol for adult soft tissue sarcoma as adjuvant chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20020901 |
| [Concomitant pulmonary nocardiosis and Hodgkin's disease: importance of long-term treatment]. | Revue de pneumologie clinique 20020901 |
| [Hodgkin's disease presenting with progressive liver failure]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20020901 |
| O6-benzylguanine-mediated enhancement of chemotherapy. | Molecular cancer therapeutics 20020901 |
| Use of the photo-micronucleus assay in Chinese hamster V79 cells to study photochemical genotoxicity. | Mutation research 20020826 |
| Cisplatin and dacarbazine with or without subcutaneous interleukin-2 and interferon alfa-2b in advanced melanoma outpatients. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020815 |
| Effect of O6-(4-bromothenyl)guanine on different temozolomide schedules in a human melanoma xenograft model. | International journal of cancer 20020810 |
| Phase I study of temozolomide in relapsed/refractory acute leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020801 |
| Anemia in oncology practice: relation to diseases and their therapies. | American journal of clinical oncology 20020801 |
| Analysis of O(6)-methylguanine-DNA methyltransferase in melanoma tumours in patients treated with dacarbazine-based chemotherapy. | Melanoma research 20020801 |
| Clinical results using biochemotherapy as a standard of care in advanced melanoma. | Melanoma research 20020801 |
| Successful palliation of stenosing anorectal melanoma by intratumoral injections with natural interferon-beta. | Melanoma research 20020801 |
| Multifaceted resistance of gliomas to temozolomide. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020801 |
| A phase II trial of oral temozolomide in patients with metastatic renal cell cancer. | Cancer chemotherapy and pharmacology 20020801 |
| Role of endothelin-1 in the development of a special type of cardiomyopathy. | Clinical science (London, England : 1979) 20020801 |
| Causative agent of vascular pain among photodegradation products of dacarbazine. | The Journal of pharmacy and pharmacology 20020801 |
| Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy. | Cancer 20020801 |
| [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20020801 |
| [Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma]. | Ai zheng = Aizheng = Chinese journal of cancer 20020801 |
| [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen]. | Ai zheng = Aizheng = Chinese journal of cancer 20020801 |
| Treatment of newly diagnosed glioblastoma multiforme. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020715 |
| Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020715 |
| Stability of dacarbazine in amber glass vials and polyvinyl chloride bags. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020715 |
| [Acquired ichthyosis disclosing Hodgkin's disease. Simultaneous recurrence]. | Presse medicale (Paris, France : 1983) 20020713 |
| Pharmacological strategies to increase the antitumor activity of methylating agents. | Current medicinal chemistry 20020701 |
| Temozolomide-induced flare in high-grade gliomas: a new clinical entity. | Internal medicine journal 20020701 |
| Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation. | British journal of haematology 20020701 |
| Hodgkin's disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony- stimulating factor. | Annals of oncology : official journal of the European Society for Medical Oncology 20020701 |
| Prognostic impact of chromosomal aberrations in Ewing tumours. | British journal of cancer 20020605 |
| Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours. | British journal of cancer 20020605 |
| Temozolomide plus thalidomide in patients with advanced melanoma: results of a dose-finding trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020601 |
| Phase II study of paclitaxel and carboplatin for malignant melanoma. | American journal of clinical oncology 20020601 |
| [Experiences with therapy of stage IV metastatic malignant melanoma with 'Legha Protocol' polychemoimmunotherapy]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20020601 |
| Salvage chemotherapy for advanced sarcoma patients: a single-institution experience survey. | Journal of experimental & clinical cancer research : CR 20020601 |
| Extreme drug resistance in primary brain tumors: in vitro analysis of 64 resection specimens. | Journal of neuro-oncology 20020601 |
| First-line therapy with temozolomide induces regression of primary CNS lymphoma. | Neurology 20020528 |
| [Treatment of recidive malignant gliomas with temozolomide]. | Orvosi hetilap 20020526 |
| Biochemotherapy for advanced melanoma: maybe it is real. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020515 |
| Clinical relevance of MGMT in the treatment of cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020501 |
| Thymosin alpha1. SciClone Pharmaceuticals. | Current opinion in investigational drugs (London, England : 2000) 20020501 |
| Temozolomide as second-line chemotherapy for relapsed gliomas. | Journal of neuro-oncology 20020501 |
| Perspectives in melanoma treatment with signal transduction. | Current medicinal chemistry. Anti-cancer agents 20020501 |
| Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020415 |
| Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency. | Thrombosis research 20020415 |
| A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use. | British journal of cancer 20020408 |
| Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine). | Cancer chemotherapy and pharmacology 20020401 |
| Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. | Melanoma research 20020401 |
| Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. | Journal of cancer research and clinical oncology 20020401 |
| A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma. | European journal of cancer (Oxford, England : 1990) 20020401 |
| Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. | Biochemical pharmacology 20020401 |
| Synthesis and antibacterial activity of dual-action agents of a beta-lactam antibiotic with cytotoxic agent mitozolomide or temozolomide. | European journal of medicinal chemistry 20020401 |
| [A case of Hodgkin's disease of mesenteric origin]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20020401 |
| [A case of leiomyosarcoma of the spermatic cord]. | Hinyokika kiyo. Acta urologica Japonica 20020401 |
| Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours. | Annals of oncology : official journal of the European Society for Medical Oncology 20020401 |
| Unusual presentation of Hodgkin's lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20020401 |
| Interdigitating dendritic cell sarcoma: a rare malignancy responsive to ABVD chemotherapy. | Leukemia & lymphoma 20020401 |
| The use of temozolomide in recurrent malignant gliomas. | Cancer treatment reviews 20020401 |
| Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site. | Blood 20020315 |
| Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315 |
| Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase. | Cancer research 20020315 |
| CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020301 |
| Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020301 |
| Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020301 |
| Renal Hodgkin's disease. | British journal of haematology 20020301 |
| Approach to Hodgkin's lymphoma in the new millennium. | Hematological oncology 20020301 |
| NICE verdict on Temozolomide: where next? | British journal of cancer 20020212 |
| A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma. | British journal of cancer 20020212 |
| High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. | International journal of cancer 20020201 |
| Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201 |
| Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study. | Melanoma research 20020201 |
| BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020201 |
| Technology evaluation: Allovectin-7, Vical. | Current opinion in molecular therapeutics 20020201 |
| The role of glucocorticoids in the treatment of fulminant hepatitis induced by dacarbazine. | Anti-cancer drugs 20020201 |
| Is there a standard for the palliative treatment of melanoma? | Onkologie 20020201 |
| [Ewing's sarcoma of the ethmoid bone. Case report]. | Neuro-Chirurgie 20020201 |
| Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM). | British journal of cancer 20020121 |
| Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020115 |
| Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020115 |
| A phase II study of neoadjuvant biochemotherapy for stage III melanoma. | Cancer 20020115 |
| A phase II study of extended low-dose temozolomide in recurrent malignant gliomas. | Neuro-oncology 20020101 |
| Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease. | Annals of hematology 20020101 |
| Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine. | Cancer 20020101 |
| Cell killing of melanoma B16 in vivo by hyperthermia and cytotoxins. | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20020101 |
| Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma. | American journal of surgery 20020101 |
| Leiomyosarcoma of the sinonasal tract: a case report and literature review. | American journal of otolaryngology 20020101 |
| [An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20020101 |
| Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer. | Drugs & aging 20020101 |
| [Use of local magnitothermia in the treatment of patients with primary-confined skin melanoma]. | Likars'ka sprava 20020101 |
| Treatment of elderly Hodgkin's lymphoma patients. The experience of the Italian Lymphoma Intergroup. | Tumori 20020101 |
| Temozolomide in glioblastoma multiforme of the elderly. | Tumori 20020101 |
| Combined radiotherapy and temozolomide in patients with recurrent high grade glioma. | Tumori 20020101 |
| Phase II trial of Paclitaxel and Dacarbazine with filgrastim administration in advanced malignant melanoma. | Cancer investigation 20020101 |
| Tumour cytochrome P450 and drug activation. | Current pharmaceutical design 20020101 |
| A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha. | In vivo (Athens, Greece) 20020101 |
| ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20020101 |
| Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704. | Annals of oncology : official journal of the European Society for Medical Oncology 20020101 |
| Concomitant radiotherapy and metronomic temozolomide in pediatric high-risk brain tumors. | Neoplasma 20020101 |
| Malignant melanoma of the anorectum: report of four cases. | Surgery today 20020101 |
| Current concepts in the management of patients with melanoma. | American journal of clinical dermatology 20020101 |
| Immunohistochemical analysis of DNA mismatch repair protein and O6-methylguanine-DNA methyltransferase in melanoma metastases in relation to clinical response to DTIC-based chemotherapy. | Oncology reports 20020101 |
| Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study. | Oncology 20020101 |
| Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas. | Cancer investigation 20020101 |
| [Cured from Hodgkin's disease]. | Bulletin du cancer 20020101 |
| Temozolomide in second-line treatment after prior nitrosurea-based chemotherapy in glioblastoma multiforme: experience from a Portuguese institution. | International journal of clinical pharmacology research 20020101 |
| Anorectal melanoma: successful treatment by surgical excision and combination chemoimmunotherapy. | Hepato-gastroenterology 20020101 |
| Radiotherapy alone for lymphocyte-predominant Hodgkin's disease. | Cancer journal (Sudbury, Mass.) 20020101 |
| Docetaxel in combination with dacarbazine in patients with advanced melanoma. | Oncology 20020101 |
| Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for gynecological sarcomas. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20020101 |
| Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20020101 |
| [High-dose chemotherapy with autologous bone marrow transplantation in children with high-risk malignant neoformations]. | Voprosy onkologii 20020101 |
| [Treatment of anaplastic astrocytomas and glioblastomas in children by the use of temozolomide (TMZ)]. | Voprosy onkologii 20020101 |
| Combined liver and pancreas resection with biochemotherapy for metastatic ocular melanoma. | Journal of hepato-biliary-pancreatic surgery 20020101 |
| Parathyroid carcinoma: difficult management options. | Indian journal of cancer 20020101 |
| Dacarbazine. | Report on carcinogens : carcinogen profiles 20020101 |
| [Correlation between functional capability and phenotypic characteristics of peripheral blood lymphocytes in patients with malignant melanoma]. | Glas. Srpska akademija nauka i umetnosti. Odeljenje medicinskih nauka 20020101 |
| Role of cytochrome P450 isoenzymes in metabolism of O(6)-benzylguanine: implications for dacarbazine activation. | Clinical cancer research : an official journal of the American Association for Cancer Research 20011201 |
| Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. | Clinical lymphoma 20011201 |
| A case of pelvic malignant paraganglioma. | International journal of urology : official journal of the Japanese Urological Association 20011201 |
| Brain metastases from fallopian tube carcinoma responsive to intra-arterial carboplatin and intravenous etoposide: a case report. | Journal of neuro-oncology 20011201 |
| Adults with newly diagnosed high-grade gliomas. | Current treatment options in oncology 20011201 |
| Possible efficacy of temozolomide in a patient with gliomatosis cerebri. | Neurology 20011127 |
| Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. | Blood 20011115 |
| Adjuvant therapy of malignant melanoma: is there a choice? | Critical reviews in oncology/hematology 20011101 |
| Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial. | British journal of cancer 20011101 |
| Primary malignant melanoma of the pharynx. | The Journal of laryngology and otology 20011101 |
| A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation. | Bone marrow transplantation 20011101 |
| Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma. | Cancer 20011015 |
| Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. | Neuro-oncology 20011001 |
| Treatment of metastatic melanoma in the brain with temozolomide and thalidomide. | The Lancet. Oncology 20011001 |
| Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors. | Diseases of the colon and rectum 20010901 |
| Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma. | Cancer gene therapy 20010901 |
| [High-dose chemotherapy in soft tissue sarcomas of adults]. | Bulletin du cancer 20010901 |
| ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease. | Annals of oncology : official journal of the European Society for Medical Oncology 20010901 |
| Current and future developments in the use of temozolomide for the treatment of brain tumours. | The Lancet. Oncology 20010901 |
| Treatment of brain metastases of malignant melanoma with temozolomide. | The New England journal of medicine 20010823 |
| Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU. | International journal of oncology 20010801 |
| Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells. | Cancer research 20010801 |
| Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients. | Melanoma research 20010801 |
| Temozolomide: the effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O(6)-alkylguanine-DNA-alkyltransferase. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010801 |
| High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma. | Cancer 20010801 |
| Primary malignant melanoma in ovarian cystic teratoma. | Gynecologic oncology 20010801 |
| Melanoma-associated retinopathy: does autoimmunity prolong survival? | Clinical & experimental ophthalmology 20010801 |
| Temozolomide for recurrent high-grade glioma. | Seminars in oncology 20010801 |
| Chemotherapy for the treatment of oligodendroglial tumors. | Seminars in oncology 20010801 |
| New approaches for temozolomide therapy: use in newly diagnosed glioma. | Seminars in oncology 20010801 |
| Temozolomide in combination with other cytotoxic agents. | Seminars in oncology 20010801 |
| Temozolomide for treating brain metastases. | Seminars in oncology 20010801 |
| Future directions for temozolomide therapy. | Seminars in oncology 20010801 |
| Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. | Annals of oncology : official journal of the European Society for Medical Oncology 20010801 |
| Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20010801 |
| Angiosarcoma of vagina successfully treated with interleukin-2 therapy and chemotherapy: a case report. | The journal of obstetrics and gynaecology research 20010801 |
| Temozolomide chemotherapy in recurrent oligodendroglioma. | Neurology 20010724 |
| Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. | Cancer research 20010715 |
| Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010701 |
| An Australian experience with temozolomide for the treatment of recurrent high grade gliomas. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20010701 |
| [Low dose CVD chemotherapy as a tumor dormancy therapy for extra-adrenal malignant pheochromocytoma: a case report]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20010701 |
| Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones. | European journal of haematology 20010701 |
| The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease. | Leukemia & lymphoma 20010701 |
| A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. | Journal of neuro-oncology 20010701 |
| [Chemotherapy in gastroenterologic neuroendocrine tumors]. | Recenti progressi in medicina 20010601 |
| True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms. | British journal of haematology 20010601 |
| Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model. | Melanoma research 20010601 |
| Prognostic factors in therapeutic lymphadenectomy in melanoma. | Melanoma research 20010601 |
| Necrosis in melanoma metastases with treatment. | Annals of oncology : official journal of the European Society for Medical Oncology 20010601 |
| 37th Annual American Society of Clinical Oncology Meeting. San Francisco, CA. May 12-15, 2001. | Clinical lymphoma 20010601 |
| Metastatic melanoma. | Current treatment options in oncology 20010601 |
| Temozolomide: a novel oral alkylating agent. | Expert review of anticancer therapy 20010601 |
| Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice. | Cancer research 20010515 |
| Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells. | Mutation research 20010510 |
| Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501 |
| Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells. | Cell death and differentiation 20010501 |
| Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide. | Journal of chromatography. B, Biomedical sciences and applications 20010415 |
| [The chemotherapeutic treatment of advanced Hodgkin's disease]. | Harefuah 20010401 |
| Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). | British journal of cancer 20010401 |
| Dacarbazine-induced carotid artery and deep venous thrombosis in a patient with leiomyosarcoma: case report. | Journal of chemotherapy (Florence, Italy) 20010401 |
| Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients. | Melanoma research 20010401 |
| Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components. | Cancer chemotherapy and pharmacology 20010401 |
| Secondary prophylactic G-CSF (filgrastim) administration in chemotherapy of stage I and II Hodgkin's lymphoma with ABVD. | Leukemia & lymphoma 20010401 |
| [Dacarbazine]. | Annales de dermatologie et de venereologie 20010401 |
| [Gastric adenocarcinoma secondary to Hodgkin's disease treatment]. | La Tunisie medicale 20010401 |
| [Treatment of metastasized malignant melanoma]. | Praxis 20010308 |
| Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: a novel tumor targeting strategy. | The Journal of pharmacology and experimental therapeutics 20010301 |
| Primary Epstein-Barr virus-associated Hodgkin disease of the ileum complicating Crohn disease. | Archives of pathology & laboratory medicine 20010301 |
| The vanishing bile duct syndrome in a child with Hodgkin disease. | Medical and pediatric oncology 20010301 |
| Metastatic osteosarcoma to the liver after treatment for synovial sarcoma: a case report. | Pediatric hematology and oncology 20010301 |
| Development and application of a sensitive and rapid immunoassay for the quantitation of N7-methyldeoxyguanosine in DNA samples. | Chemical research in toxicology 20010301 |
| p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. | Cancer research 20010301 |
| Immunoglobulin D myeloma presenting as an extraosseous soft tissue tumor. | Skeletal radiology 20010301 |
| Atypical teratoid/rhabdoid tumors in adult patients: case report and review of the literature. | Journal of neuro-oncology 20010301 |
| [Adjuvant therapy of malignant melanoma]. | Praxis 20010222 |
| Treatment of mandibular malignant fibrous histiocytoma during pregnancy. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20010201 |
| Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010201 |
| Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials. | Melanoma research 20010201 |
| Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. | Annals of oncology : official journal of the European Society for Medical Oncology 20010201 |
| Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20010201 |
| Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. | Annals of oncology : official journal of the European Society for Medical Oncology 20010201 |
| Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: case report and review of the literature. | Annals of oncology : official journal of the European Society for Medical Oncology 20010201 |
| Spin labelled nitrosoureas and triazenes and their non-labelled clinically used analogues--a comparative study on their physicochemical properties and antimelanomic effects. | International journal of pharmaceutics 20010116 |
| Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector. | Molecular therapy : the journal of the American Society of Gene Therapy 20010101 |
| Radiotherapy of esthesioneuroblastoma. | International journal of radiation oncology, biology, physics 20010101 |
| Repeatable acute rhabdomyolysis with multiple organ dysfunction because of interferon alpha and dacarbazine treatment in metastatic melanoma. | The British journal of dermatology 20010101 |
| Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease. | European journal of haematology 20010101 |
| Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1-, GLP-2- and PYY-producing neuroendocrine carcinoma. | Digestion 20010101 |
| Hodgkin's disease: clinical presentation and treatment. | Cancer treatment and research 20010101 |
| High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma. | Journal of pharmaceutical and biomedical analysis 20010101 |
| Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report. | Journal of periodontology 20010101 |
| Treatment of advanced stage Hodgkin's disease. | Oncology 20010101 |
| Clinical management of malignant adrenal tumors. | Journal of cancer research and clinical oncology 20010101 |
| Treatment of classical type Kaposi's sarcoma with paclitaxel. | Anticancer research 20010101 |
| Technetium-99m-tetrofosmin scintigraphy in the prediction of chemotherapy response of untreated malignant lymphomas and comparison with other prognostic factors. | Anticancer research 20010101 |
| The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review. | Health technology assessment (Winchester, England) 20010101 |
| Anaplastic large-cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL-6 serum levels after long-term immunosuppressive therapy. | American journal of hematology 20010101 |
| Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856. | Cancer investigation 20010101 |
| Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma. | Medical and pediatric oncology 20010101 |
| Ovarian fibrosarcoma with long-term survival: a case report. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101 |
| Late recurrence of a primitive neuro-ectodermal tumor. | Oncology 20010101 |
| Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha. | Neoplasma 20010101 |
| [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV]. | La Clinica terapeutica 20010101 |
| A feasibility study using polychemotherapy (cisplatin + vindesine + dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanoma. | Tumori 20010101 |
| [Clinical evaluation of the efficacy of modern first, second, and third line regimes of chemotherapy in patients with disseminated cutaneous melanoma]. | Voprosy onkologii 20010101 |
| Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma. | Anticancer research 20010101 |
| Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice. | Journal of cellular biochemistry 20010101 |
| Intraarterial chemotherapy of malignant melanoma metastatic to the liver. | Hepato-gastroenterology 20010101 |
| Daily general anaesthesia for radiotherapy in unco-operative patients: ingredients for successful management. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101 |
| Prospective randomized comparison of dacarbazine (DTIC) versus DTIC plus interferon-alpha (IFN-alpha) in metastatic melanoma. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101 |
| Radiation recall dermatitis in a patient treated with dacarbazine. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101 |
| Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20010101 |
| Communication challenges in a young man with Hodgkin's disease. | Cancer practice 20010101 |
| Temozolomide (Temodar). | Clinical journal of oncology nursing 20010101 |
| Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures: a single-center study. | Medical oncology (Northwood, London, England) 20010101 |
| Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression. | The Journal of clinical endocrinology and metabolism |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.